No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, d3gw9B_, 1.0000, 0.00, 1.000, 449, 449, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
2, d4g3jB_, 0.9971, 0.19, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
3, d3gw9D_, 0.9955, 0.52, 1.000, 449, 449, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
4, d3g1qA_, 0.9952, 0.39, 1.000, 448, 448, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
5, d4g7gA_, 0.9950, 0.40, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
6, d4g3jC_, 0.9934, 0.51, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
7, d4g7gD_, 0.9928, 0.55, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
8, d4g7gC_, 0.9927, 0.55, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
9, d3g1qD_, 0.9922, 0.59, 1.000, 448, 448, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
10, d3gw9A_, 0.9920, 0.70, 1.000, 450, 449, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
11, d4g3jD_, 0.9909, 0.70, 1.000, 450, 449, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
12, d3tikD1, 0.9902, 0.64, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
13, d4g7gB_, 0.9900, 0.44, 1.000, 446, 446, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(34 -DIFLUOROBIPHENYL-4-YL)-2-(1H- IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [VNI/VNF (VFV)]
14, d3tikC1, 0.9894, 0.68, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
15, d3p99D_, 0.9887, 0.48, 1.000, 446, 446, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
16, d4g3jA_, 0.9883, 0.73, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE VNI DERIVATIVE (R)-N-(1-(24-DICHLOROPHENYL)-2-(1H-124- TRIAZOL-1-YL)ETHYL)-4-(5-PHENYL-134-OXADIAZOL-2-YL)BENZAMIDE [R- VNI-TRIAZOLE (VNT)]
17, d3p99A_, 0.9883, 0.76, 1.000, 448, 448, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
18, d3tikA1, 0.9879, 0.74, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
19, d3gw9C_, 0.9877, 0.57, 1.000, 446, 446, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI BOUND TO AN INHIBITOR N-(1-(24- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-PHENYL-13 4-OXAZIAZOL-2-YL)BENZAMIDE
20, d3p99B_, 0.9862, 1.02, 1.000, 449, 449, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
21, d3tikB1, 0.9851, 0.83, 1.000, 448, 448, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH THE TIPIFARNIB DERIVATIVE 6-((4-CHLOROPHENYL)(METHOXY)(1-METHYL- 1H-IMIDAZOL-5-YL)METHYL)-4-(26-DIFLUOROPHENYL)-1-METHYLQUINOLIN- 2(1H)-ONE
22, d3g1qC_, 0.9830, 0.77, 1.000, 446, 446, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
23, d2x2nA_, 0.9822, 0.70, 1.000, 447, 445, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
24, d4bjkC1, 0.9821, 0.92, 0.987, 448, 447, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
25, d4bjkA1, 0.9807, 0.84, 0.991, 447, 446, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
26, d3p99C_, 0.9807, 0.91, 0.991, 447, 446, STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH DELTA7-14ALPHA-METHYLENE-CYCLOPROPYL-DIHYDROLANOSTEROL
27, d3zg2A_, 0.9796, 0.71, 1.000, 444, 444, STEROL 14 ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR (S)-2-(4-CHLOROPHENYL)-2- (PYRIDIN-3-YL)-1-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL) ETHANONE (EPL-BS1246UDO)
28, d3g1qB_, 0.9796, 1.01, 0.850, 449, 447, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA BRUCEI IN LIGAND FREE STATE
29, d2wv2A_, 0.9783, 0.74, 1.000, 444, 444, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA BRUCEI IN COMPLEX WITH FLUCONAZOLE
30, d2x2nD_, 0.9781, 0.73, 0.995, 443, 443, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
31, d4ck8A1, 0.9779, 1.07, 0.987, 447, 447, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
32, d4ck8B1, 0.9775, 0.92, 0.852, 446, 445, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (R)-1-(24-DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL 4-(4-(34-DICHLOROPHENYL)PIPERAZIN-1-YL)PHENYLCARBAMATE (LFD)
33, d4bjkB1, 0.9768, 0.95, 0.852, 446, 445, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
34, d2x2nB_, 0.9742, 1.06, 0.991, 447, 446, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
35, d5ajrA1, 0.9738, 0.97, 0.989, 444, 444, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE 1-TETRAZOLE DERIVATIVE VT-1161 ((R)-2-( 24-DIFLUOROPHENYL)-11-DIFLUORO-3-(1H-TETRAZOL-1-YL)-1-(5- (4-(222-TRIFLUOROETHOXY)PHENYL)PYRIDIN-2-YL)PROPAN-2-OL)
36, d3zg3A_, 0.9705, 1.07, 0.852, 446, 445, STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE PYRIDINE INHIBITOR N-(1-(5-( TRIFLUOROMETHYL)(PYRIDIN-2-YL))PIPERIDIN-4YL)-N-(4-( TRIFLUOROMETHYL)PHENYL)PYRIDIN-3-AMINE (EPL-BS967 UDD)
37, d4c27A_, 0.9671, 1.14, 0.851, 445, 444, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
38, d4c28A_, 0.9670, 1.36, 0.856, 444, 443, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
39, d3l4dA1, 0.9670, 1.37, 0.856, 443, 443, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
40, d2x2nC_, 0.9668, 1.24, 0.788, 445, 444, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA BRUCEI IN COMPLEX WITH POSACONAZOLE IN TWO DIFFERENT CONFORMATIONS
41, d2wuzA_, 0.9667, 0.99, 0.991, 441, 441, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
42, d4bmmD1, 0.9658, 1.07, 0.853, 444, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
43, d4bmmB1, 0.9658, 0.96, 0.859, 440, 440, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
44, d4bmmA1, 0.9658, 0.95, 0.861, 440, 440, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
45, d4c0cA1, 0.9657, 0.87, 0.861, 439, 439, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(24-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
46, d4c27B_, 0.9655, 1.10, 0.860, 443, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-2- FLUORO-4-(4-(4-(TRIFLUOROMETHYL)PHENYL)PIPERAZIN-1-YL)BENZAMIDE
47, d4by0A1, 0.9649, 1.32, 0.857, 443, 442, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
48, d3k1oA_, 0.9649, 0.93, 0.861, 439, 439, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH A POTENTIAL ANTICHAGASIC DRUG POSACONAZOLE
49, d4bjkD1, 0.9647, 1.17, 0.855, 442, 442, CYP51 OF TRYPANOSOMA BRUCEI BOUND TO (S)-N-(3-(1H-INDOL-3- YL)-1-OXO-1-(PYRIDIN-4-YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-( 11 -BIPHENYL)-4-CARBOXAMIDE
50, d3l4dB1, 0.9645, 1.00, 0.993, 441, 440, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
51, d4by0B1, 0.9644, 1.30, 0.788, 445, 444, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-33 -DIFLUORO-(11 -BIPHENYL)-4- CARBOXAMIDE
52, d4c28B_, 0.9637, 1.02, 0.859, 440, 440, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(4-CHLOROPHENYL)PIPERAZIN-1-YL)- 2-FLUOROBENZAMIDE.
53, d2wuzB_, 0.9635, 1.31, 0.855, 441, 441, X-RAY STRUCTURE OF CYP51 FROM TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE IN ALTERNATIVE CONFORMATION
54, d3l4dC1, 0.9621, 1.03, 0.855, 444, 440, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
55, d4uqhA1, 0.9608, 1.32, 0.790, 444, 443, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)-4-(4-(34-DIFLUOROPHENYL)PIPERAZIN-1- YL)-2-FLUOROBENZAMIDE.
56, d4bmmC1, 0.9597, 1.05, 0.861, 439, 439, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE INHIBITOR (R)-N-(3-(1H-INDOL-3-YL)-1-OXO-1-(PYRIDIN-4- YLAMINO)PROPAN-2-YL)- 2 35 -TRIFLUORO-(11 -BIPHENYL)-4-CARBOXAMIDE
57, d3l4dD1, 0.9597, 1.01, 0.861, 438, 438, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM LEISHMANIA INFANTUM IN COMPLEX WITH FLUCONAZOLE
58, d4cohB_, 0.9572, 1.15, 0.791, 441, 440, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
59, d4uvrA1, 0.9564, 1.64, 0.855, 445, 442, BINDING MODE SELECTIVITY AND POTENCY OF N-INDOLYL- OXOPYRIDINYL-4-AMINO-PROPANYL-BASED INHIBITORS TARGETING TRYPANOSOMA CRUZI CYP51
60, d4cohA_, 0.9564, 0.98, 0.860, 436, 436, CRYSTAL STRUCTURE OF TRYPANOSOMA CRUZI CYP51 BOUND TO THE SULFONAMIDE DERIVATIVE OF THE 4-AMINOPYRIDYL-BASED INHIBITOR
61, d4h6oA1, 0.9525, 1.61, 0.857, 442, 441, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH THE INHIBITOR NEU321 (1-(3-(4-CHLORO-35-DIMETHYLPHENOXY) BENZYL)-1H-IMIDAZOLE
62, d3khmA_, 0.9502, 0.95, 0.859, 434, 434, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH INHIBITOR FLUCONAZOLE
63, d4ckaA1, 0.9478, 1.07, 0.853, 441, 434, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-FLUOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFS)
64, d4ck9A1, 0.9469, 0.88, 0.863, 431, 431, STEROL 14-ALPHA DEMETHYLASE (CYP51)FROM TRYPANOSOMA CRUZI IN COMPLEX WITH (S)-1-(4-CHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL) ETHYL 4-ISOPROPYLPHENYLCARBAMATE (LFT)
65, d3kswA_, 0.9458, 0.91, 0.863, 431, 431, CRYSTAL STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) FROM TRYPANOSOMA CRUZI IN COMPLEX WITH AN INHIBITOR VNF ((4-(4- CHLOROPHENYL)-N-[2-(1H-IMIDAZOL-1-YL)-1-PHENYLETHYL]BENZAMIDE)
66, d2wx2A_, 0.9312, 1.71, 0.849, 444, 444, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
67, d2wx2B1, 0.9181, 1.47, 0.819, 441, 432, X-RAY STRUCTURE OF CYP51 FROM THE HUMAN PATHOGEN TRYPANOSOMA CRUZI IN COMPLEX WITH FLUCONAZOLE
68, d3jusB_, 0.9155, 1.86, 0.810, 440, 432, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
69, d3jusA_, 0.9150, 1.89, 0.341, 445, 434, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH ECONAZOLE
70, d3i3kA_, 0.9127, 1.90, 0.341, 445, 434,  
71, d3ld6A_, 0.9126, 1.96, 0.341, 445, 434, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
72, d3ld6B_, 0.9124, 1.96, 0.341, 445, 434, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51) IN COMPLEX WITH KETOCONAZOLE
73, d3i3kB_, 0.9124, 1.92, 0.342, 444, 433,  
74, d4uhlH1, 0.9098, 1.92, 0.342, 444, 433, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
75, d4uhlD1, 0.9091, 1.89, 0.341, 442, 431, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
76, d3juvA_, 0.9084, 1.91, 0.341, 442, 431, CRYSTAL STRUCTURE OF HUMAN LANOSTEROL 14ALPHA-DEMETHYLASE (CYP51)
77, d4uhiD_, 0.9079, 2.05, 0.333, 448, 433, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
78, d4uhiB_, 0.9077, 2.05, 0.333, 448, 433, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
79, d4uhlC1, 0.9075, 1.89, 0.333, 442, 430, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
80, d4uhlG1, 0.9074, 1.88, 0.335, 442, 430, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
81, d6ay4A1, 0.9061, 1.94, 0.341, 442, 431, NAEGLERIA FOWLERI CYP51-FLUCONAZOLE COMPLEX
82, d4uhlA1, 0.9061, 1.89, 0.335, 442, 430, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
83, d4uhiA_, 0.9060, 2.07, 0.354, 448, 432, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
84, d4uhlE1, 0.9056, 2.07, 0.354, 448, 432, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
85, d4uhlB1, 0.9050, 1.91, 0.335, 442, 430, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
86, d6aycA1, 0.9048, 1.98, 0.341, 442, 431, NAEGLERIA FOWLERI CYP51-ITRACONAZOLE COMPLEX
87, d6ay6A1, 0.9048, 1.99, 0.341, 442, 431, NAEGLERIA FOWLERI CYP51-VORICONAZOLE COMPLEX
88, d4uhiC_, 0.9043, 1.99, 0.341, 442, 431, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN C121 SPACE GROUP
89, d4uhlF1, 0.9038, 2.10, 0.356, 447, 432, HUMAN STEROL 14-ALPHA DEMETHYLASE (CYP51) IN COMPLEX WITH VFV IN P1 SPACE GROUP
90, d5frbA1, 0.9018, 2.05, 0.357, 446, 431, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH A TETRAZOLE-BASED INHIBITOR VT-1598
91, p5eagA_, 0.9018, 2.00, 0.343, 442, 431, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR PROCHLORAZ
92, p6cr2B_, 0.9005, 1.97, 0.333, 442, 430, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
93, d6aybA1, 0.9003, 2.30, 0.306, 469, 435, NAEGLERIA FOWLERI CYP51-KETOCONAZOLE COMPLEX
94, d5tl8A1, 0.9001, 2.35, 0.289, 497, 436, NAEGLERIA FOWLERI CYP51-POSACONAZOLE COMPLEX
95, p5eqbA_, 0.8999, 2.33, 0.301, 469, 435, CRYSTAL STRUCTURE OF LANOSTEROL 14-ALPHA DEMETHYLASE WITH INTACT TRANSMEMBRANE DOMAIN BOUND TO ITRACONAZOLE
96, p5jlcA_, 0.8997, 2.10, 0.358, 445, 430, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA GLABRATA
97, p5esnA_, 0.8996, 2.10, 0.358, 446, 430, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT STRUCTURE
98, p5esiA_, 0.8996, 2.50, 0.288, 499, 438, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT
99, p4ze0A_, 0.8995, 2.50, 0.288, 499, 438, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH VORICONAZOLE
100, d4uymA1, 0.8995, 2.39, 0.289, 487, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
101, p4lxjA_, 0.8995, 2.42, 0.286, 497, 437, SACCHAROMYCES CEREVISIAE LANOSTEROL 14-ALPHA DEMETHYLASE WITH LANOSTEROL BOUND
102, p5esmA_, 0.8994, 2.41, 0.286, 498, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH FLUCONAZOLE
103, p5eabA_, 0.8994, 2.39, 0.287, 498, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-TEBUCONAZOLE
104, d4uylA1, 0.8994, 2.34, 0.306, 469, 435, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
105, p6cr2A_, 0.8993, 2.42, 0.288, 498, 437, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM ASPERGILLUS FUMIGATUS IN COMPLEX WITH THE VNI DERIVATIVE N-(1-(2;4- DICHLOROPHENYL)-2-(1H-IMIDAZOL-1-YL)ETHYL)-4-(5-(2-FLUORO-4-(2;2;2- TRIFLUOROETHOXY)PHENYL)-1;3;4-OXADIAZOL-2-YL)BENZAMIDE 
106, p5eafB_, 0.8992, 2.40, 0.287, 497, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
107, p5eafA_, 0.8992, 2.39, 0.289, 495, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR FLUQUINCONAZOLE
108, p5eslA_, 0.8990, 2.37, 0.303, 469, 435, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) T322I MUTANT COMPLEXED WITH ITRACONAZOLE
109, p5eaeA_, 0.8989, 2.34, 0.303, 469, 435, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-DESTHIO-PROTHIOCONAZOLE
110, p5eahA_, 0.8988, 2.40, 0.287, 497, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR DIFENOCONAZOLE
111, p4zdyA_, 0.8987, 2.40, 0.287, 498, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH ITRACONAZOLE
112, p4zdzA_, 0.8986, 2.40, 0.287, 497, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140F MUTANT COMPLEXED WITH FLUCONAZOLE
113, p5esfA_, 0.8985, 2.40, 0.289, 498, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH FLUCONAZOLE
114, d4uymB1, 0.8985, 2.40, 0.289, 497, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VORICONAZOLE
115, p5tz1A_, 0.8983, 2.41, 0.287, 497, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
116, p5esjA_, 0.8981, 2.44, 0.286, 497, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH FLUCONAZOLE
117, p5eacA_, 0.8981, 2.43, 0.287, 493, 436, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR R-TEBUCONAZOLE
118, p5hs1A_, 0.8978, 2.35, 0.306, 469, 435, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) COMPLEXED WITH VORICONAZOLE
119, p5eadA_, 0.8978, 2.50, 0.304, 484, 438, SACCHAROMYCES CEREVISIAE CYP51 COMPLEXED WITH THE PLANT PATHOGEN INHIBITOR S-DESTHIO-PROTHIOCONAZOLE
120, p5eshA_, 0.8977, 2.43, 0.287, 498, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73W MUTANT IN COMPLEX WITH ITRACONAZOLE
121, p5v5zA_, 0.8976, 2.42, 0.289, 498, 436, STRUCTURE OF CYP51 FROM THE PATHOGEN CANDIDA ALBICANS
122, p5eseA_, 0.8974, 2.43, 0.289, 497, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73R MUTANT COMPLEXED WITH FLUCONAZOLE
123, p4wmzA_, 0.8973, 2.45, 0.288, 497, 437, S. CEREVISIAE CYP51 COMPLEXED WITH FLUCONAZOLE IN THE ACTIVE SITE
124, d4uylB1, 0.8971, 2.43, 0.287, 497, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51B) FROM A PATHOGENIC FILAMENTOUS FUNGUS ASPERGILLUS FUMIGATUS IN COMPLEX WITH VNI
125, p4ze3A_, 0.8967, 2.52, 0.300, 488, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH FLUCONAZOLE
126, p4ze2A_, 0.8964, 2.45, 0.287, 497, 436, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) Y140H MUTANT COMPLEXED WITH ITRACONAZOLE
127, p5esgA_, 0.8960, 2.47, 0.288, 496, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G73E MUTANT COMPLEXED WITH ITRACONAZOLE
128, p5ul0A_, 0.8958, 2.39, 0.303, 469, 435, S. CEREVISIAE CYP51 COMPLEXED WITH VT-1161
129, p4ze1A_, 0.8953, 2.48, 0.286, 496, 437, SACCHAROMYCES CEREVISIAE CYP51 Y140F MUTANT COMPLEXED WITH POSACONAZOLE IN THE ACTIVE SITE
130, p5eskA_, 0.8952, 2.49, 0.286, 497, 437, SACCHAROMYCES CEREVISIAE CYP51 (LANOSTEROL 14-ALPHA DEMETHYLASE) G464S MUTANT COMPLEXED WITH ITRACONAZOLE
131, p5tz1B_, 0.8935, 2.47, 0.287, 496, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM CANDIDA ALBICANS IN COMPLEX WITH THE TETRAZOLE-BASED ANTIFUNGAL DRUG CANDIDATE VT1161 (VT1)
132, p5fsaA_, 0.8916, 2.47, 0.289, 497, 436, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
133, p5fsaB_, 0.8898, 2.51, 0.286, 497, 437, CRYSTAL STRUCTURE OF STEROL 14-ALPHA DEMETHYLASE (CYP51) FROM A PATHOGENIC YEAST CANDIDA ALBICANS IN COMPLEX WITH THE ANTIFUNGAL DRUG POSACONAZOLE
134, d5te8B_, 0.8661, 2.51, 0.286, 497, 437, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
135, d4i3qA_, 0.8653, 2.51, 0.304, 484, 438, CRYSTAL STRUCTURE OF HUMAN CYP3A4 COORDINATED TO A WATER MOLECULE
136, d1tqnA_, 0.8651, 2.56, 0.304, 484, 438, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 3A4
137, d5te8A_, 0.8648, 2.57, 0.304, 483, 437, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
138, d5te8C_, 0.8636, 3.15, 0.195, 471, 437, CRYSTAL STRUCTURE OF THE MIDAZOLAM-BOUND HUMAN CYP3A4
139, d5a1pA_, 0.8629, 3.15, 0.195, 471, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE AND CITRATE
140, d6bd7A_, 0.8616, 3.09, 0.200, 465, 436, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
141, d6bdiA_, 0.8614, 3.01, 0.200, 468, 435, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
142, d4d6zA_, 0.8608, 3.10, 0.195, 470, 436, CYTOCHROME P450 3A4 BOUND TO IMIDAZOLE AND AN INHIBITOR
143, d6bdkA_, 0.8595, 3.09, 0.198, 469, 435, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
144, d5a1rA_, 0.8591, 3.10, 0.198, 465, 434, CRYSTAL STRUCTURE OF CYTOCHROME P450 3A4 BOUND TO PROGESTERONE
145, p6c94A_, 0.8585, 3.16, 0.198, 462, 434, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH THE INHIBITOR HET0016 
146, d6bczA_, 0.8580, 3.11, 0.199, 462, 433, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
147, p6c93A_, 0.8576, 3.10, 0.199, 460, 433, EFFECTS OF THE E310A MUTATION OF CYTOCHROME P450 4B1 (CYP4B1) ON N- OCTANE BINDING AND HEME RUFFLING 
148, d5vcgA_, 0.8571, 3.11, 0.199, 461, 432, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO BROMOERGOCRYPTINE
149, d4d75A_, 0.8565, 3.10, 0.199, 462, 432, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
150, d6bd8A_, 0.8561, 3.25, 0.168, 471, 440, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
151, d4ny4A_, 0.8556, 3.03, 0.202, 461, 431, CRYSTAL STRUCTURE OF CYP3A4 IN COMPLEX WITH AN INHIBITOR
152, d6bd5A_, 0.8555, 3.26, 0.168, 478, 440, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
153, d2v0mC1, 0.8547, 3.00, 0.200, 461, 431, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
154, d2j0cC_, 0.8547, 3.14, 0.197, 460, 432,  
155, d5vccA_, 0.8545, 2.92, 0.203, 457, 428, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO GLYCEROL
156, d6bdmA_, 0.8544, 2.99, 0.200, 460, 430, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
157, d5vcdA_, 0.8535, 3.00, 0.203, 457, 429, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO GLYCEROL
158, p5t6qA_, 0.8531, 3.18, 0.200, 465, 436, STRUCTURE OF CYTOCHROME P450 4B1 (CYP4B1) COMPLEXED WITH OCTANE: AN N- ALKANE AND FATTY ACID OMEGA-HYDROXYLASE WITH A COVALENTLY BOUND HEME
159, d6bd6A_, 0.8528, 3.18, 0.200, 465, 436, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
160, d5vc0A_, 0.8527, 2.96, 0.203, 457, 428, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO RITONAVIR
161, d5veuB_, 0.8524, 3.10, 0.202, 456, 430, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
162, d4d7dA_, 0.8523, 2.96, 0.201, 460, 428, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
163, d4k9tA_, 0.8521, 3.22, 0.165, 461, 436, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
164, d4k9vA_, 0.8518, 3.22, 0.165, 461, 436, COMPLEX OF CYP3A4 WITH A DESOXYRITONAVIR ANALOG
165, d5veuH_, 0.8511, 3.12, 0.200, 457, 429, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
166, d3ua1A_, 0.8511, 3.08, 0.199, 463, 433, CRYSTAL STRUCTURE OF THE CYTOCHROME P4503A4-BROMOERGOCRYPTINE COMPLEX
167, d5veuD_, 0.8508, 3.05, 0.194, 458, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
168, d5veuJ_, 0.8507, 2.94, 0.200, 458, 429, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
169, d4i4gA_, 0.8507, 2.99, 0.201, 455, 428, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO OXAZOLE-SUBSTITUTED DESOXYRITONAVIR
170, d4d78A_, 0.8505, 3.08, 0.199, 456, 428, CYTOCHROME P450 3A4 BOUND TO AN INHIBITOR
171, d5veuF_, 0.8501, 3.07, 0.194, 459, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
172, d5veuI_, 0.8494, 2.93, 0.200, 456, 426, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
173, d1w0fA_, 0.8487, 3.07, 0.194, 459, 432, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
174, d5veuC_, 0.8484, 3.07, 0.194, 458, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
175, d3kx4B_, 0.8484, 2.94, 0.201, 459, 428, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
176, d2hpdB_, 0.8484, 2.94, 0.201, 459, 428, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
177, d4k9wC_, 0.8482, 3.07, 0.194, 456, 432, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
178, d4i4hA_, 0.8481, 3.21, 0.198, 464, 435, CRYSTAL STRUCTURE OF CYP3A4 LIGATED TO PYRIDINE-SUBSTITUTED DESOXYRITONAVIR
179, d4ducA_, 0.8481, 2.93, 0.205, 459, 425, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
180, d4dufD_, 0.8478, 3.18, 0.196, 469, 434, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
181, d4dudA_, 0.8473, 3.27, 0.164, 454, 434, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
182, d4dufC_, 0.8472, 3.27, 0.171, 457, 434, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
183, d2bmhB_, 0.8471, 3.04, 0.205, 458, 430, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
184, d1fahB_, 0.8469, 2.97, 0.203, 457, 428, STRUCTURE OF CYTOCHROME P450
185, d5vceA_, 0.8468, 3.28, 0.166, 456, 434, CRYSTAL STRUCTURE OF THE CYSTEINE DEPLETED CYP3A4 BOUND TO RITONAVIR
186, d4dufB_, 0.8468, 3.20, 0.169, 456, 433, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
187, d1bu7B_, 0.8468, 3.24, 0.166, 456, 433, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
188, d4dufA_, 0.8467, 2.99, 0.171, 456, 426, CYTOCHROME P450 BM3H-2G9 MRI SENSOR BOUND TO SEROTONIN
189, d2x80B_, 0.8467, 3.29, 0.168, 455, 434, P450 BM3 F87A IN COMPLEX WITH DMSO
190, d3nxuB_, 0.8464, 3.30, 0.168, 455, 434, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
191, d2hpdA_, 0.8463, 2.97, 0.198, 457, 425, CRYSTAL STRUCTURE OF HEMOPROTEIN DOMAIN OF P450BM-3 A PROTOTYPE FOR MICROSOMAL P450 S
192, d4dudB_, 0.8462, 3.30, 0.166, 456, 434, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR NO LIGAND
193, d1zo4B_, 0.8462, 3.23, 0.169, 455, 432, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
194, d1fahA_, 0.8462, 3.23, 0.166, 456, 433, STRUCTURE OF CYTOCHROME P450
195, d4k9wD_, 0.8461, 3.33, 0.166, 455, 434, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
196, d2x80A_, 0.8461, 3.06, 0.195, 457, 430, P450 BM3 F87A IN COMPLEX WITH DMSO
197, d5veuK_, 0.8459, 3.31, 0.173, 457, 434, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
198, d5b2xA_, 0.8458, 3.11, 0.173, 456, 428, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
199, d4duaA_, 0.8457, 3.27, 0.169, 457, 433, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
200, d3nxuA_, 0.8456, 3.16, 0.175, 455, 429, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P4503A4 BOUND TO AN INHIBITOR RITONAVIR
201, d2j0dA1, 0.8456, 3.12, 0.195, 458, 431, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
202, d5veuA_, 0.8454, 3.23, 0.171, 455, 432, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
203, d5g5jA_, 0.8452, 3.11, 0.197, 458, 431, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO METFORMIN
204, d5jtdA_, 0.8451, 2.95, 0.182, 453, 424, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
205, d4k9wA_, 0.8451, 3.26, 0.169, 457, 433, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
206, d3benB_, 0.8450, 3.07, 0.195, 457, 430, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
207, d4dueA_, 0.8449, 2.98, 0.200, 445, 424, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
208, d4hghA_, 0.8447, 3.20, 0.184, 462, 434, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
209, d3kx4A_, 0.8447, 3.07, 0.198, 452, 424, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT I401E
210, d4hgiA_, 0.8446, 3.12, 0.166, 458, 427, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
211, d2bmhA_, 0.8446, 3.12, 0.197, 458, 431, MODELING PROTEIN-SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450BM-3
212, d3kx5B_, 0.8444, 3.23, 0.169, 457, 431, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
213, d4ducB_, 0.8443, 2.98, 0.176, 453, 425, CYTOCHROME P450 BM3H-2G9 MRI SENSOR NO LIGAND
214, d2ij3B_, 0.8443, 3.19, 0.168, 455, 429, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
215, d5e7yB_, 0.8442, 3.13, 0.172, 453, 429, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
216, d5ucwA_, 0.8441, 3.25, 0.167, 455, 430, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
217, d4k9wB_, 0.8441, 3.24, 0.172, 455, 430, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
218, d4hghB_, 0.8440, 3.21, 0.167, 455, 431, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET I)
219, d4dubA_, 0.8440, 3.12, 0.171, 456, 428, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
220, d3k9yA_, 0.8440, 3.25, 0.164, 454, 433, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
221, d4k9uA_, 0.8439, 3.20, 0.172, 452, 430, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
222, d2j1mB_, 0.8439, 3.00, 0.169, 453, 427, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
223, d1p0wB_, 0.8438, 3.08, 0.203, 457, 429, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
224, d1bu7A_, 0.8438, 3.23, 0.165, 455, 430, CRYOGENIC STRUCTURE OF CYTOCHROME P450BM-3 HEME DOMAIN
225, p4h23A_, 0.8436, 3.23, 0.167, 456, 432, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
226, p5xa3D_, 0.8435, 3.23, 0.160, 461, 432, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
227, p5xa3C_, 0.8434, 2.94, 0.206, 450, 423, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
228, p5xa3A_, 0.8434, 3.09, 0.171, 454, 426, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
229, d2ve4B_, 0.8434, 3.07, 0.168, 448, 428, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
230, d1w0gA_, 0.8434, 3.12, 0.169, 455, 426, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
231, d1p0xB_, 0.8434, 2.98, 0.167, 454, 426, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
232, p5xa3B_, 0.8433, 3.10, 0.183, 453, 427, CRYSTAL STRUCTURE OF P450BM3 WITH BENZYLOXYCARBONYL-L-PROLYL-L- PHENYLALANINE
233, d5jtdB_, 0.8432, 3.09, 0.183, 453, 427, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH DMSO.
234, d4duaB_, 0.8432, 3.10, 0.183, 453, 427, CYTOCHROME P450 BM3H-9D7 MRI SENSOR NO LIGAND
235, d2v0mA1, 0.8432, 2.84, 0.212, 432, 420, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
236, d2j0cA_, 0.8432, 3.06, 0.203, 455, 423,  
237, d1zo4A_, 0.8432, 3.08, 0.171, 448, 428, CRYSTAL STRUCTURE OF A328S MUTANT OF THE HEME DOMAIN OF P450BM-3
238, d4h24A_, 0.8431, 3.09, 0.183, 453, 427, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
239, d5b2uB_, 0.8429, 3.24, 0.167, 458, 431, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
240, d2vkuA_, 0.8429, 3.15, 0.178, 457, 428, 44 -DIHYDROXYBENZOPHENONE MIMICS STEROL SUBSTRATE IN THE BINDING SITE OF STEROL 14ALPHA-DEMETHYLASE (CYP51) IN THE X-RAY STRUCTURE OF THE COMPLEX
241, d2ij2A_, 0.8428, 3.03, 0.204, 455, 427, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
242, d3tjsA_, 0.8427, 3.03, 0.204, 455, 427, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN CYTOCHROME P450 3A4 AND DESTHIAZOLYLMETHYLOXYCARBONYL RITONAVIR
243, d2ve3A_, 0.8425, 3.27, 0.174, 456, 432, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
244, d5b2yA_, 0.8424, 3.09, 0.178, 457, 426, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
245, d5e78B_, 0.8421, 3.07, 0.177, 453, 424, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
246, d4h24C_, 0.8421, 3.08, 0.290, 444, 428, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
247, d3benA_, 0.8421, 3.07, 0.168, 450, 428, STRUCTURE OF N-(12-IMIDAZOLYL-DODECANOYL)-L-LEUCINE INHIBITOR BOUND TO THE HEME DOMAIN OF CYTOCHROME P450-BM3
248, d3k9vA_, 0.8420, 2.96, 0.202, 449, 425, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
249, d2j4sA_, 0.8420, 2.85, 0.207, 435, 420, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
250, d4zf8A_, 0.8419, 2.85, 0.207, 435, 420, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND METYRAPONE
251, d4dubB_, 0.8419, 3.13, 0.175, 452, 428, CYTOCHROME P450 BM3H-9D7 MRI SENSOR BOUND TO DOPAMINE
252, d2ve4A_, 0.8419, 3.14, 0.169, 454, 425, SUBSTRATE FREE CYANOBACTERIAL CYP120A1
253, d3wspA_, 0.8418, 3.05, 0.176, 456, 425, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
254, d3ekbB_, 0.8418, 3.12, 0.180, 454, 427, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
255, d2uwhA_, 0.8418, 3.30, 0.165, 464, 431, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
256, d4hgiB_, 0.8416, 3.30, 0.165, 464, 431, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT COMPLEXED WITH STYRENE (DATASET II)
257, d3na1B_, 0.8416, 3.26, 0.166, 452, 429, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
258, d4h24D_, 0.8415, 3.24, 0.169, 460, 432, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
259, d4k9xA_, 0.8414, 3.12, 0.178, 456, 427, COMPLEX OF HUMAN CYP3A4 WITH A DESOXYRITONAVIR ANALOG
260, d3na1A_, 0.8414, 2.83, 0.212, 431, 419, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 20- HYDROXYCHOLESTEROL
261, d4dtyA_, 0.8413, 3.19, 0.172, 453, 429, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
262, d5xhjB_, 0.8412, 3.18, 0.168, 457, 429, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
263, d4wg2A1, 0.8412, 3.14, 0.171, 458, 428, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
264, d2v0mD1, 0.8412, 3.26, 0.168, 453, 429, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
265, d2j0cD_, 0.8412, 3.33, 0.147, 471, 434,  
266, d5b2uA_, 0.8411, 3.08, 0.169, 455, 425, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL -L-TRYPTOPHAN
267, d5veuG_, 0.8410, 3.11, 0.202, 449, 425, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
268, d3wspB_, 0.8410, 3.34, 0.147, 472, 434, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORONONANOYL-L-TRYPTOPHAN
269, d3kx5A_, 0.8410, 3.34, 0.147, 472, 434, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT F261E
270, d1p0vB_, 0.8410, 3.22, 0.179, 453, 429, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
271, d4dtwB_, 0.8409, 3.05, 0.174, 453, 425, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
272, d5xhjA_, 0.8408, 3.07, 0.175, 460, 424, CRYSTAL STRUCTURE OF P450BM3 WITH 5-CYCLOHEXYLVALEROYL-L-TRYPTOPHAN
273, d4dtzA_, 0.8408, 3.07, 0.175, 460, 424, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
274, p3tdaC_, 0.8407, 3.08, 0.197, 453, 427, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
275, d2j1mA_, 0.8407, 3.08, 0.197, 453, 427, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
276, d4dtwA_, 0.8406, 3.11, 0.178, 453, 427, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO SEROTONIN
277, d3n9zB_, 0.8406, 3.13, 0.196, 455, 429, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
278, d4zfaA_, 0.8405, 3.09, 0.185, 453, 426, CYTOCHROME P450 WILD TYPE FROM BM3 WITH BOUND PEG
279, d4dtyB_, 0.8405, 3.14, 0.173, 455, 427, CYTOCHROME P450 BM3H-8C8 MRI SENSOR NO LIGAND
280, d1zo9A_, 0.8405, 3.03, 0.169, 444, 426, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
281, d5jquB_, 0.8404, 3.14, 0.178, 453, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
282, d3n9zA_, 0.8404, 3.16, 0.170, 453, 429, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 22- HYDROXYCHOLESTEROL
283, d2v0mB1, 0.8404, 3.15, 0.178, 453, 426, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH KETOCONAZOLE
284, d2j0cB_, 0.8404, 3.50, 0.151, 467, 438,  
285, d1jpzB_, 0.8404, 3.17, 0.169, 454, 426, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
286, d5jq2A_, 0.8403, 3.23, 0.179, 453, 429, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
287, d3m4vA_, 0.8403, 3.33, 0.148, 470, 433, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
288, d4dtzB_, 0.8402, 3.38, 0.168, 460, 434, CYTOCHROME P450 BM3H-8C8 MRI SENSOR BOUND TO DOPAMINE
289, d1zo9B_, 0.8402, 3.16, 0.178, 453, 426, CRYSTAL STRUCTURE OF THE WILD TYPE HEME DOMAIN OF P450BM-3 WITH N- PALMITOYLMETHIONINE
290, d5b2yB_, 0.8401, 3.12, 0.169, 458, 427, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODECANOYL-L-TRYPTOPHAN
291, d4dueB_, 0.8398, 3.19, 0.172, 453, 429, CYTOCHROME P450 BM3H-2G9C6 MRI SENSOR BOUND TO SEROTONIN
292, d1zoaB_, 0.8398, 3.37, 0.152, 470, 434, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
293, d1zoaA_, 0.8398, 3.07, 0.197, 451, 427, CRYSTAL STRUCTURE OF A328V MUTANT OF THE HEME DOMAIN OF P450BM-3 WITH N-PALMITOYLGLYCINE
294, d5jquA_, 0.8397, 3.08, 0.197, 451, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
295, d5b2vA_, 0.8397, 3.12, 0.169, 458, 427, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
296, p3tbgC_, 0.8397, 3.13, 0.166, 457, 427, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
297, d3n9yB_, 0.8397, 3.14, 0.178, 451, 426, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
298, d3n9yA_, 0.8397, 3.14, 0.178, 453, 426, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH CHOLESTEROL
299, d2ij3A_, 0.8397, 3.12, 0.169, 458, 427, STRUCTURE OF THE A264H MUTANT OF CYTOCHROME P450 BM3
300, d1smiB_, 0.8397, 3.16, 0.176, 452, 426, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
301, d5b2xB_, 0.8396, 2.97, 0.177, 450, 423, CRYSTAL STRUCTURE OF P450BM3 MUTANT WITH N-PERFLUOROHEPTANOYL-L- TRYPTOPHAN
302, d5b2wA_, 0.8396, 3.15, 0.166, 457, 428, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
303, d4zf6A_, 0.8396, 3.09, 0.169, 457, 426, CYTOCHROME P450 PENTAMUTANT FROM BM3 WITH BOUND PEG
304, d1smjA_, 0.8396, 3.23, 0.168, 452, 429, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
305, d2j0dB1, 0.8395, 3.34, 0.169, 453, 432, CRYSTAL STRUCTURE OF HUMAN P450 3A4 IN COMPLEX WITH ERYTHROMYCIN
306, d1yqoB_, 0.8394, 3.52, 0.151, 467, 438, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
307, d5b2vB_, 0.8393, 3.33, 0.148, 470, 433, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUOROHEXANOYL-L-TRYPTOPHAN
308, d4zfbA_, 0.8393, 3.33, 0.150, 471, 433, CYTOCHROME P450 PENTAMUTANT FROM BM3 BOUND TO PALMITIC ACID
309, d4wg2C_, 0.8393, 3.25, 0.164, 453, 428, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
310, d3na0A_, 0.8393, 3.04, 0.167, 455, 424, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
311, p5tftA_, 0.8392, 3.19, 0.178, 453, 427, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
312, d5jquD_, 0.8392, 3.02, 0.172, 452, 424, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
313, d5e7yA_, 0.8391, 3.29, 0.169, 460, 432, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN M7 VARIANT
314, p3tbgA_, 0.8391, 3.20, 0.164, 455, 428, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
315, d3na0B_, 0.8391, 2.87, 0.200, 441, 419, CRYSTAL STRUCTURE OF HUMAN CYP11A1 IN COMPLEX WITH 2022- DIHYDROXYCHOLESTEROL
316, d2uwhF_, 0.8391, 2.98, 0.165, 441, 423, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
317, d2nnbB_, 0.8390, 3.15, 0.171, 453, 427, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
318, d1fagA_, 0.8388, 3.29, 0.167, 460, 430, STRUCTURE OF CYTOCHROME P450
319, d3cbdB_, 0.8387, 3.23, 0.163, 460, 429, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
320, d2ij4B_, 0.8387, 3.38, 0.147, 470, 434, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
321, d1fagB_, 0.8387, 3.55, 0.151, 467, 438, STRUCTURE OF CYTOCHROME P450
322, d5b2wB_, 0.8386, 3.28, 0.164, 454, 428, CRYSTAL STRUCTURE OF P450BM3 WITH N-PERFLUORODODECANOYL-L-TRYPTOPHAN
323, d1smjB_, 0.8386, 3.22, 0.180, 451, 428, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
324, p5vbuA_, 0.8384, 3.54, 0.151, 467, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
325, d4hgjA_, 0.8384, 3.54, 0.151, 467, 438, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
326, d5jq2B_, 0.8383, 3.33, 0.148, 470, 433, CRYSTAL STRUCTURE OF THE RU(BPY)2PHENA FUNCTIONALIZED P450 BM3 L407C HEME DOMAIN MUTANT IN COMPLEX WITH N-PALMITOYLGLYCINE
327, p3tdaA_, 0.8383, 3.18, 0.172, 458, 429, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
328, d2uwhC_, 0.8383, 2.99, 0.168, 441, 423, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
329, d1smjC_, 0.8383, 3.21, 0.166, 455, 428, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
330, d1fagD_, 0.8383, 3.17, 0.164, 455, 427, STRUCTURE OF CYTOCHROME P450
331, d5e78A_, 0.8381, 3.06, 0.167, 455, 424, CRYSTAL STRUCTURE OF P450 BM3 HEME DOMAIN VARIANT COMPLEXED WITH CO(III)SEP
332, d3k9vB_, 0.8381, 3.23, 0.168, 455, 428, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CHAPS
333, d2uwhD_, 0.8380, 3.08, 0.172, 452, 424, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
334, d1jmeB_, 0.8380, 3.33, 0.163, 455, 430, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
335, d5jquG_, 0.8379, 3.23, 0.152, 442, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
336, d4du2B_, 0.8378, 3.06, 0.175, 448, 424, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
337, d3kx3B_, 0.8378, 3.32, 0.163, 459, 430, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
338, d2uwhB_, 0.8376, 3.50, 0.151, 467, 437, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
339, d1fagC_, 0.8376, 3.23, 0.168, 458, 428, STRUCTURE OF CYTOCHROME P450
340, d1yqpB_, 0.8374, 3.22, 0.164, 455, 428, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
341, d5jqvD_, 0.8372, 3.25, 0.168, 455, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
342, d5jqvA_, 0.8371, 3.14, 0.174, 447, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
343, d2j4sB_, 0.8371, 3.34, 0.162, 464, 431, P450 BM3 HEME DOMAIN IN COMPLEX WITH DMSO
344, d1p0wA_, 0.8371, 3.22, 0.171, 458, 428, F393W MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
345, d3k9yB_, 0.8369, 2.97, 0.170, 441, 423, CRYSTAL STRUCTURE OF RAT MITOCHONDRIAL P450 24A1 S57D IN COMPLEX WITH CYMAL-5
346, d1p0xA_, 0.8369, 3.24, 0.169, 451, 426, F393Y MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
347, d1yqpA_, 0.8368, 2.91, 0.176, 444, 421, T268N MUTANT CYTOCHROME DOMAIN OF FLAVOCYTOCHROME P450 BM3
348, d3cbdA_, 0.8367, 3.16, 0.166, 456, 427, DIRECTED EVOLUTION OF CYTOCHROME P450 BM3 TO OCTANE MONOXYGENASE 139-3
349, d1smjD_, 0.8367, 3.22, 0.168, 458, 428, STRUCTURE OF THE A264E MUTANT OF CYTOCHROME P450 BM3 COMPLEXED WITH PALMITOLEATE
350, d5dypC_, 0.8366, 3.15, 0.169, 455, 426, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
351, p5og9B_, 0.8365, 2.98, 0.170, 441, 423, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
352, d5e9zB_, 0.8364, 3.26, 0.172, 454, 429, CYTOCHROME P450 BM3 MUTANT M11
353, d5jqvB_, 0.8363, 3.32, 0.169, 453, 431, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
354, d2ve3B_, 0.8363, 3.35, 0.163, 450, 430, RETINOIC ACID BOUND CYANOBACTERIAL CYP120A1
355, d1jpzA_, 0.8363, 2.97, 0.178, 441, 421, CRYSTAL STRUCTURE OF A COMPLEX OF THE HEME DOMAIN OF P450BM- 3 WITH N-PALMITOYLGLYCINE
356, d5jquC_, 0.8361, 3.37, 0.157, 462, 432, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
357, d4y8wC1, 0.8361, 2.92, 0.179, 441, 420, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
358, d3nplA_, 0.8361, 2.97, 0.178, 441, 421, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
359, p5vbuC_, 0.8360, 3.33, 0.167, 455, 431, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
360, d4hgjB_, 0.8360, 3.24, 0.166, 454, 427, CRYSTAL STRUCTURE OF P450 BM3 5F5 HEME DOMAIN VARIANT
361, d2nnbA_, 0.8360, 3.29, 0.172, 450, 429, THE Q403K MUTNAT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
362, d1yqoA_, 0.8360, 3.31, 0.170, 454, 430, T268A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
363, d1jmeA_, 0.8360, 3.22, 0.166, 451, 429, CRYSTAL STRUCTURE OF PHE393HIS CYTOCHROME P450 BM3
364, d4wg2B_, 0.8359, 3.30, 0.172, 453, 430, P411BM3-CIS T438S I263F REGIOSELECTIVE C-H AMINATION CATALYST
365, d1p0vA_, 0.8359, 2.87, 0.204, 427, 416, F393A MUTANT HEME DOMAIN OF FLAVOCYTOCHROME P450 BM3
366, d5dyzC_, 0.8357, 3.12, 0.169, 456, 425, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
367, d4kpbB_, 0.8356, 3.29, 0.164, 453, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
368, d5jqvG_, 0.8355, 3.23, 0.150, 441, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
369, d5jqvF_, 0.8355, 3.27, 0.166, 456, 429, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
370, d5jquF_, 0.8354, 3.20, 0.152, 442, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
371, d3mzsD_, 0.8354, 3.24, 0.171, 451, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
372, d2ij2B_, 0.8354, 2.98, 0.178, 441, 421, ATOMIC STRUCTURE OF THE HEME DOMAIN OF FLAVOCYTOCHROME P450- BM3
373, d3ekfB_, 0.8352, 2.94, 0.179, 441, 420, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
374, p5vbuB_, 0.8351, 2.98, 0.178, 441, 421, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 HYDROXYPROGESTERONE COMPLEX
375, d5jquH_, 0.8350, 3.17, 0.171, 451, 427, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
376, d4y8wA1, 0.8348, 2.98, 0.178, 441, 421, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
377, d4rsnB1, 0.8348, 3.17, 0.167, 453, 426, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
378, d4rsnA1, 0.8347, 3.03, 0.170, 444, 423, CRYSTAL STRUCTURE OF THE E267V MUTANT OF CYTOCHROME P450 BM3
379, d5e9zA_, 0.8343, 3.26, 0.171, 451, 426, CYTOCHROME P450 BM3 MUTANT M11
380, d4h24B_, 0.8343, 3.22, 0.169, 455, 426, CYTOCHROME P450BM3-CIS CYCLOPROPANATION CATALYST
381, d2uwhE_, 0.8343, 3.34, 0.166, 455, 428, CYTOCHROME P450 BM3 MUTANT IN COMPLEX WITH PALMITIC ACID
382, p4wnvA_, 0.8341, 3.36, 0.139, 470, 433, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
383, d3dgiA_, 0.8341, 2.87, 0.181, 448, 419, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
384, d3nplB_, 0.8340, 3.18, 0.171, 452, 426, STRUCTURE OF RU(BPY)2(A-PHEN)(K97C) P450 BM3 HEME DOMAIN A RUTHENIUM MODIFIED P450 BM3 MUTANT
385, d4y8wB1, 0.8339, 3.25, 0.152, 441, 427, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 21A2 PROGESTERONE COMPLEX
386, d4du2A_, 0.8339, 3.19, 0.167, 450, 426, CYTOCHROME P450 BM3H-B7 MRI SENSOR BOUND TO DOPAMINE
387, d5jqvC_, 0.8337, 3.16, 0.151, 439, 425, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
388, d3kx3A_, 0.8337, 3.39, 0.163, 456, 430, CRYSTAL STRUCTURE OF BACILLUS MEGATERIUM BM3 HEME DOMAIN MUTANT L86E
389, d3mzsC_, 0.8334, 3.39, 0.163, 456, 430, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
390, d2ij4A_, 0.8333, 3.28, 0.168, 452, 429, STRUCTURE OF THE A264K MUTANT OF CYTOCHROME P450 BM3
391, d3mzsA_, 0.8332, 3.15, 0.165, 452, 423, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
392, d5dypA_, 0.8331, 3.36, 0.172, 458, 431, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3
393, d3mzsB_, 0.8331, 3.50, 0.156, 464, 435, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP11A1 IN COMPLEX WITH 22- HYDROXY-CHOLESTEROL
394, p5og9A_, 0.8329, 3.06, 0.171, 449, 422, THE BM3 MUTANT WIFI-WC HEME DOMAIN IN COMPLEX WITH TESTOSTERONE 
395, p4h23B_, 0.8328, 3.30, 0.166, 456, 429, CYTOCHROME P411BM3-CIS CYCLOPROPANATION CATALYST
396, d4kewA_, 0.8325, 3.14, 0.153, 439, 424, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
397, d1w0eA_, 0.8325, 3.02, 0.176, 443, 421, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 3A4
398, d5e9zC1, 0.8324, 3.18, 0.170, 452, 424, CYTOCHROME P450 BM3 MUTANT M11
399, d5ucwB_, 0.8323, 3.22, 0.172, 454, 425, CYTOCHROME P411 P-4 A82L A78V F263L AMINATION CATALYST
400, d4kpaA1, 0.8323, 3.40, 0.141, 470, 433, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 IN COMPLEX WITH N- PALMITOYLGLYCINE (NPG)
401, d5dyzA_, 0.8322, 3.19, 0.167, 451, 424, CRYSTAL STRUCTURE OF ASP251GLY/GLN307HIS MUTANT OF CYTOCHROME P450 BM3 IN COMPLEX WITH N-PALMITOYLGLYCINE
402, d5jqvE_, 0.8321, 3.41, 0.141, 470, 433, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
403, p4xryA_, 0.8321, 3.03, 0.173, 440, 422, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
404, d6bdhA_, 0.8319, 3.42, 0.131, 470, 434, CRYSTAL STRUCTURE OF HUMAN CYP3A4 BOUND TO AN INHIBITOR
405, d5jquE_, 0.8315, 3.30, 0.171, 454, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN G265F/T269V/L272W/L322I/F405M/A406S (WIVS-FM) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
406, d4o4pA_, 0.8315, 3.08, 0.171, 448, 422, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
407, d4keyA_, 0.8314, 3.09, 0.175, 450, 422, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
408, d5jqvH_, 0.8309, 3.09, 0.203, 450, 418, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM3 HEME DOMAIN T269V/L272W/L322I/A406S (WIVS) VARIANT WITH IRON(III) DEUTEROPORPHYRIN IX BOUND
409, d3qz1A_, 0.8303, 3.08, 0.173, 444, 423, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
410, d3m4vB_, 0.8302, 3.17, 0.168, 453, 423, CRYSTAL STRUCTURE OF THE A330P MUTANT OF CYTOCHROME P450 BM3
411, d3ekdB_, 0.8298, 3.21, 0.169, 456, 425, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
412, d5veuL_, 0.8296, 3.09, 0.176, 445, 421, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
413, p4zgxJ_, 0.8292, 3.16, 0.173, 451, 423, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
414, p5jl9A_, 0.8291, 3.55, 0.161, 464, 435, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #4
415, d4dvqG_, 0.8289, 2.98, 0.199, 439, 417, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
416, d4fdhG_, 0.8288, 3.21, 0.165, 451, 424, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
417, p3s7sA_, 0.8287, 3.15, 0.173, 450, 423, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH BREAST CANCER DRUG EXEMESTANE
418, p5jkwA_, 0.8285, 3.18, 0.170, 450, 424, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) COMPLEXED WITH TESTOSTERONE
419, p5jl7A_, 0.8284, 3.34, 0.168, 450, 428, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #3
420, d4hggB_, 0.8283, 3.38, 0.140, 445, 429, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
421, p5jl6A_, 0.8282, 3.38, 0.140, 445, 429, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1): ANDROSTENEDIONE COMPLEX #2
422, p3s79A_, 0.8281, 3.00, 0.174, 438, 419, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) REFINED AT 2.75 ANGSTROM
423, d2x7yB_, 0.8281, 3.40, 0.167, 455, 430, P450 BM3 F87A IN COMPLEX WITH DMSO
424, p5jkvA_, 0.8279, 3.14, 0.194, 448, 423, HUMAN PLACENTAL AROMATASE CYTOCHROME P450 (CYP19A1) AT 2.75 ANGSTROM WITH BOUND POLYETHYLENE GLYCOL
425, p3eqmA_, 0.8279, 3.42, 0.170, 463, 430, CRYSTAL STRUCTURE OF HUMAN PLACENTAL AROMATASE CYTOCHROME P450 IN COMPLEX WITH ANDROSTENEDIONE
426, d3ekbA_, 0.8277, 3.55, 0.159, 452, 434, CRYSTAL STRUCTURE OF THE A264C MUTANT HEME DOMAIN OF CYTOCHROME P450 BM3
427, d4dvqE1, 0.8275, 3.37, 0.171, 462, 428, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
428, p2hi4A_, 0.8275, 3.39, 0.170, 463, 429, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 1A2 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
429, p4zgxA_, 0.8274, 3.55, 0.159, 452, 434, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
430, d4hgfA_, 0.8274, 3.55, 0.161, 452, 434, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
431, p4zgxD_, 0.8273, 3.56, 0.161, 452, 434, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
432, d4o4pB_, 0.8273, 3.11, 0.188, 441, 420, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH S-OMEPRAZOL
433, p4kq8A_, 0.8273, 3.56, 0.161, 452, 434, STRUCTURE OF RECOMBINANT HUMAN CYTOCHROME P450 AROMATASE
434, d4fdhE1, 0.8273, 3.55, 0.161, 452, 434, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
435, d4hgfB_, 0.8272, 3.01, 0.181, 439, 419, CRYSTAL STRUCTURE OF P450 BM3 5F5K HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
436, p4zgxB_, 0.8271, 3.56, 0.161, 452, 434, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
437, p4zgxH_, 0.8270, 3.56, 0.161, 452, 434, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
438, d3ekfA_, 0.8270, 3.56, 0.161, 452, 434, CRYSTAL STRUCTURE OF THE A264Q HEME DOMAIN OF CYTOCHROME P450 BM3
439, p4gl7A_, 0.8266, 3.16, 0.168, 442, 422, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG046 (COMPOUND 5)
440, d1nr6A1, 0.8266, 3.51, 0.160, 464, 432, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH DICLOFENAC
441, d2nnhB_, 0.8264, 3.64, 0.172, 480, 437, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
442, p4zgxC_, 0.8263, 3.64, 0.172, 480, 437, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
443, d4fdhF1, 0.8263, 3.56, 0.169, 465, 432, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
444, d4dvqF1, 0.8263, 3.11, 0.179, 442, 420, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
445, p4gl5A_, 0.8262, 3.57, 0.167, 465, 432, STRUCTURE OF HUMAN PLACENTAL AROMATASE COMPLEXED WITH DESIGNED INHIBITOR HDDG029 (COMPOUND 4)
446, d4fdhB_, 0.8260, 3.19, 0.171, 446, 422, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
447, d1n6bA1, 0.8257, 3.58, 0.157, 452, 434, MICROSOMAL CYTOCHROME P450 2C5/3LVDH COMPLEX WITH A DIMETHYL DERIVATIVE OF SULFAPHENAZOLE
448, d4fdhK_, 0.8256, 3.47, 0.165, 464, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
449, d4kpbA_, 0.8255, 3.09, 0.186, 441, 419, CRYSTAL STRUCTURE OF CYTOCHROME P450 BM-3 R47E MUTANT
450, d2nnhA_, 0.8255, 3.56, 0.167, 465, 432, CYP2C8DH COMPLEXED WITH 2 MOLECULES OF 9-CIS RETINOIC ACID
451, p6b82B_, 0.8254, 3.54, 0.169, 465, 432, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
452, d4fdhD_, 0.8249, 3.15, 0.169, 441, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
453, d3ekdA_, 0.8248, 3.53, 0.157, 452, 433, CRYSTAL STRUCTURE OF THE A264M HEME DOMAIN OF CYTOCHROME P450 BM3
454, p4zgxK_, 0.8247, 3.61, 0.167, 461, 436, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
455, d4dvqB_, 0.8246, 3.79, 0.159, 463, 440, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
456, d4dvqH_, 0.8245, 3.56, 0.167, 465, 432, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
457, d2x7yA_, 0.8245, 3.48, 0.165, 463, 430, P450 BM3 F87A IN COMPLEX WITH DMSO
458, d2vn0A_, 0.8245, 3.49, 0.165, 463, 430, CYP2C8DH COMPLEXED WITH TROGLITAZONE
459, d4dvqA_, 0.8244, 3.59, 0.157, 452, 434, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
460, d4kf2A_, 0.8243, 3.53, 0.169, 465, 431, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
461, d4dvqC_, 0.8241, 3.65, 0.172, 461, 436, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
462, d5e9zD_, 0.8239, 3.53, 0.167, 469, 431, CYTOCHROME P450 BM3 MUTANT M11
463, p4zgxF_, 0.8239, 3.53, 0.167, 469, 431, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
464, d2nniA_, 0.8238, 2.98, 0.180, 440, 417, CYP2C8DH COMPLEXED WITH MONTELUKAST
465, d4fdhA_, 0.8237, 3.82, 0.159, 463, 440, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
466, d4dvqI_, 0.8237, 3.66, 0.179, 470, 436, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
467, d4dvqJ_, 0.8236, 3.66, 0.179, 470, 436, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
468, d4fdhI_, 0.8235, 3.53, 0.165, 465, 431, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
469, p4zgxL_, 0.8234, 3.39, 0.168, 454, 428, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
470, d4kewB_, 0.8231, 3.53, 0.163, 461, 430, STRUCTURE OF THE A82F BM3 HEME DOMAIN IN COMPLEX WITH OMEPRAZOLE
471, d4hggA_, 0.8231, 3.54, 0.170, 463, 430, CRYSTAL STRUCTURE OF P450 BM3 5F5R HEME DOMAIN VARIANT COMPLEXED WITH STYRENE
472, d4dvqD_, 0.8231, 3.52, 0.170, 462, 429, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
473, d4kf0A_, 0.8230, 2.88, 0.179, 437, 414, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
474, d4fdhC_, 0.8230, 3.88, 0.154, 464, 442, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
475, d4fdhH_, 0.8229, 3.88, 0.154, 464, 442, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
476, d1e9xA_, 0.8228, 3.56, 0.160, 463, 431, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH 4-PHENYLIMIDAZOLE
477, d4gqsA1, 0.8225, 3.31, 0.180, 451, 422, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
478, d1pq2A_, 0.8224, 3.48, 0.171, 462, 428, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
479, d4dvqK_, 0.8223, 3.18, 0.173, 444, 421, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
480, d1pq2B_, 0.8223, 3.54, 0.169, 464, 431, CRYSTAL STRUCTURE OF HUMAN DRUG METABOLIZING CYTOCHROME P450 2C8
481, p6b82A_, 0.8218, 3.83, 0.152, 463, 440, ZEBRA FISH CYP-450 17A1 MUTANT ABIRATERONE COMPLEX
482, d5xxiA_, 0.8217, 3.56, 0.160, 463, 431, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
483, d4kf2B_, 0.8217, 3.51, 0.168, 462, 429, STRUCTURE OF THE P4509 BM3 A82F F87V HEME DOMAIN
484, p3tdaD_, 0.8217, 3.56, 0.172, 462, 430, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
485, d3qz1C_, 0.8216, 3.52, 0.168, 462, 429, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
486, d2nnjA_, 0.8216, 3.48, 0.166, 462, 429, CYP2C8DH COMPLEXED WITH FELODIPINE
487, d4fdhL_, 0.8215, 3.11, 0.172, 443, 418, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
488, d1smiA_, 0.8213, 3.04, 0.175, 435, 417, A SINGLE MUTATION OF P450 BM3 INDUCES THE CONFORMATIONAL REARRANGEMENT SEEN UPON SUBSTRATE-BINDING IN WILD-TYPE ENZYME
489, p4xryB_, 0.8212, 3.51, 0.166, 462, 429, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
490, p4zgxE_, 0.8211, 3.41, 0.179, 451, 424, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
491, p3tbgD_, 0.8211, 3.56, 0.165, 462, 430, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
492, p3tbgB_, 0.8207, 3.54, 0.168, 462, 429, HUMAN CYTOCHROME P450 2D6 WITH TWO THIORIDAZINES BOUND IN ACTIVE SITE
493, d4fdhJ_, 0.8206, 3.42, 0.272, 449, 427, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH FADROZOLE
494, p3tdaB_, 0.8206, 3.42, 0.272, 449, 427, COMPETITIVE REPLACEMENT OF THIORIDAZINE BY PRINOMASTAT IN CRYSTALS OF CYTOCHROME P450 2D6
495, p3qi8B_, 0.8205, 3.77, 0.157, 461, 439, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
496, d1ea1A_, 0.8204, 3.84, 0.153, 463, 439, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH FLUCONAZOLE
497, d3qz1B_, 0.8203, 3.45, 0.169, 460, 427, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
498, d5x23A_, 0.8202, 3.85, 0.152, 463, 441, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT A477T (*30) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
499, p4zgxI_, 0.8202, 3.57, 0.179, 465, 431, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
500, d3ua5A1, 0.8201, 3.64, 0.159, 463, 435, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
501, d5x24A_, 0.8199, 3.37, 0.180, 448, 423, CRYSTAL STRUCTURE OF CYP2C9 GENETIC VARIANT I359L (*3) IN COMPLEX WITH MULTIPLE LOSARTAN MOLECULES
502, d4dvqL_, 0.8198, 3.45, 0.152, 456, 427, STRUCTURE OF HUMAN ALDOSTERONE SYNTHASE CYP11B2 IN COMPLEX WITH DEOXYCORTICOSTERONE
503, p4wnvB_, 0.8196, 3.34, 0.133, 437, 422, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
504, d4i8vB1, 0.8196, 3.88, 0.154, 463, 441, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
505, d4kf0B_, 0.8195, 3.38, 0.162, 456, 425, STRUCTURE OF THE A82F P450 BM3 HEME DOMAIN
506, d4nz2B1, 0.8190, 3.13, 0.172, 439, 418, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
507, d4keyB_, 0.8189, 3.49, 0.161, 455, 428, STRUCTURE OF P450 BM3 A82F F87V IN COMPLEX WITH OMEPRAZOLE
508, p5e0eA_, 0.8186, 3.47, 0.169, 459, 426, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B37 FROM DESERT WOODRAT IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
509, p4wnvC_, 0.8184, 3.47, 0.150, 456, 427, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
510, p4wntB_, 0.8182, 3.49, 0.152, 456, 427, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
511, d3hf2A_, 0.8181, 3.60, 0.167, 462, 430, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
512, d4nz2A1, 0.8178, 3.43, 0.155, 456, 426, CRYSTAL STRUCTURE OF CYP2C9 IN COMPLEX WITH AN INHIBITOR
513, p2f9qC_, 0.8174, 3.38, 0.175, 452, 423, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
514, d3ua5B1, 0.8173, 3.49, 0.273, 447, 428, CRYSTAL STRUCTURE OF P450 2B6 (Y226H/K262R) IN COMPLEX WITH TWO MOLECULES OF AMLODIPINE
515, p2f9qA_, 0.8173, 3.32, 0.128, 436, 421, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
516, p3qm4A_, 0.8171, 3.67, 0.159, 463, 435, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
517, p4xrzB_, 0.8170, 3.42, 0.167, 458, 425, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
518, d4i8vA_, 0.8170, 3.87, 0.163, 464, 442, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
519, d4i8vD_, 0.8169, 3.72, 0.156, 463, 436, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
520, p4wntA_, 0.8167, 3.37, 0.168, 454, 423, HUMAN CYTOCHROME P450 2D6 AJMALICINE COMPLEX
521, d3qz1D_, 0.8167, 3.45, 0.150, 455, 426, CRYSTAL STRUCTURE OF BOVINE STEROID OF 21-HYDROXYLASE (P450C21)
522, d4i8vC_, 0.8165, 3.84, 0.172, 471, 437, HUMAN CYTOCHROME P450 1A1 IN COMPLEX WITH ALPHA-NAPHTHOFLAVONE
523, d5veuE_, 0.8162, 3.29, 0.179, 441, 420, HUMAN CYTOCHROME P450 3A5 (CYP3A5)
524, d3dl9B2, 0.8162, 3.62, 0.164, 462, 434, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
525, d2ojdB1, 0.8162, 3.17, 0.168, 442, 417,  
526, d3c6gB2, 0.8160, 3.77, 0.167, 463, 438, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
527, d3dl9A2, 0.8154, 3.46, 0.160, 454, 425, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH 1-ALPHA-HYDROXY- VITAMIN D2
528, d1og2B_, 0.8153, 3.43, 0.158, 455, 425, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
529, p4xrzD_, 0.8150, 2.72, 0.178, 428, 405, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
530, p4wnvD_, 0.8148, 3.72, 0.156, 462, 436, HUMAN CYTOCHROME P450 2D6 QUININE COMPLEX
531, p5tfuB_, 0.8147, 3.52, 0.148, 454, 425, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
532, p4xrzA_, 0.8146, 3.90, 0.159, 461, 441, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
533, p4xrzC_, 0.8144, 3.52, 0.148, 454, 425, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 6 COMPLEX
534, p4wnuB_, 0.8142, 3.71, 0.152, 465, 433, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
535, d4ejgH_, 0.8142, 3.60, 0.165, 458, 430, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
536, d4ejhH_, 0.8138, 3.91, 0.171, 477, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
537, d3czhB1, 0.8136, 3.78, 0.175, 467, 435, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
538, d1og5A_, 0.8135, 3.52, 0.159, 457, 427, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
539, d4gqsC1, 0.8134, 3.33, 0.138, 434, 420, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
540, d4ejhG_, 0.8133, 3.85, 0.172, 468, 436, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
541, p4wnuC_, 0.8131, 3.19, 0.199, 441, 418, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
542, d2ojdA1, 0.8130, 3.65, 0.141, 463, 432,  
543, p5tftD_, 0.8129, 3.64, 0.146, 463, 432, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
544, p4wnuA_, 0.8129, 3.65, 0.141, 463, 432, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
545, p4wnwA_, 0.8128, 3.71, 0.143, 464, 434, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
546, d1bvyB_, 0.8128, 3.71, 0.143, 464, 434, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
547, d4gqsB1, 0.8127, 3.71, 0.161, 461, 434, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
548, d1og2A_, 0.8126, 3.55, 0.155, 455, 427, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
549, d1og5B_, 0.8125, 3.46, 0.151, 453, 424, STRUCTURE OF HUMAN CYTOCHROME P450 CYP2C9
550, d3hf2B_, 0.8122, 3.47, 0.156, 451, 424, CRYSTAL STRUCTURE OF THE I401P MUTANT OF CYTOCHROME P450 BM3
551, p5tfuD_, 0.8118, 3.61, 0.166, 457, 429, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
552, p5tfuA_, 0.8118, 3.54, 0.155, 455, 426, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
553, d3czhA1, 0.8118, 3.50, 0.151, 453, 424, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D2
554, p2f9qB_, 0.8117, 3.71, 0.155, 458, 433, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
555, p3qm4B_, 0.8116, 3.72, 0.152, 459, 433, HUMAN CYTOCHROME P450 (CYP) 2D6 - PRINOMASTAT COMPLEX
556, d1bvyA_, 0.8116, 3.66, 0.142, 462, 431, COMPLEX OF THE HEME AND FMN-BINDING DOMAINS OF THE CYTOCHROME P450(BM-3)
557, p4wnuD_, 0.8115, 3.76, 0.154, 461, 435, HUMAN CYTOCHROME P450 2D6 QUINIDINE COMPLEX
558, d3c6gA1, 0.8115, 3.74, 0.154, 461, 434, CRYSTAL STRUCTURE OF CYP2R1 IN COMPLEX WITH VITAMIN D3
559, p2f9qD_, 0.8113, 3.82, 0.167, 463, 436, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2D6
560, p5tfuC_, 0.8108, 3.49, 0.158, 452, 423, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
561, d3dgiB_, 0.8108, 3.72, 0.141, 463, 433, CRYSTAL STRUCTURE OF F87A/T268A MUTANT OF CYP BM3
562, p4xryD_, 0.8106, 3.50, 0.151, 453, 424, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
563, d4ejgG_, 0.8098, 3.46, 0.156, 449, 422, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
564, p5tftC_, 0.8096, 3.78, 0.145, 461, 433, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
565, d2w0bA_, 0.8091, 3.31, 0.167, 438, 414, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR 3-{[(4- METHYLPHENYL)SULFONYL]AMINO}PROPYL PYRIDIN-4-YLCARBAMATE
566, d2bz9B_, 0.8088, 3.93, 0.154, 455, 436, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
567, d3tmzA1, 0.8078, 3.76, 0.161, 461, 434, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH AMLODIPINE
568, d4gqsD1, 0.8074, 3.71, 0.154, 461, 434, STRUCTURE OF HUMAN MICROSOMAL CYTOCHROME P450 (CYP) 2C19
569, d2p85B_, 0.8072, 2.78, 0.179, 423, 403, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
570, p4xryC_, 0.8068, 3.51, 0.153, 453, 424, HUMAN CYTOCHROME P450 2D6 BACE1 INHIBITOR 5 COMPLEX
571, p4wnwB_, 0.8054, 3.49, 0.159, 451, 422, HUMAN CYTOCHROME P450 2D6 THIORIDAZINE COMPLEX
572, d2iagA1, 0.8051, 3.72, 0.141, 462, 432, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
573, d1dt6A1, 0.8051, 3.52, 0.149, 451, 422, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2C5
574, p5iutA_, 0.8043, 3.82, 0.148, 457, 433, STRUCTURE OF P450 2B4 F202W MUTANT
575, d3ebsB1, 0.8042, 3.31, 0.169, 439, 414, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
576, d3b6hA1, 0.8040, 3.52, 0.151, 450, 423, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
577, d1suoA1, 0.8038, 3.78, 0.141, 462, 433, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4 WITH BOUND 4-(4- CHLOROPHENYL)IMIDAZOLE
578, d2pg7B1, 0.8037, 3.53, 0.152, 451, 422, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
579, d2bz9A_, 0.8037, 3.49, 0.151, 450, 423, LIGAND-FREE STRUCTURE OF STEROL 14ALPHA-DEMETHYLASE FROM MYCOBACTERIUM TUBERCULOSIS IN P2(1) SPACE GROUP
580, d1x8vA_, 0.8034, 2.70, 0.184, 425, 402, ESTRIOL-BOUND AND LIGAND-FREE STRUCTURES OF STEROL 14ALPHA- DEMETHYLASE (CYP51)
581, d3b6hB1, 0.8032, 3.51, 0.154, 452, 423, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE IN COMPLEX WITH INHIBITOR MINOXIDIL
582, d1z11C_, 0.8032, 3.86, 0.165, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
583, d2fduC_, 0.8031, 3.42, 0.152, 447, 420, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
584, d1z11B1, 0.8029, 3.37, 0.275, 440, 418, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
585, d1z10C_, 0.8026, 3.22, 0.283, 432, 414, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
586, d1u13A_, 0.8024, 3.96, 0.162, 462, 438, CRYSTAL STRUCTURE ANALYSIS OF THE C37L/C151T/C442A-TRIPLE MUTANT OF CYP51 FROM MYCOBACTERIUM TUBERCULOSIS
587, d2pg6C_, 0.8023, 3.76, 0.158, 451, 431, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
588, d2fdvC_, 0.8022, 3.99, 0.176, 464, 438, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
589, d3ebsC_, 0.8021, 3.45, 0.153, 446, 419, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
590, d2pg5C_, 0.8020, 3.75, 0.150, 452, 428, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
591, d2fdwB1, 0.8020, 3.47, 0.175, 470, 418, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
592, p3me6D_, 0.8018, 3.47, 0.175, 470, 418, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
593, p3me6B_, 0.8018, 3.64, 0.158, 447, 425, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
594, d2fdyC_, 0.8018, 3.98, 0.151, 460, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
595, d2pg6B1, 0.8017, 4.01, 0.172, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
596, d2fdwC_, 0.8016, 3.57, 0.176, 468, 420, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
597, p3el3A_, 0.8014, 4.02, 0.158, 464, 437, DISTINCT MONOOXYGENASE AND FARNESENE SYNTHASE ACTIVE SITES IN CYTOCHROME P450 170A1
598, d2pg7C_, 0.8013, 3.98, 0.163, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
599, p5iuzB_, 0.8012, 3.39, 0.280, 429, 414, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
600, p3me6C_, 0.8012, 3.20, 0.279, 429, 412, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
601, d2fduB_, 0.8012, 3.57, 0.171, 469, 420, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
602, p3me6A_, 0.8011, 4.03, 0.165, 464, 437, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG CLOPIDOGREL
603, d2pg5B1, 0.8010, 4.03, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
604, d1z10B1, 0.8010, 4.00, 0.163, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
605, d2iagB1, 0.8009, 4.04, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN PROSTACYCLIN SYNTHASE
606, d1h5zA_, 0.8007, 3.26, 0.276, 433, 413, CYTOCHROME P450 14 ALPHA-STEROL DEMETHYLASE (CYP51) FROM MYCOBACTERIUM TUBERCULOSIS IN FERRIC LOW-SPIN STATE
607, d3t3qC_, 0.8004, 4.05, 0.165, 464, 437, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
608, p3tk3D_, 0.8002, 4.04, 0.165, 464, 437, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
609, p3tk3B_, 0.7999, 4.03, 0.167, 464, 437, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
610, d3ibdA1, 0.7999, 4.02, 0.163, 463, 436, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2B6 GENETIC VARIANT IN COMPLEX WITH THE INHIBITOR 4-(4-CHLOROPHENYL)IMIDAZOLE
611, d1z11D_, 0.7999, 4.02, 0.165, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
612, d2fdvB1, 0.7998, 4.08, 0.153, 465, 438, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
613, d2fduD_, 0.7997, 4.08, 0.153, 465, 438, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
614, d4ejgE1, 0.7996, 4.05, 0.165, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
615, d1z11A1, 0.7996, 4.02, 0.158, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH METHOXSALEN BOUND
616, p5iuzA_, 0.7995, 4.05, 0.165, 464, 437, STRUCTURE OF P450 2B4 F202W MUTANT (CYMAL-5)
617, d4ruiE1, 0.7995, 2.97, 0.187, 417, 401, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
618, d4ejjC_, 0.7995, 2.97, 0.187, 417, 401, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
619, p3tk3C_, 0.7994, 4.06, 0.162, 464, 437, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
620, d3kw4A1, 0.7994, 4.04, 0.149, 464, 436, CRYSTAL STRUCTURE OF CYTOCHROME 2B4 IN COMPLEX WITH THE ANTI-PLATELET DRUG TICLOPIDINE
621, d3uasA1, 0.7993, 4.09, 0.158, 465, 438, CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR 9-ETHYNYLPHENANTHRENE
622, p3tk3A_, 0.7993, 4.03, 0.163, 463, 436, CYTOCHROME P450 2B4 MUTANT L437A IN COMPLEX WITH 4-(4-CHLOROPHENYL) IMIDAZOLE
623, d4ruiF1, 0.7990, 4.08, 0.158, 465, 438, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
624, d4ejjA_, 0.7990, 4.03, 0.163, 463, 436, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
625, d2pg7A_, 0.7990, 4.03, 0.163, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
626, d4ruiC_, 0.7989, 3.43, 0.173, 466, 415, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
627, d3t3rA_, 0.7989, 3.38, 0.280, 434, 414, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
628, d3t3qD_, 0.7989, 4.03, 0.167, 463, 436, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
629, d2fduA_, 0.7989, 4.10, 0.153, 465, 438, MICROSOMAL P450 2A6 WITH THE INHIBITOR NN-DIMETHYL(5- (PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
630, d4ruiD1, 0.7988, 4.11, 0.158, 465, 438, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
631, d2fdvA_, 0.7988, 4.01, 0.154, 462, 435, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
632, d1z10D_, 0.7988, 4.07, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
633, d4ejhE_, 0.7987, 4.05, 0.163, 463, 436, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
634, d4ejjB_, 0.7985, 4.07, 0.165, 464, 437, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
635, d4ejgA_, 0.7985, 4.07, 0.167, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
636, d4jltA1, 0.7984, 4.08, 0.165, 465, 437, CRYSTAL STRUCTURE OF P450 2B4(H226Y) IN COMPLEX WITH PAROXETINE
637, d4ejgF1, 0.7983, 3.96, 0.145, 459, 433, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
638, d2pg5D_, 0.7983, 4.08, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
639, p5wbgB_, 0.7982, 4.06, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
640, d4ruiA_, 0.7982, 4.12, 0.158, 465, 438, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
641, d3ebsD_, 0.7981, 4.01, 0.159, 465, 435, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
642, d2pg7D_, 0.7980, 4.01, 0.152, 460, 434, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q/I300V
643, d4ejgC_, 0.7979, 4.11, 0.158, 465, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
644, d3t3qB_, 0.7979, 4.07, 0.165, 464, 437, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
645, d3ebsA_, 0.7979, 4.07, 0.165, 465, 437, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PHENACETIN
646, p5wbgC_, 0.7978, 4.08, 0.167, 464, 437, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
647, d4ruiB1, 0.7978, 4.07, 0.162, 464, 437, CRYSTAL STRUCTURE OF A CYTOCHROME P450 2A6 IN COMPLEX WITH A MONOTERPENE - SABINENE.
648, d4ejhC_, 0.7977, 4.06, 0.158, 463, 436, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
649, p5wbgF_, 0.7976, 4.07, 0.167, 463, 436, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
650, d2fdwD_, 0.7976, 4.09, 0.162, 465, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
651, d1z10A_, 0.7976, 4.08, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH COUMARIN BOUND
652, d3t3rD1, 0.7975, 4.09, 0.162, 465, 437, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
653, d2pg5A_, 0.7974, 4.08, 0.165, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 N297Q
654, p5wbgA_, 0.7973, 4.12, 0.171, 464, 438, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
655, d4ejgD1, 0.7973, 4.07, 0.167, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
656, d4ejgB_, 0.7971, 4.14, 0.174, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH NICOTINE
657, p5wbgE_, 0.7970, 3.98, 0.150, 457, 433, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
658, d4ejhB_, 0.7970, 4.10, 0.172, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
659, d4ejhF_, 0.7969, 4.10, 0.165, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
660, d4ejhA_, 0.7969, 4.15, 0.160, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
661, d2p85E_, 0.7969, 4.08, 0.165, 464, 437, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
662, d2fdwA_, 0.7969, 4.09, 0.169, 464, 437, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 WITH THE INHIBITOR (5-(PYRIDIN-3-YL)FURAN-2-YL)METHANAMINE BOUND
663, d4ejhD_, 0.7968, 4.11, 0.165, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH 4-(METHYLNITROSAMINO)-1-(3- PYRIDYL)-1-BUTANONE (NNK)
664, d3t3sC_, 0.7968, 4.10, 0.167, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
665, d2pg6D_, 0.7968, 4.07, 0.165, 463, 436, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
666, p5wbgD_, 0.7967, 4.10, 0.167, 465, 437, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH AN ANALOG OF A DRUG EFAVIRENZ 
667, d4ejjD_, 0.7967, 4.17, 0.160, 464, 438, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH NICOTINE
668, d4r21A_, 0.7966, 4.09, 0.165, 464, 437, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
669, d3sn5A1, 0.7966, 4.10, 0.172, 464, 437, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
670, d2pg6A_, 0.7966, 4.17, 0.160, 464, 438, CRYSTAL STRUCTURE OF HUMAN MICROSOMAL P450 2A6 L240C/N297Q
671, d2fdvD_, 0.7966, 4.10, 0.165, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR N-METHYL(5-(PYRIDIN- 3-YL)FURAN-2-YL)METHANAMINE BOUND
672, d3t3sD_, 0.7965, 4.11, 0.162, 465, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
673, p6chiC_, 0.7964, 4.11, 0.162, 465, 437, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
674, d3mvrA1, 0.7963, 4.00, 0.159, 463, 434, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
675, d2q6nG1, 0.7963, 4.11, 0.165, 464, 437, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
676, p4h1nA_, 0.7962, 4.16, 0.160, 463, 438, CRYSTAL STRUCTURE OF P450 2B4 F297A MUTANT IN COMPLEX WITH ANTI- PLATELET DRUG CLOPIDOGREL
677, d3mvrB1, 0.7961, 4.10, 0.169, 464, 437, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4-H226Y IN A CLOSED CONFORMATION
678, p3kohB_, 0.7961, 4.14, 0.174, 464, 438, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
679, d3t3sB_, 0.7960, 4.16, 0.160, 463, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
680, p6chiB_, 0.7958, 4.11, 0.169, 464, 437, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
681, p6chiA_, 0.7958, 4.10, 0.169, 464, 437, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
682, p5irvD_, 0.7958, 4.11, 0.169, 464, 437, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
683, d2p85C_, 0.7958, 4.11, 0.172, 464, 437, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
684, p6cizB_, 0.7956, 4.12, 0.162, 465, 437, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
685, p3r1aA_, 0.7956, 4.15, 0.174, 464, 438, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
686, p6cizA_, 0.7955, 4.16, 0.174, 464, 438, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
687, d3t3sA_, 0.7955, 4.12, 0.162, 464, 437, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
688, d3t3qA_, 0.7955, 4.18, 0.155, 464, 438, HUMAN CYTOCHROME P450 2A6 I208S/I300F/G301A/S369G IN COMPLEX WITH PILOCARPINE
689, p5em4A_, 0.7954, 4.11, 0.165, 464, 437, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
690, p4nkvB_, 0.7953, 3.33, 0.171, 422, 409, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
691, d3t3rB_, 0.7953, 3.67, 0.178, 467, 422, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
692, d3qu8A1, 0.7953, 4.13, 0.160, 465, 437, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
693, p3kohA_, 0.7953, 4.11, 0.165, 464, 437, CYTOCHROME P450 2E1 WITH OMEGA-IMIDAZOLYL OCTANOIC ACID
694, p5irvC_, 0.7952, 4.11, 0.169, 464, 437, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
695, p5em4B_, 0.7952, 3.73, 0.170, 465, 423, STRUCTURE OF CYP2B4 F244W IN A LIGAND FREE CONFORMATION
696, p4j14A_, 0.7952, 4.10, 0.158, 462, 436, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH POSACONAZOLE BOUND
697, d2fdyA_, 0.7951, 4.11, 0.160, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
698, p6cizC_, 0.7950, 4.07, 0.147, 459, 435, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
699, d3t3rC_, 0.7950, 4.10, 0.158, 462, 436, HUMAN CYTOCHROME P450 2A6 IN COMPLEX WITH PILOCARPINE
700, p3r1aC_, 0.7950, 4.14, 0.158, 463, 437, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
701, d2q6nB1, 0.7949, 4.12, 0.172, 464, 437, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
702, d2fdyB1, 0.7949, 3.71, 0.168, 457, 422, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
703, p5uysA_, 0.7948, 3.77, 0.165, 455, 423, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
704, d4ejiA_, 0.7948, 3.76, 0.173, 461, 423, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH TWO MOLECULES OF 4- (METHYLNITROSAMINO)-1-(3-PURIDYL)-1-BUTANONE
705, d2fdyD_, 0.7948, 4.12, 0.167, 464, 437, MICROSOMAL P450 2A6 WITH THE INHIBITOR ADRITHIOL BOUND
706, d3sn5B_, 0.7947, 3.71, 0.166, 458, 422, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH CHOLEST-4-EN-3-ONE
707, d2p85F_, 0.7947, 4.19, 0.164, 465, 439, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
708, p6cizD_, 0.7945, 3.76, 0.163, 457, 423, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 NITRILE 
709, d3t3sG_, 0.7945, 4.16, 0.174, 464, 438, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
710, p4nkvA_, 0.7944, 4.10, 0.165, 463, 436, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
711, d3t3sF_, 0.7944, 4.08, 0.149, 460, 435, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
712, p6chiD_, 0.7943, 3.77, 0.165, 456, 423, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 AMIDE 
713, d3qu8C1, 0.7943, 4.10, 0.161, 463, 436, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
714, d3qu8B1, 0.7943, 4.12, 0.160, 461, 437, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
715, p3e6iA_, 0.7943, 4.16, 0.158, 463, 437, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
716, p5irvB_, 0.7942, 3.72, 0.171, 464, 422, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
717, p5e58C_, 0.7942, 3.72, 0.171, 464, 422, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
718, p3r1aD_, 0.7941, 4.08, 0.152, 459, 435, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
719, p3danA_, 0.7941, 3.48, 0.153, 436, 412, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
720, d2p85D_, 0.7941, 3.48, 0.153, 436, 412, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
721, p5uysB_, 0.7940, 4.13, 0.165, 465, 437, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
722, d2q6nF1, 0.7940, 3.70, 0.168, 464, 422, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
723, p2q9fA_, 0.7939, 4.10, 0.161, 463, 436, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1 IN COMPLEX WITH CHOLESTEROL-3-SULPHATE
724, p5irqB_, 0.7938, 4.16, 0.160, 465, 438, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
725, d3qu8E1, 0.7938, 4.13, 0.158, 464, 437, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
726, p3mdmA_, 0.7938, 4.04, 0.161, 463, 434, THIOPERAMIDE COMPLEX OF CYTOCHROME P450 46A1
727, d3qu8D_, 0.7937, 3.74, 0.164, 460, 422, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
728, p3e6iB_, 0.7937, 4.17, 0.172, 464, 437, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR INDAZOLE
729, p2q9gA_, 0.7937, 4.14, 0.162, 464, 437, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 46A1
730, d2p85A_, 0.7937, 3.63, 0.183, 466, 420, STRUCTURE OF HUMAN LUNG CYTOCHROME P450 2A13 WITH INDOLE BOUND IN TWO ALTERNATE CONFORMATIONS
731, p5uysC_, 0.7935, 4.18, 0.176, 464, 438, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
732, p3e4eA_, 0.7935, 3.76, 0.170, 457, 423, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
733, p2rclA_, 0.7935, 4.16, 0.176, 464, 438, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
734, p5irvA_, 0.7934, 3.75, 0.166, 455, 422, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITOR VT-464
735, p3rukD_, 0.7934, 4.13, 0.167, 464, 437, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
736, p3mdrA_, 0.7934, 3.73, 0.168, 456, 422, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
737, p3cliA_, 0.7933, 4.16, 0.160, 461, 437, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
738, p6cirA_, 0.7932, 4.05, 0.157, 458, 434, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
739, p4zv8A_, 0.7932, 4.15, 0.161, 462, 436, STRUCTURE OF CYP2B6 (Y226H/K262R) WITH ADDITIONAL MUTATION Y244W IN COMPLEX WITH ALPHA-PINENE
740, p3t3zA_, 0.7932, 3.75, 0.168, 460, 422, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
741, p3swzA_, 0.7932, 4.16, 0.148, 465, 438, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
742, p3gphB_, 0.7932, 4.18, 0.160, 465, 438, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
743, p5e58A_, 0.7931, 3.46, 0.140, 473, 413, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
744, p3r1aG_, 0.7931, 3.46, 0.140, 473, 413, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
745, p2rcmA_, 0.7931, 4.18, 0.171, 464, 438, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
746, p4nkvC_, 0.7930, 3.70, 0.166, 459, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
747, p5uecA_, 0.7929, 4.21, 0.164, 464, 438, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH MYRTENYL BROMIDE.
748, p3t3zB_, 0.7929, 3.32, 0.152, 433, 409, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
749, p5uysD_, 0.7928, 3.76, 0.164, 456, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 WITH 3ALPHAOH-5ALPHA- ABIRATERONE ANALOG
750, p3e4eB_, 0.7928, 4.06, 0.157, 458, 434, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH THE INHIBITOR 4- METHYLPYRAZOLE
751, p3damA_, 0.7928, 3.45, 0.160, 435, 412, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
752, p3mdtB_, 0.7927, 4.06, 0.157, 458, 434, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
753, p3lc4B_, 0.7926, 4.16, 0.161, 461, 436, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
754, p5irqC_, 0.7925, 3.26, 0.148, 422, 406, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
755, p5irqA_, 0.7924, 4.16, 0.172, 464, 437, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
756, p3gphA_, 0.7924, 3.72, 0.169, 462, 421, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DECANOIC ACID
757, d3t3sE_, 0.7923, 4.13, 0.161, 461, 435, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
758, p3r1aF_, 0.7923, 3.38, 0.144, 465, 411, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
759, d3t3sH_, 0.7922, 3.77, 0.166, 460, 422, HUMAN CYTOCHROME P450 2A13 IN COMPLEX WITH PILOCARPINE
760, p3lc4A_, 0.7922, 3.74, 0.166, 462, 421, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH OMEGA-IMIDAZOLYL-DODECANOIC ACID
761, p3dsjA_, 0.7922, 3.23, 0.157, 427, 407, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
762, p6cirB_, 0.7921, 3.39, 0.144, 465, 411, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
763, d4rqlA1, 0.7921, 3.78, 0.164, 455, 422, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
764, p5e58D_, 0.7920, 4.22, 0.159, 465, 439, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
765, d4rqlB1, 0.7920, 4.16, 0.161, 464, 436, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE - SABINENE
766, p3dsiA_, 0.7920, 3.74, 0.168, 460, 422, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
767, p4enhA_, 0.7919, 4.16, 0.161, 461, 436, CRYSTAL STRUCTURE OF HUMAN CYTOCHROME P450 CYP46A1 WITH FLUVOXAMINE BOUND
768, p2rchA_, 0.7919, 4.16, 0.146, 464, 437, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
769, d3qoaA1, 0.7918, 4.19, 0.160, 465, 438, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-BENZYLPYRIDINE.
770, p3mdrB_, 0.7918, 3.39, 0.144, 465, 411, TRANYLCYPROMINE COMPLEX OF CYTOCHROME P450 46A1
771, p3dskA_, 0.7918, 3.73, 0.173, 460, 421, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
772, d2q6nC1, 0.7918, 4.23, 0.159, 465, 439, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
773, d4r21B_, 0.7917, 4.17, 0.161, 464, 436, ZEBRA FISH CYTOCHROME P450 17A2 WITH PROGESTERONE
774, p3t3zC_, 0.7917, 3.69, 0.169, 462, 420, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
775, p3dbmA_, 0.7917, 4.14, 0.161, 461, 435, CRYSTAL STRUCTURE OF ALLENE OXIDE SYNTHASE
776, d3daxA1, 0.7917, 3.46, 0.140, 467, 413, CRYSTAL STRUCTURE OF HUMAN CYP7A1
777, d4rrtA_, 0.7916, 3.19, 0.151, 424, 404, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
778, p4nkyA_, 0.7916, 4.09, 0.148, 459, 433, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
779, d3v8dA1, 0.7916, 3.74, 0.169, 461, 421, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
780, p3rukB_, 0.7916, 3.74, 0.162, 455, 421, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
781, p3r1aE_, 0.7916, 4.17, 0.161, 461, 436, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
782, p3mdtA_, 0.7916, 4.15, 0.169, 464, 437, VORICONAZOLE COMPLEX OF CYTOCHROME P450 46A1
783, p4nkwA_, 0.7915, 4.19, 0.164, 465, 438, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
784, p3t3zD_, 0.7915, 4.15, 0.174, 464, 437, HUMAN CYTOCHROME P450 2E1 IN COMPLEX WITH PILOCARPINE
785, p5e58E_, 0.7913, 4.15, 0.159, 460, 435, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
786, p4nkzB_, 0.7913, 3.43, 0.133, 465, 412, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
787, p4nkwB_, 0.7913, 3.80, 0.164, 455, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
788, d4rrtB_, 0.7912, 4.21, 0.160, 464, 438, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH (+)-3-CARENE
789, p4nkxB_, 0.7912, 4.14, 0.147, 463, 436, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
790, d4i91A1, 0.7912, 4.21, 0.160, 464, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH ALPHA-PINENE.
791, p3r1aH_, 0.7912, 3.44, 0.133, 466, 412, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
792, p5irqD_, 0.7911, 3.29, 0.160, 426, 407, HUMAN CYTOCHROME P450 17A1 BOUND TO INHIBITORS (R)- AND (S)- ORTERONEL
793, p4nkxA_, 0.7910, 3.43, 0.133, 465, 412, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
794, p3mdvB_, 0.7910, 4.17, 0.154, 459, 436, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
795, p3mdvA_, 0.7910, 3.23, 0.158, 425, 406, CLOTRIMAZOLE COMPLEX OF CYTOCHROME P450 46A1
796, p6cirC_, 0.7909, 3.44, 0.133, 466, 412, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
797, d3psxB_, 0.7909, 4.18, 0.162, 464, 437, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
798, p5uapB_, 0.7908, 3.36, 0.164, 423, 408, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
799, p4nkyC_, 0.7908, 3.36, 0.164, 423, 408, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
800, p4nkwC_, 0.7908, 4.18, 0.161, 464, 436, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
801, p4fiaA_, 0.7908, 3.48, 0.140, 467, 413, CRYSTAL STRUCTURE OF HUMAN CYP46A1 P450 WITH BICALUTAMIDE BOUND
802, p3swzB_, 0.7907, 3.72, 0.167, 469, 420, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
803, p5uapA_, 0.7906, 4.17, 0.156, 461, 436, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH BORNYL BROMIDE
804, p4nkwD_, 0.7906, 3.81, 0.166, 451, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PREGNENOLONE
805, p3swzC_, 0.7906, 3.79, 0.166, 476, 422, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
806, p4nkyB_, 0.7905, 3.79, 0.166, 476, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
807, p4nkzA_, 0.7904, 3.76, 0.162, 454, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
808, d3daxB1, 0.7903, 4.12, 0.163, 465, 436, CRYSTAL STRUCTURE OF HUMAN CYP7A1
809, d2q6nD1, 0.7903, 3.17, 0.149, 424, 403, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
810, p4nkxC_, 0.7902, 3.80, 0.166, 453, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
811, p6cirD_, 0.7901, 4.18, 0.161, 464, 436, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH INHIBITOR: ABIRATERONE C6 OXIME 
812, p3swzD_, 0.7901, 4.19, 0.149, 462, 437, HUMAN CYTOCHROME P450 17A1 IN COMPLEX WITH TOK-001
813, p3rukC_, 0.7901, 3.77, 0.162, 450, 421, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
814, d2w09A_, 0.7901, 3.73, 0.166, 453, 421, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR CIS-4- METHYL-N-[(1S)-3-(METHYLSULFANYL)-1-(PYRIDIN-4- YLCARBAMOYL)PROPYL]CYCLOHEXANECARBOXAMIDE
815, p5udaA_, 0.7900, 4.18, 0.156, 461, 436, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
816, p3rukA_, 0.7900, 3.79, 0.166, 457, 422, HUMAN CYTOCHROME P450 CYP17A1 IN COMPLEX WITH ABIRATERONE
817, d3psxA_, 0.7898, 4.18, 0.156, 464, 436, CRYSTAL STRUCTURE OF THE KT2 MUTANT OF CYTOCHROME P450 BM3
818, d2q6nE1, 0.7898, 4.16, 0.158, 464, 436, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
819, d2q6nA1, 0.7898, 3.82, 0.171, 454, 422, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND 1-(4- CHOLOROPHENYL)IMIDAZOLE
820, p5ufgA_, 0.7897, 3.79, 0.166, 455, 422, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R/I114V) IN COMPLEX WITH MYRTENYL BROMIDE
821, p5udaB_, 0.7897, 3.21, 0.158, 424, 405, CRYSTAL STRUCTURE OF CYP2B6 (Y226H/K262R) IN COMPLEX WITH A MONOTERPENE BORNANE
822, d2w0aA_, 0.7897, 3.21, 0.158, 424, 405, CYP51 OF M. TUBERCULOSIS BOUND TO AN INHIBITOR N-[(1S)-2-METHYL-1-(PYRIDIN-4-YLCARBAMOYL)PROPYL] CYCLOHEXANECARBOXAMIDE
823, p4nkvD_, 0.7895, 3.76, 0.169, 461, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH INHIBITOR ABIRATERONE
824, p3r1aB_, 0.7895, 2.69, 0.192, 414, 391, CLOSED CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
825, d1r9oA1, 0.7895, 4.24, 0.155, 463, 438, CRYSTAL STRUCTURE OF P4502C9 WITH FLURBIPROFEN BOUND
826, p4mgjA_, 0.7893, 3.72, 0.171, 456, 420, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 F429H IN COMPLEX WITH 4-CPI
827, p4nkxD_, 0.7892, 3.79, 0.169, 456, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE PROGESTERONE
828, p5e58B_, 0.7886, 3.29, 0.160, 426, 407, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
829, p4nkyD_, 0.7882, 3.82, 0.166, 454, 422, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPROGESTERONE
830, d5m0pA1, 0.7880, 4.24, 0.160, 464, 438, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
831, p5k7kA_, 0.7878, 3.79, 0.173, 456, 421, DESIGN AND OPTIMIZATION OF BIARYL ETHER ARYL SULFONAMIDES AS SELECTIVE INHIBITORS OF NAV1.7: DISCOVERY OF CLINICAL CANDIDATE PF-05089771
832, d5m0pB_, 0.7874, 3.75, 0.173, 459, 421, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET F79A IN COMPLEX WITH ARACHIDONIC ACID
833, d3v8dB1, 0.7870, 3.76, 0.164, 453, 421, CRYSTAL STRUCTURE OF HUMAN CYP7A1 IN COMPLEX WITH 7-KETOCHOLESTEROL
834, d3g5nA1, 0.7868, 3.82, 0.166, 452, 422, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
835, d3pm0A_, 0.7867, 3.75, 0.176, 469, 421, STRUCTURAL CHARACTERIZATION OF THE COMPLEX BETWEEN ALPHA- NAPHTHOFLAVONE AND HUMAN CYTOCHROME P450 1B1 (CYP1B1)
836, d5a5jA1, 0.7865, 4.22, 0.162, 464, 438, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
837, p4nkzD_, 0.7865, 3.79, 0.169, 458, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
838, p4nkzC_, 0.7865, 3.79, 0.171, 459, 421, HUMAN STEROIDOGENIC CYTOCHROME P450 17A1 MUTANT A105L WITH SUBSTRATE 17ALPHA-HYDROXYPREGNENOLONE
839, p2rclB_, 0.7863, 3.85, 0.168, 455, 423, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 2.4 A RESOLUTION
840, d5m0nA1, 0.7853, 3.81, 0.168, 461, 422, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET IN COMPLEX WITH FORMATE
841, d5a5iA1, 0.7852, 3.22, 0.287, 421, 404, CYTOCHROME 2C9 P450 INHIBITOR COMPLEX
842, p3cliB_, 0.7850, 4.24, 0.160, 461, 438, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) AT 1.80 A RESOLUTION
843, p2rcmB_, 0.7850, 3.82, 0.164, 453, 422, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A) AT 1.73 A RESOLUTION
844, d3qu8F_, 0.7843, 2.84, 0.191, 412, 392, CRYSTAL STRUCTURE OF A HUMAN CYTOCHROME P450 2B6 (Y226H/K262R) IN COMPLEX WITH THE INHIBITOR 4-(4-NITROBENZYL)PYRIDINE.
845, d5m0oA_, 0.7837, 4.17, 0.163, 464, 436, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
846, d3g5nB1, 0.7836, 4.21, 0.158, 464, 437, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
847, d4r20B1, 0.7834, 4.19, 0.149, 464, 436, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
848, p2rchB_, 0.7830, 4.20, 0.156, 460, 436, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.85 A RESOLUTION
849, p3dsjB_, 0.7829, 3.29, 0.285, 424, 407, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOD AT 1.60 A RESOLUTION
850, p3dsiB_, 0.7827, 3.78, 0.171, 454, 421, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE (AOS CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 13(S)-HOT AT 1.60 A RESOLUTION
851, p3dskB_, 0.7826, 4.19, 0.160, 465, 437, CRYSTAL STRUCTURE OF ARABIDOPSIS THALIANA ALLENE OXIDE SYNTHASE VARIANT (F137L) (AT-AOS(F137L) CYTOCHROME P450 74A CYP74A) COMPLEXED WITH 12R13S-VERNOLIC ACID AT 1.55 A RESOLUTION
852, d3g5nC1, 0.7822, 3.98, 0.150, 453, 426, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
853, p5e58F_, 0.7821, 3.98, 0.157, 452, 428, CRYSTAL STRUCTURE OF CYTOCHROME P450 2B35 FROM DESERT WOODRAT NEOTOMA LEPIDA IN COMPLEX WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
854, d5m0oC1, 0.7817, 3.80, 0.166, 457, 421, CRYSTAL STRUCTURE OF CYTOCHROME P450 OLET H85Q IN COMPLEX WITH ARACHIDONIC ACID
855, d3g5nD1, 0.7809, 4.10, 0.141, 458, 433, TRIPLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
856, d4l54A_, 0.7791, 3.81, 0.171, 454, 421, STRUCTURE OF CYTOCHROME P450 OLET LIGAND-FREE
857, d2ci0A_, 0.7790, 3.29, 0.133, 422, 406, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
858, d4l40A_, 0.7789, 4.17, 0.164, 455, 432, STRUCTURE OF THE P450 OLET WITH A C20 FATTY ACID SUBSTRATE BOUND
859, d2cibA_, 0.7778, 3.27, 0.133, 421, 405, HIGH THROUGHPUT SCREENING AND X-RAY CRYSTALLOGRAPHY ASSISTED EVALUATION OF SMALL MOLECULE SCAFFOLDS FOR CYP51 INHIBITORS
860, d5w0cA1, 0.7744, 3.80, 0.167, 466, 420, CYTOCHROME P450 (CYP) 2C9 TCA007 INHIBITOR COMPLEX
861, d4r20A_, 0.7726, 4.15, 0.151, 454, 423, ZEBRA FISH CYTOCHROME P450 17A2 WITH ABIRATERONE
862, d5yhjB_, 0.7694, 3.73, 0.149, 459, 415, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
863, d5yhjA_, 0.7683, 3.73, 0.149, 459, 415, CYTOCHROME P450EX ALPHA (CYP152N1) WILD-TYPE WITH MYRISTIC ACID
864, d2zqjC_, 0.7683, 4.11, 0.150, 452, 427, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
865, d2zqxC_, 0.7677, 3.85, 0.166, 454, 421, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
866, d1izoB_, 0.7669, 3.80, 0.167, 453, 420, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
867, d1izoA_, 0.7662, 3.63, 0.144, 465, 411, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
868, d1cptA_, 0.7661, 3.40, 0.135, 422, 407, CRYSTAL STRUCTURE AND REFINEMENT OF CYTOCHROME P450-TERP AT 2.3 ANGSTROMS RESOLUTION
869, d2zqjB_, 0.7659, 3.40, 0.135, 422, 407, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
870, d1izoC_, 0.7653, 3.96, 0.151, 450, 423, CYTOCHROME P450 BS BETA COMPLEXED WITH FATTY ACID
871, d2zqjA_, 0.7651, 3.60, 0.144, 465, 410, SUBSTRATE-FREE FORM OF CYTOCHROME P450BSBETA
872, d3b99A_, 0.7647, 3.53, 0.144, 465, 409, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
873, d2zqxB_, 0.7646, 4.06, 0.156, 453, 429, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
874, d3b98A_, 0.7643, 3.25, 0.139, 419, 402, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
875, d2zqxA_, 0.7640, 4.12, 0.152, 450, 421, CYTOCHROME P450BSBETA COCRYSTALLIZED WITH HEPTANOIC ACID
876, d3tktA_, 0.7606, 3.26, 0.172, 413, 401, CRYSTAL STRUCTURE OF CYP108D1 FROM NOVOSPHINGOBIUM AROMATICIVORANS DSM12444
877, d5fygA_, 0.7592, 3.57, 0.144, 465, 409, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
878, d1po5A1, 0.7592, 3.65, 0.134, 465, 411, STRUCTURE OF MAMMALIAN CYTOCHROME P450 2B4
879, d3vm4A_, 0.7587, 3.65, 0.134, 465, 411, CYTOCHROME P450SP ALPHA (CYP152B1) IN COMPLEX WITH (R)-IBUPROPHEN
880, d5fyfA_, 0.7584, 3.52, 0.145, 465, 408, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
881, d4uaxA1, 0.7579, 4.00, 0.148, 451, 418, X-RAY CRYSTAL STRUCTURE OF LIGAND FREE CYP142A2 FROM MYCOBACTERIUM SMEGMATIS
882, d3awqA_, 0.7578, 4.22, 0.141, 457, 433, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT L78F
883, d5fygB_, 0.7575, 3.27, 0.134, 419, 403, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI IN COMPLEX WITH HYDROXYDODECANOIC ACID
884, d3vooA_, 0.7571, 4.13, 0.140, 450, 421, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245E
885, d3awmA_, 0.7571, 3.35, 0.136, 419, 403, CYTOCHROME P450SP ALPHA (CYP152B1) WILD-TYPE WITH PALMITIC ACID
886, d3vnoA_, 0.7569, 3.32, 0.286, 421, 402, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT R241E
887, d3zbyF1, 0.7564, 3.41, 0.136, 419, 404, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
888, d3zbyA1, 0.7564, 3.27, 0.287, 419, 400, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
889, d3zbyE1, 0.7562, 4.06, 0.141, 463, 418, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
890, d3zbyC1, 0.7561, 3.30, 0.172, 406, 395, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
891, d3vtjA_, 0.7561, 3.37, 0.155, 411, 399, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT A245H
892, d3zbyD1, 0.7560, 3.37, 0.155, 411, 399, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
893, d3zbyB1, 0.7560, 3.38, 0.156, 406, 398, LIGAND-FREE STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
894, d3awpA_, 0.7560, 3.43, 0.153, 411, 399, CYTOCHROME P450SP ALPHA (CYP152B1) MUTANT F288G
895, d2bdmA2, 0.7550, 3.40, 0.153, 411, 398, STRUCTURE OF CYTOCHROME P450 2B4 WITH BOUND BIFONAZOLE
896, p5omrA_, 0.7547, 3.51, 0.155, 411, 400, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH VANILLIN. 
897, p5omsA_, 0.7545, 3.43, 0.153, 411, 398, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAETHOL. 
898, d2xkrA_, 0.7504, 3.43, 0.153, 411, 398, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP142: A NOVEL CHOLESTEROL OXIDASE
899, p3r1bA1, 0.7498, 3.12, 0.172, 412, 389, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
900, p4r1zB_, 0.7491, 3.12, 0.172, 412, 389, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
901, d3rwlA_, 0.7481, 3.44, 0.153, 411, 399, STRUCTURE OF P450PYR HYDROXYLASE
902, d1n97A_, 0.7477, 3.51, 0.155, 411, 400, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
903, d3bujA1, 0.7476, 3.47, 0.153, 411, 399, CRYSTAL STRUCTURE OF CALO2
904, d1egyA_, 0.7471, 3.78, 0.162, 445, 407, CYTOCHROME P450ERYF WITH 9-AMINOPHENANTHRENE BOUND
905, d1eupA_, 0.7470, 3.46, 0.153, 411, 399, X-RAY CRYSTAL STRUCTURE OF CYTOCHROME P450ERYF WITH ANDROSTENDIONE BOUND
906, d1eh0A_, 0.7470, 3.81, 0.159, 446, 408,  
907, d4dxyA_, 0.7462, 3.81, 0.159, 446, 408, CRYSTAL STRUCTURES OF CYP101D2 Y96A MUTANT
908, d5fyfB_, 0.7457, 3.48, 0.153, 411, 399, STRUCTURE OF CYP153A FROM MARINOBACTER AQUAEOLEI
909, p4r1zA_, 0.7455, 3.02, 0.169, 411, 385, ZEBRA FISH CYTOCHROME P450 17A1 WITH ABIRATERONE
910, d1jioA_, 0.7455, 3.02, 0.169, 411, 385, P450ERYF/6DEB
911, d1jinA_, 0.7455, 3.56, 0.139, 422, 397, P450ERYF/KETOCONAZOLE
912, d1k2oB_, 0.7451, 3.56, 0.139, 422, 397, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
913, d1jipA_, 0.7451, 4.33, 0.147, 464, 415, P450ERYF(A245S)/KETOCONAZOLE
914, d1oxaA_, 0.7449, 3.38, 0.153, 407, 393, CYTOCHROME P450 (DONOR:O2 OXIDOREDUCTASE)
915, d1k2oA_, 0.7442, 3.60, 0.144, 420, 397, CYTOCHROME P450CAM WITH BOUND BIS(22 -BIPYRIDINE)-(5-METHYL-2-2 - BIPYRIDINE)-C2-ADAMANTANE RUTHENIUM (II)
916, d4ep6A_, 0.7433, 3.10, 0.150, 399, 386, CRYSTAL STRUCTURE OF THE XPLA HEME DOMAIN IN COMPLEX WITH IMIDAZOLE AND PEG
917, p5ncbA_, 0.7432, 3.40, 0.153, 407, 393, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH GUAIACOL. 
918, d4jx1B_, 0.7430, 3.62, 0.149, 419, 397, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
919, d2wm5A_, 0.7426, 3.40, 0.150, 407, 393, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124
920, d3b98B_, 0.7423, 3.42, 0.150, 407, 393, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1)
921, p2wiyA_, 0.7422, 3.42, 0.150, 407, 393, CYTOCHROME P450 XPLA HEME DOMAIN P21212
922, d1z8qA_, 0.7422, 3.42, 0.150, 407, 393, FERROUS DIOXYGEN COMPLEX OF THE A245T CYTOCHROME P450ERYF
923, d1qmqA_, 0.7419, 3.41, 0.151, 400, 391, OPTICAL DETECTION OF CYTOCHROME P450 BY SENSITIZER-LINKED SUBSTRATES
924, p5nwsA_, 0.7418, 3.41, 0.151, 400, 391, CRYSTAL STRUCTURE OF SAACMM INVOLVED IN ACTINOMYCIN BIOSYNTHESIS
925, d1z8pA_, 0.7418, 3.41, 0.151, 400, 391, FERROUS DIOXYGEN COMPLEX OF THE A245S CYTOCHROME P450ERYF
926, d3wriB1, 0.7415, 3.41, 0.151, 400, 391, CRYSTAL STRUCTURE OF P450CAM
927, d5hiwA1, 0.7413, 3.42, 0.151, 400, 391, SORANGIUM CELLULOSUM SO CE56 CYTOCHROME P450 260B1
928, d3wriA1, 0.7413, 3.43, 0.153, 407, 393, CRYSTAL STRUCTURE OF P450CAM
929, d1z8oA_, 0.7413, 3.41, 0.151, 400, 391, FERROUS DIOXYGEN COMPLEX OF THE WILD-TYPE CYTOCHROME P450ERYF
930, d3nv5A_, 0.7412, 3.41, 0.151, 400, 391, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D2
931, p6giiA_, 0.7409, 3.43, 0.153, 407, 393, THE CRYSTAL STRUCTURE OF TEPIDIPHILUS THERMOPHILUS P450 HEME DOMAIN 
932, d3nv6A_, 0.7409, 4.48, 0.146, 464, 419, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D2
933, d4jwuA_, 0.7408, 3.50, 0.142, 403, 395, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
934, d4jx1A_, 0.7407, 3.51, 0.142, 403, 395, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
935, d3p6sA_, 0.7406, 3.35, 0.163, 395, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
936, d3p6uA_, 0.7404, 3.98, 0.147, 427, 402, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C6-DANS
937, d1uedA_, 0.7398, 3.43, 0.178, 411, 388, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
938, d4jx1F_, 0.7397, 3.42, 0.158, 404, 386, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
939, p2wivB_, 0.7397, 3.12, 0.186, 385, 377, CYTOCHROME-P450 XPLA HEME DOMAIN P21
940, d3p6tA_, 0.7392, 3.12, 0.186, 385, 377, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-C8-DANS
941, d3p6qA_, 0.7391, 3.16, 0.167, 396, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC2-ETG-BOC
942, d1n97B_, 0.7390, 3.16, 0.167, 396, 383, CRYSTAL STUCTURE OF CYP175A1 FROM THERMUS THERMOPHILLUS STRAIN HB27
943, d5it1B_, 0.7388, 3.18, 0.167, 403, 383, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
944, d4jx1E_, 0.7388, 3.18, 0.167, 403, 383, CRYSTAL STRUCTURE OF REDUCED CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX BOUND TO CAMPHOR AND 5-EXO-HYDROXYCAMPHOR
945, d5it1D_, 0.7387, 3.19, 0.159, 403, 383, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
946, d5it1C_, 0.7386, 3.19, 0.162, 403, 383, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
947, d3p6vA_, 0.7386, 3.51, 0.156, 406, 391, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3ET-ADAC1-ETG-BOC
948, d3p3zA1, 0.7386, 3.54, 0.136, 411, 391, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH FROM STREPTOMYCES THIOLUTEUS IN COMPLEX WITH ANCYMIDOL
949, d1uedB_, 0.7386, 3.59, 0.174, 417, 390, CRYSTAL STRUCTURE OF OXYC A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE C-C COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS.
950, d3p6wA_, 0.7385, 3.15, 0.162, 403, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-ETG-BOC
951, d3l62A_, 0.7384, 3.14, 0.162, 403, 382, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT LOW [K+]
952, d5it1A_, 0.7383, 3.42, 0.165, 406, 387, STREPTOMYCES PEUCETIUS CYP105P2 COMPLEX WITH BIPHENYL COMPOUND
953, d2wm4A_, 0.7383, 3.15, 0.160, 403, 382, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP124 IN COMPLEX WITH PHYTANIC ACID
954, d4jwuB_, 0.7382, 3.15, 0.162, 403, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
955, p2wivA_, 0.7382, 3.50, 0.162, 406, 388, CYTOCHROME-P450 XPLA HEME DOMAIN P21
956, d1rf9A_, 0.7382, 3.36, 0.143, 392, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-4-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-BUTYL-AMIDE)
957, d1pkfA_, 0.7380, 3.47, 0.144, 396, 388, CRYSTAL STRUCTURE OF EPOTHILONE D-BOUND CYTOCHROME P450EPOK
958, d3w9cA_, 0.7379, 3.52, 0.165, 405, 387, CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
959, d5gxgA_, 0.7375, 3.54, 0.147, 425, 388, HIGH-RESOLUTION CRYSTAL STRUCTURE OF THE ELECTRON TRANSFER COMPLEX OF CYTOCHROME P450CAM WITH PUTIDAREDOXIN
960, d3abaA1, 0.7375, 3.50, 0.173, 427, 387, CRYSTAL STRUCTURE OF CYP105P1 IN COMPLEX WITH FILIPIN I
961, d3p6xA_, 0.7371, 3.43, 0.143, 394, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC3-C8-DANS
962, d3p3oA1, 0.7371, 3.43, 0.143, 394, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERMII) FROM STREPTOMYCES THIOLUTEUS
963, d4mm0B_, 0.7369, 3.17, 0.165, 403, 381, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
964, d3p6oA_, 0.7369, 3.49, 0.165, 406, 387, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-ETG-DANS
965, d3ol5A_, 0.7369, 3.27, 0.176, 395, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED WITH A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-C8-DANS
966, d4dnjA_, 0.7367, 3.27, 0.176, 395, 380, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A2
967, d3oiaA_, 0.7365, 3.21, 0.162, 403, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8GLUETG-BIO
968, d3p6mA_, 0.7364, 3.39, 0.169, 401, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
969, d2zbzA1, 0.7364, 3.12, 0.161, 390, 379, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D3
970, d3ejdD_, 0.7363, 3.12, 0.161, 390, 379, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
971, d2z36B1, 0.7363, 3.39, 0.169, 401, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
972, d3p6rA_, 0.7362, 3.19, 0.163, 402, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG 3OH-ADAC1-ETG-BOC
973, d3p3lA_, 0.7362, 3.42, 0.155, 399, 386, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
974, d3ejbH_, 0.7362, 3.64, 0.143, 416, 391, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
975, d1q5eA_, 0.7362, 3.53, 0.154, 404, 389, SUBSTRATE-FREE CYTOCHROME P450EPOK
976, d3p6pA_, 0.7361, 3.48, 0.166, 405, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C6-BIO
977, d3p3lB_, 0.7360, 3.53, 0.162, 405, 388, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (WILDTYPE) FROM STREPTOMYCES THIOLUTEUS
978, d5x7eA1, 0.7358, 3.45, 0.169, 404, 385, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT) IN COMPLEX WITH 125-DIHYDROXYVITAMIN D2
979, d4mm0A_, 0.7358, 3.53, 0.168, 402, 386, CRYSTAL STRUCTURE ANALYSIS OF THE PUTATIVE THIOETHER SYNTHASE SGVP INVOLVED IN THE TAILORING STEP OF GRISEOVIRIDIN
980, d1gwiB_, 0.7358, 3.12, 0.186, 391, 377, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
981, d4jbtB_, 0.7357, 3.12, 0.186, 391, 377, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
982, d3p6nA_, 0.7356, 3.44, 0.161, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM CRYSTALLIZED IN THE PRESENCE OF A TETHERED SUBSTRATE ANALOG ADAC1-C8-DANS
983, d1xqdA_, 0.7356, 3.38, 0.144, 391, 383, CRYSTAL STRUCTURE OF P450NOR COMPLEXED WITH 3- PYRIDINEALDEHYDE ADENINE DINUCLEOTIDE
984, d4j6cB_, 0.7355, 3.50, 0.168, 404, 386, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
985, d1lwlA_, 0.7355, 3.42, 0.167, 401, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
986, d1re9A_, 0.7354, 3.36, 0.187, 385, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM WITH A FLUORESCENT PROBE D-8-AD (ADAMANTANE-1-CARBOXYLIC ACID-5-DIMETHYLAMINO- NAPHTHALENE-1-SULFONYLAMINO-OCTYL-AMIDE)
987, d4jbtA_, 0.7352, 3.16, 0.172, 395, 378, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH ANDROSTENEDIONE
988, d4j6cA_, 0.7352, 3.48, 0.168, 405, 386, THE 1.9 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PROGESTERONE
989, d1q5dA_, 0.7352, 3.17, 0.164, 395, 378, EPOTHILONE B-BOUND CYTOCHROME P450EPOK
990, d3ejeD_, 0.7351, 3.17, 0.164, 395, 378, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
991, d2z36A1, 0.7351, 3.53, 0.169, 398, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 MOXA FROM NONOMURAEA RECTICATENA (CYP105)
992, d4triB_, 0.7350, 3.69, 0.151, 406, 390, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
993, d3ejbD_, 0.7350, 3.09, 0.189, 391, 375, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
994, d3cv9A1, 0.7350, 3.52, 0.166, 400, 385, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R73A/R84A MUTANT) IN COMPLEX WITH 1ALPHA25- DIHYDROXYVITAMIN D3
995, d4j6dB_, 0.7349, 3.58, 0.168, 400, 386, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
996, d5ikiB_, 0.7345, 3.17, 0.164, 395, 378, CYP106A2 WITH SUBSTRATE ABIETIC ACID
997, d5foiB_, 0.7345, 3.17, 0.164, 395, 378, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
998, d5foiA1, 0.7345, 3.49, 0.142, 426, 386, CRYSTAL STRUCTURE OF MYCINAMICIN VIII C21 METHYL HYDROXYLASE MYCCI FROM MICROMONOSPORA GRISEORUBIDA BOUND TO MYCINAMICIN VIII
999, d5cjeA_, 0.7345, 3.49, 0.142, 426, 386, STRUCTURE OF CYP107L2
1000, d2jjpA_, 0.7344, 3.46, 0.161, 403, 385, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH INHIBITOR KETOCONAZOLE (KC)
1001, d5h1zA_, 0.7343, 3.41, 0.144, 391, 383, CYP153D17 FROM SPHINGOMONAS SP. PAMC 26605
1002, d3ejdB_, 0.7343, 3.53, 0.168, 404, 386, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1003, d3cv8A1, 0.7343, 3.27, 0.163, 403, 380, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84F MUTANT)
1004, d2fr7A_, 0.7342, 3.42, 0.164, 401, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP199A2
1005, d4apyA_, 0.7340, 3.43, 0.164, 401, 383, ETHYLENE GLYCOL-BOUND FORM OF P450 CYP125A3 FROM MYCOBACTERIUM SMEGMATIS
1006, d4j6dA_, 0.7339, 3.07, 0.173, 393, 375, THE 2.4 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH TESTOSTERONE
1007, d4j6bB_, 0.7338, 3.46, 0.172, 399, 383, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
1008, d4jwsB_, 0.7337, 3.71, 0.149, 406, 390, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1009, d3p3xA_, 0.7336, 3.71, 0.149, 406, 390, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
1010, d2jjoA_, 0.7335, 3.33, 0.179, 394, 379, STRUCTURE OF CYTOCHROME P450 ERYK IN COMPLEX WITH ITS NATURAL SUBSTRATE ERD
1011, d4j6bA_, 0.7334, 3.33, 0.179, 394, 379, THE 2.2 A CRYSTAL STRUCTURE OF CYP154C5 FROM NOCARDIA FARCINICA IN COMPLEX WITH PREGNENOLONE
1012, d4wq0A_, 0.7333, 3.43, 0.158, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH OLIGOMYCIN A
1013, p4l0fA_, 0.7333, 3.48, 0.158, 405, 386, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (OPEN ACTIVE SITE)
1014, d3p3xB_, 0.7333, 3.53, 0.143, 399, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 MONOOXYGENASE AURH (NTERM- AURH-I) FROM STREPTOMYCES THIOLUTEUS
1015, d3ejdF_, 0.7333, 3.53, 0.143, 399, 385, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1016, d2zbyA1, 0.7332, 3.48, 0.158, 405, 386, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (R84A MUTANT)
1017, d3nc6B_, 0.7331, 3.50, 0.158, 404, 386, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1018, d1s1fA1, 0.7331, 3.35, 0.136, 403, 381, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1019, d4yzrA_, 0.7330, 3.35, 0.136, 403, 381, BACILLUS SUBTILIS 168 BACILLAENE POLYKETIDE SYNTHASE (PKS) CYTOCHROME P450 PKSS
1020, d3ejeH_, 0.7330, 3.28, 0.152, 385, 376, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1021, d2d0eA1, 0.7327, 3.46, 0.161, 399, 379, SUBSTRATE ASSITED IN OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
1022, d4ggvA_, 0.7324, 3.46, 0.161, 399, 379, CRYSTAL STRUCTURE OF HMTT INVOLVED IN HIMASTATIN BIOSYNTHESIS
1023, d4c9oA_, 0.7324, 3.46, 0.173, 398, 382, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1024, d2jjnA_, 0.7324, 3.75, 0.151, 403, 390, STRUCTURE OF CLOSED CYTOCHROME P450 ERYK
1025, d5gweC_, 0.7323, 3.34, 0.153, 387, 378, CYTOCHROME P450 CREJ
1026, d5dqnA_, 0.7322, 3.34, 0.153, 387, 378, POLYETHYLENE 600-BOUND FORM OF P450 CYP125A3 MUTANT FROM MYOBACTERIUM SMEGMATIS - W83Y
1027, d4c9pA_, 0.7322, 3.30, 0.161, 404, 380, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1028, d4c9nA_, 0.7322, 3.30, 0.161, 404, 380, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1029, d4egoC_, 0.7321, 3.45, 0.161, 407, 385, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1030, d3l61A_, 0.7321, 3.74, 0.151, 403, 390, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CAM AT 200 MM [K+]
1031, d3ejbB_, 0.7321, 3.48, 0.136, 403, 383, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1032, d2yooA_, 0.7321, 3.23, 0.178, 392, 377, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1033, d4c9mA_, 0.7319, 3.35, 0.174, 400, 380, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1034, d5gweA_, 0.7316, 3.54, 0.172, 407, 384, CYTOCHROME P450 CREJ
1035, d3lxhA_, 0.7316, 3.50, 0.158, 404, 386, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1036, d3ejdH_, 0.7316, 3.30, 0.161, 399, 380, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH HEXADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1037, d2yooC_, 0.7316, 3.61, 0.171, 406, 385, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1038, d5xjnA_, 0.7314, 3.45, 0.158, 404, 385, CYTOCHROME P450 CREJ IN COMPLEX WITH (4-ETHYLPHENYL) DIHYDROGEN PHOSPHATE
1039, d4egmC_, 0.7314, 3.45, 0.158, 404, 385, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1040, d4c9oB_, 0.7313, 3.55, 0.172, 407, 384, STRUCTURE OF CYANIDE AND CAMPHOR BOUND D259N MUTANT OF CYP101D1
1041, d4c9mB_, 0.7313, 3.55, 0.172, 407, 384, STRUCTURE OF SUBSTRATE FREE GLYCEROL BOUND WILD TYPE CYP101D1
1042, d2yooD_, 0.7313, 3.55, 0.172, 407, 384, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1043, d2x5wA_, 0.7313, 3.31, 0.169, 401, 379, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH SUBSTRATE CHOLEST-4-EN-3-ONE
1044, p5kdbA_, 0.7312, 3.31, 0.154, 385, 376, THE CRYSTAL STRUCTURE OF 4-ISOPROPYLBENZOATE-BOUND CYP199A4
1045, d4do1C_, 0.7312, 3.39, 0.162, 398, 377, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1046, d4c9kA_, 0.7312, 3.55, 0.153, 400, 386, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1047, d4c9pB_, 0.7311, 3.28, 0.149, 386, 376, STRUCTURE OF CAMPHOR BOUND T260A MUTANT OF CYP101D1
1048, d3lxiA_, 0.7311, 3.35, 0.142, 399, 381, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1049, d5cweA_, 0.7310, 3.50, 0.172, 406, 383, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1050, d4egpB_, 0.7310, 3.49, 0.175, 399, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1051, d4egnC_, 0.7310, 3.49, 0.175, 399, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1052, d4triA1, 0.7309, 3.15, 0.155, 388, 374, X-RAY CRYSTAL STRUCTURE OF CYP142A2 FROM MYCOBACTERIUM SMEGMATIS COMPLEXED WITH CHOLESTEROL SULFATE.
1053, p5kdyA_, 0.7308, 3.15, 0.155, 388, 374, THE CRYSTAL STRUCTURE OF THE D251N MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1054, d4dnzD_, 0.7308, 3.15, 0.155, 388, 374, THE CRYSTAL STRUCTURES OF CYP199A4
1055, p5u6wA_, 0.7307, 3.26, 0.170, 390, 376, THE CRYSTAL STRUCTURE OF 4-METHYLAMINOBENZOATE-BOUND CYP199A4 
1056, p5u6uA_, 0.7307, 3.70, 0.152, 397, 388, THE CRYSTAL STRUCTURE OF 4-ETHYLTHIOBENZOATE-BOUND CYP199A4 
1057, d4c9nB_, 0.7307, 3.70, 0.152, 397, 388, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND D259N MUTANT OF CYP101D1
1058, d3lxiB_, 0.7307, 3.60, 0.147, 400, 382, CRYSTAL STRUCTURE OF CAMPHOR-BOUND CYP101D1
1059, d3e5lA1, 0.7307, 3.60, 0.147, 400, 382, CRYSTAL STRUCTURE OF CYP105P1 H72A MUTANT
1060, d3a1lA_, 0.7307, 3.16, 0.147, 382, 373, CRYSTAL STRUCTURE OF 1111 -DICHLOROCHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
1061, d4pxhA_, 0.7306, 3.38, 0.142, 400, 381, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1062, d5cweB_, 0.7305, 3.75, 0.139, 397, 388, STRUCTURE OF CYP107L2 FROM STREPTOMYCES AVERMITILIS WITH LAURIC ACID
1063, d4egoD_, 0.7305, 3.79, 0.170, 414, 388, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1064, d4c9lA_, 0.7305, 3.53, 0.175, 406, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1065, d3b99B_, 0.7305, 3.51, 0.165, 405, 382, CRYSTAL STRUCTURE OF ZEBRAFISH PROSTACYCLIN SYNTHASE (CYTOCHROME P450 8A1) IN COMPLEX WITH SUBSTRATE ANALOG U51605
1066, p5kt1A_, 0.7304, 3.56, 0.170, 395, 382, THE CRYSTAL STRUCTURE OF 4-METHYLTHIOBENZOATE-BOUND CYP199A4
1067, d4l4dA_, 0.7304, 3.66, 0.152, 397, 388, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A
1068, d4c9lB_, 0.7304, 3.58, 0.162, 393, 383, STRUCTURE OF CYANIDE AND CAMPHOR BOUND WILD TYPE CYP101D1
1069, d4egmB_, 0.7303, 3.52, 0.168, 405, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1070, d4dnzC_, 0.7303, 3.26, 0.146, 397, 378, THE CRYSTAL STRUCTURES OF CYP199A4
1071, d3ofuC_, 0.7302, 3.26, 0.146, 397, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1072, d4egmD_, 0.7301, 3.73, 0.167, 437, 389, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1073, d4c9kB_, 0.7301, 3.73, 0.167, 437, 389, STRUCTURE OF CAMPHOR AND HYDROXYCAMPHOR BOUND WILD TYPE CYP101D1
1074, d2z3uA_, 0.7301, 3.63, 0.160, 399, 387, CRYSTAL STRUCTURE OF CHROMOPYRROLIC ACID BOUND CYTOCHROME P450 STAP (CYP245A1)
1075, d5l1pA_, 0.7300, 3.17, 0.145, 381, 373, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE
1076, d4l4fA_, 0.7300, 3.39, 0.139, 399, 381, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G/D182N
1077, d3ejbF_, 0.7300, 3.21, 0.171, 389, 375, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH TETRADECANOIC ACID LIGATED ACYL CARRIER PROTEIN
1078, d2yooB_, 0.7300, 3.21, 0.171, 389, 375, CHOLEST-4-EN-3-ONE BOUND STRUCTURE OF CYP142 FROM MYCOBACTERIUM SMEGMATIS
1079, p5kdzA_, 0.7299, 3.33, 0.158, 395, 379, THE CRYSTAL STRUCTURE OF THE T252A MUTANT OF CYP199A4 IN COMPLEX WITH 4-METHOXYBENZOATE
1080, d4l4eA_, 0.7299, 3.38, 0.158, 388, 379, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358A/K178G
1081, d4egnD_, 0.7299, 3.38, 0.158, 388, 379, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1082, d4do1D_, 0.7299, 3.26, 0.152, 383, 374, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1083, d1gwiA_, 0.7299, 3.39, 0.155, 401, 381, THE 1.92 A STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP154C1: A NEW MONOOXYGENASE THAT FUNCTIONALIZES MACROLIDE RING SYSTEMS
1084, d4pxhE_, 0.7298, 3.61, 0.170, 396, 382, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1085, d5l1qA_, 0.7296, 3.61, 0.170, 396, 382, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH DIHYDROPENTALENOLACTONE F
1086, p5uvbA_, 0.7294, 3.77, 0.145, 408, 392, THE CRYSTAL STRUCTURE OF 4-CYCLOPROPYLBENZOATE-BOUND CYP199A4
1087, d5gweD_, 0.7294, 3.66, 0.155, 395, 386, CYTOCHROME P450 CREJ
1088, d2xfhA_, 0.7294, 3.62, 0.166, 405, 385, STRUCTURE OF CYTOCHROME P450 ERYK COCRYSTALLIZED WITH INHIBITOR CLOTRIMAZOLE.
1089, d2whwA_, 0.7294, 3.63, 0.177, 410, 384, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1090, d5l1sA_, 0.7293, 3.75, 0.146, 408, 391, X-RAY STRUCTURE OF F232L MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1091, d5l1oA_, 0.7293, 3.78, 0.145, 408, 392, X-RAY STRUCTURE OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1092, d3ejeF_, 0.7293, 3.46, 0.160, 393, 381, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1093, d5l1rA_, 0.7292, 3.51, 0.171, 396, 381, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PNTM
1094, d4jwsA_, 0.7292, 3.22, 0.150, 380, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM-PUTIDAREDOXIN COMPLEX
1095, d3zkpA_, 0.7292, 3.54, 0.149, 396, 383, STRUCTURE OF A MUTANT OF P450 ERYK IN COMPLEX WITH ERYTHROMYCIN B.
1096, d2zbxA1, 0.7292, 3.74, 0.148, 408, 391, CRYSTAL STRUCTURE OF VITAMIN D HYDROXYLASE CYTOCHROME P450 105A1 (WILD TYPE) WITH IMIDAZOLE BOUND
1097, d2h7qA_, 0.7292, 3.62, 0.161, 405, 385, CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1098, d5l1vA_, 0.7291, 3.62, 0.161, 405, 385, X-RAY STRUCTURE OF M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1099, d3ofuA_, 0.7291, 3.76, 0.146, 408, 391, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1100, d5l1uA_, 0.7290, 3.76, 0.146, 408, 391, X-RAY STRUCTURE OF M81A MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1101, d5wk9A_, 0.7289, 3.18, 0.153, 382, 372, R186AP450CAM WITH CN AND CAMPHOR
1102, d4dnzB_, 0.7289, 3.54, 0.164, 395, 383, THE CRYSTAL STRUCTURES OF CYP199A4
1103, d5l1tA_, 0.7288, 3.60, 0.164, 403, 384, X-RAY STRUCTURE OF M77S MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1104, d4l4aA_, 0.7288, 3.47, 0.157, 393, 381, STRUCTURE OF L358A/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1105, d5wk7A_, 0.7287, 3.75, 0.146, 407, 391, P450CAM MUTANT R186A
1106, d3oftA_, 0.7287, 3.76, 0.146, 407, 391, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1107, d4ubsA_, 0.7286, 3.54, 0.162, 394, 383, THE CRYSTAL STRUCTURE OF CYTOCHROME P450 105D7 FROM STREPTOMYCES AVERMITILIS IN COMPLEX WITH DICLOFENAC
1108, d4egoA_, 0.7286, 3.58, 0.157, 409, 383, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1109, d4egmA_, 0.7285, 3.46, 0.160, 393, 381, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 4-ETHYLBENZOIC ACID
1110, d5cp4A_, 0.7284, 3.47, 0.160, 393, 381, CRYOGENIC STRUCTURE OF P450CAM
1111, d4egoB_, 0.7282, 3.80, 0.143, 408, 392, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH INDOLE-6- CARBOXYLIC ACID
1112, d3lxhB_, 0.7282, 3.82, 0.143, 407, 392, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101D1
1113, d1t86A_, 0.7282, 3.77, 0.148, 408, 391, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1114, d4l4bA_, 0.7281, 3.44, 0.166, 393, 379, STRUCTURE OF L358A/K178G/D182N MUTANT OF P450CAM BOUND TO CAMPHOR
1115, d4ek1B_, 0.7281, 3.72, 0.153, 393, 385, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1116, d4egnA_, 0.7281, 3.51, 0.162, 393, 382, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1117, d4do1B_, 0.7281, 3.52, 0.162, 397, 383, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1118, d1phcA_, 0.7281, 3.47, 0.160, 393, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE PSEUDOMONAS PUTIDA CYTOCHROME P450
1119, d4do1A_, 0.7280, 3.49, 0.160, 393, 381, THE CRYSTAL STRUCTURES OF 4-METHOXYBENZOATE BOUND CYP199A4
1120, d4dnzA_, 0.7280, 3.47, 0.163, 393, 381, THE CRYSTAL STRUCTURES OF CYP199A4
1121, d4pxhC_, 0.7279, 3.46, 0.160, 393, 381, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1122, d4egnB_, 0.7279, 3.75, 0.146, 407, 391, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH VERATRIC ACID
1123, d3cp4A_, 0.7279, 3.82, 0.148, 407, 392, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1124, d1romA_, 0.7279, 3.28, 0.171, 393, 375, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM
1125, d1iwkA_, 0.7279, 3.67, 0.166, 411, 385, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(112K) CYTOCHROME P450CAM
1126, d1t93A1, 0.7278, 3.50, 0.160, 417, 382, EVIDENCE FOR MULTIPLE SUBSTRATE RECOGNITION AND MOLECULAR MECHANISM OF C-C REACTION BY CYTOCHROME P450 CYP158A2 FROM STREPTOMYCES COELICOLOR A3(2)
1127, d5l91A1, 0.7277, 3.44, 0.169, 393, 379, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1128, d5l1wA_, 0.7277, 3.49, 0.160, 393, 381, X-RAY STRUCTURE OF 2-MERCAPTOETHANOL MODIFIED M81C MUTANT OF CYTOCHROME P450 PNTM WITH PENTALENOLACTONE F
1129, d2d09A1, 0.7277, 3.75, 0.143, 408, 391, A ROLE FOR ACTIVE SITE WATER MOLECULES AND HYDROXYL GROUPS OF SUBSTRATE FOR OXYGEN ACTIVATION IN CYTOCHROME P450 158A2
1130, d2bvjB_, 0.7277, 3.49, 0.171, 415, 380, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1131, d4l49A_, 0.7276, 3.47, 0.157, 393, 381, STRUCTURE OF L358A MUTANT OF P450CAM BOUND TO CAMPHOR
1132, d1pheA_, 0.7275, 3.59, 0.151, 405, 385, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1133, d4egpA_, 0.7274, 3.82, 0.143, 407, 392, THE X-RAY CRYSTAL STRUCTURE OF CYP199A4 IN COMPLEX WITH 2-NAPHTHOIC ACID
1134, d1ulwA_, 0.7274, 3.51, 0.157, 394, 382, CRYSTAL STRUCTURE OF P450NOR SER73GLY/SER75GLY MUTANT
1135, d5ik1A_, 0.7273, 3.49, 0.160, 393, 381, OPEN STATE OF P450CAM AFTER SOAKING IN CAMPHOR
1136, d2wi9A_, 0.7273, 3.60, 0.164, 396, 384, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1137, d3ejeB_, 0.7272, 3.48, 0.157, 393, 381, CRYSTAL STRUCTURE OF P450BIOI IN COMPLEX WITH OCTADEC-9Z-ENOIC ACID LIGATED ACYL CARRIER PROTEIN
1138, d6cppA_, 0.7271, 3.76, 0.146, 407, 391, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1139, d2romA_, 0.7271, 3.64, 0.169, 411, 384, CRYSTAL STRUCTURE OF NITRIC REDUCTASE FROM DENITRIFYING FUNGUS FUSARIUM OXYSPORUM COMPLEX WITH CARBON MONOXIDE
1140, d1iwiA_, 0.7271, 3.64, 0.169, 411, 384, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF CYTOCHROME P450CAM
1141, d1gemA_, 0.7270, 3.39, 0.166, 397, 379, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1142, d1nooA_, 0.7269, 3.61, 0.151, 405, 385, CYTOCHROME P450-CAM COMPLEXED WITH 5-EXO-HYDROXYCAMPHOR
1143, d1akdA_, 0.7269, 3.11, 0.149, 378, 370, CYTOCHROME P450CAM FROM PSEUDOMONAS PUTIDA COMPLEXED WITH 1S-CAMPHOR
1144, d4umzA_, 0.7268, 3.53, 0.162, 395, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1145, d3l63A_, 0.7268, 3.49, 0.157, 393, 381, CRYSTAL STRUCTURE OF CAMPHOR-BOUND P450CAM AT LOW [K+]
1146, d1iwjA_, 0.7268, 3.61, 0.151, 405, 385, PUTIDAREDOXIN-BINDING STABLILIZES AN ACTIVE CONFORMER OF CYTOCHROME P450CAM IN ITS REDUCED STATE; CRYSTAL STRUCTURE OF MUTANT(109K) CYTOCHROME P450CAM
1147, d5y1iB_, 0.7267, 3.50, 0.160, 393, 381, THE CRYSTAL STRUCTURE OF GFSF
1148, d4cppA_, 0.7267, 3.49, 0.160, 393, 381, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1149, d2x5lA_, 0.7267, 3.43, 0.184, 402, 380, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 ALTERNATIVE CRYSTAL FORM
1150, d1gekA_, 0.7267, 3.57, 0.159, 407, 383, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1151, d1phaA_, 0.7266, 3.39, 0.166, 397, 379, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1152, d4kkyX_, 0.7265, 3.49, 0.160, 393, 381, CRYSTAL STRUCTURE OF N-(1-PYRENE)ACETAMIDE LABELED P450CAM IN SUBSTRATE BOUND FORM.
1153, d1t86B_, 0.7264, 3.61, 0.164, 403, 384, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM MUTANT (L358P/C334A)
1154, d1phbA_, 0.7264, 3.79, 0.167, 394, 383, INHIBITOR-INDUCED CONFORMATIONAL CHANGE IN CYTOCHROME P450- CAM
1155, d3nc3B_, 0.7263, 3.52, 0.202, 396, 381, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1156, d1dz6B_, 0.7263, 3.40, 0.166, 397, 379, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1157, d2cppA_, 0.7262, 3.40, 0.166, 397, 379, HIGH-RESOLUTION CRYSTAL STRUCTURE OF CYTOCHROME P450-CAM
1158, d1geiA_, 0.7262, 3.40, 0.166, 397, 379, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1159, d8cppA_, 0.7261, 3.21, 0.153, 380, 372, CRYSTAL STRUCTURES OF CYTOCHROME P450-CAM COMPLEXED WITH CAMPHANE THIOCAMPHOR AND ADAMANTANE: FACTORS CONTROLLING P450 SUBSTRATE HYDROXYLATION
1160, d4cp4A_, 0.7261, 3.40, 0.166, 397, 379, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1161, d1phgA_, 0.7261, 3.47, 0.169, 392, 378, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1162, d1cp4A_, 0.7261, 3.54, 0.163, 390, 380, FORMATION CRYSTAL STRUCTURE AND REARRANGEMENT OF A CYTOCHROME P450-CAM IRON-PHENYL COMPLEX
1163, d5vwsA_, 0.7260, 3.49, 0.139, 395, 380, LIGAND FREE STRUCTURE OF CYTOCHROME P450 TBTJ1
1164, p5livD_, 0.7260, 3.61, 0.148, 405, 385, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1165, d1phfA_, 0.7260, 3.40, 0.166, 397, 379, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE- INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1166, d1dz8B_, 0.7260, 3.62, 0.164, 396, 384, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1167, d7cppA_, 0.7259, 3.41, 0.166, 397, 379, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P450(CAM)
1168, d6cp4A_, 0.7259, 3.63, 0.153, 405, 385, P450CAM D251N MUTANT
1169, d5cppA_, 0.7259, 3.57, 0.157, 393, 382, THE STRUCTURAL BASIS FOR SUBSTRATE-INDUCED CHANGES IN REDOX POTENTIAL AND SPIN EQUILIBRIUM IN CYTOCHROME P-450(CAM)
1170, d3r9cA_, 0.7259, 3.41, 0.166, 397, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 WITH ECONAZOLE BOUND
1171, d1t87A_, 0.7259, 3.63, 0.151, 405, 385, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1172, d4ek1A_, 0.7258, 3.65, 0.153, 405, 385, CRYSTAL STRUCTURE OF ELECTRON-SPIN LABELED CYTOCHROME P450CAM
1173, d3ofuB_, 0.7258, 3.63, 0.169, 396, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1174, d2cp4A_, 0.7258, 3.63, 0.169, 396, 384, CRYSTAL STRUCTURE OF THE CYTOCHROME P450-CAM ACTIVE SITE MUTANT THR252ALA
1175, d1t85A_, 0.7258, 3.35, 0.155, 393, 375, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM MUTANT (L358P/C334A)
1176, d1phdA_, 0.7258, 3.51, 0.160, 393, 381, CRYSTAL STRUCTURES OF METYRAPONE-AND PHENYLIMIDAZOLE-INHIBITED COMPLEXES OF CYTOCHROME P450-CAM
1177, d5l90A1, 0.7257, 3.58, 0.154, 393, 382, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1178, d1o76B_, 0.7257, 3.60, 0.153, 406, 385, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1179, d3cppA_, 0.7256, 3.53, 0.157, 393, 381, CRYSTAL STRUCTURE OF THE CARBON MONOXY-SUBSTRATE-CYTOCHROME P450-CAM TERNARY COMPLEX
1180, d1uyuB_, 0.7256, 3.83, 0.143, 405, 391, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1181, d3ofuD_, 0.7255, 3.59, 0.156, 406, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1182, d3iw0A_, 0.7255, 3.62, 0.153, 405, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 C2221 CRYSTAL FORM
1183, d2a1oA_, 0.7255, 3.60, 0.154, 404, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1184, d1dz4B_, 0.7255, 3.55, 0.154, 393, 382, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1185, d4umzB_, 0.7254, 3.52, 0.160, 393, 381, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED SUBSTRATE MIMIC BEARING A 2-DIMETHYLAMINOMETHYLBENZOATE GROUP
1186, d1dz9B_, 0.7254, 3.61, 0.151, 405, 384, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1187, d2h7sC_, 0.7253, 3.53, 0.157, 393, 381, L244A MUTANT OF CYTOCHROME P450CAM
1188, d1f25A_, 0.7253, 3.53, 0.157, 393, 381, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ASN MUTANTS OF CYTOCHROME P450NOR
1189, d2a1mA_, 0.7252, 3.60, 0.159, 409, 383, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1190, d1jfbA_, 0.7252, 3.53, 0.157, 393, 381, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERRIC RESTING STATE AT ATOMIC RESOLUTION
1191, d5y5jB_, 0.7251, 3.62, 0.148, 405, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
1192, d1cmjA_, 0.7251, 3.57, 0.155, 399, 380, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1193, d5y5iB_, 0.7250, 3.62, 0.151, 405, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1194, d4wpzA_, 0.7250, 3.57, 0.167, 401, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP107W1 FROM STREPTOMYCES AVERMITILIS
1195, d2ferA_, 0.7250, 3.57, 0.167, 401, 383, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1196, d1t88A_, 0.7250, 3.32, 0.177, 388, 373, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1197, d1dz8A_, 0.7250, 3.32, 0.177, 388, 373, OXYGEN COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1198, d5y5kB_, 0.7249, 3.38, 0.167, 396, 378, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1199, d5y5kA_, 0.7249, 3.55, 0.175, 401, 382, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR : 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE ABSENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1200, d4l4gA_, 0.7249, 3.40, 0.202, 391, 377, STRUCTURE OF CYANIDE AND CAMPHOR BOUND P450CAM MUTANT L358P/K178G
1201, d3oftB_, 0.7249, 3.62, 0.153, 405, 385, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1202, d2h7sA_, 0.7249, 3.63, 0.154, 405, 384, L244A MUTANT OF CYTOCHROME P450CAM
1203, d2feuB_, 0.7249, 3.54, 0.150, 393, 381, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1204, d1j51A_, 0.7249, 3.38, 0.162, 399, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1205, d4bf4M_, 0.7248, 3.45, 0.161, 394, 378, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1206, d1o76A_, 0.7248, 3.52, 0.199, 396, 382, CYANIDE COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1207, d1jfcA_, 0.7248, 3.18, 0.146, 378, 370, X-RAY STRUCTURE OF NITRIC OXIDE REDUCTASE (CYTOCHROME P450NOR) IN THE FERROUS CO STATE AT ATOMIC RESOLUTION
1208, d2a1nA_, 0.7247, 3.63, 0.151, 405, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1209, d1mpwA_, 0.7247, 3.56, 0.164, 399, 379, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1210, d1lgfA_, 0.7247, 3.61, 0.154, 405, 384, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1211, d5y5lB_, 0.7246, 3.61, 0.154, 405, 384, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
1212, d5ex6C_, 0.7246, 3.61, 0.156, 405, 384, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1213, d3wrhA_, 0.7246, 3.58, 0.151, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1214, d2whwB_, 0.7246, 3.56, 0.194, 396, 381, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1215, d2qbmA_, 0.7246, 3.61, 0.159, 405, 384, CRYSTAL STRUCTURE OF THE P450CAM G248T MUTANT IN THE CYANIDE BOUND STATE
1216, d1gebA_, 0.7246, 3.61, 0.151, 405, 384, X-RAY CRYSTAL STRUCTURE AND CATALYTIC PROPERTIES OF THR252ILE MUTANT OF CYTOCHROME P450CAM
1217, d5y5lA_, 0.7245, 3.41, 0.152, 394, 376, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE ABSENCE OF NADH (RESTING STATE)
1218, d5l90B1, 0.7245, 3.41, 0.152, 394, 376, THE CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109E1 FROM BACILLUS MEGATERIUM AT 2.55 ANGSTROM RESOLUTION
1219, d4bf4D_, 0.7245, 3.64, 0.151, 405, 384, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1220, d3wrlA_, 0.7245, 3.62, 0.160, 414, 382, CRYSTAL STRUCTURE OF P450CAM
1221, d2a1oB_, 0.7245, 3.62, 0.160, 414, 382, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF T252A CYTOCHROME P450CAM
1222, d5y5jA_, 0.7244, 3.63, 0.153, 406, 385, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: DARK-2 DATA IN THE PRESENCE OF NADH (RESTING STATE)
1223, d5y5iA_, 0.7244, 3.63, 0.151, 405, 384, TIME-RESOLVED SFX STRUCTURE OF CYTOCHROME P450NOR: 20 MS AFTER PHOTO- IRRADIATION OF CAGED NO IN THE PRESENCE OF NADH (NO-BOUND STATE) LIGHT DATA
1224, d4bf4O_, 0.7244, 3.68, 0.158, 411, 385, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1225, d3wrmA_, 0.7244, 3.68, 0.158, 411, 385, CRYSTAL STRUCTURE OF P450CAM
1226, d3r9bC_, 0.7244, 3.61, 0.156, 406, 384, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1227, d3r9bB_, 0.7244, 3.63, 0.151, 405, 384, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1228, d2gqxA_, 0.7244, 3.30, 0.171, 385, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1229, d1dz9A_, 0.7244, 3.60, 0.154, 405, 384, PUTATIVE OXO COMPLEX OF P450CAM FROM PSEUDOMONAS PUTIDA
1230, d3wrjA_, 0.7243, 3.65, 0.151, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1231, d3r9bA_, 0.7243, 3.57, 0.161, 399, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM SMEGMATIS CYP164A2 IN LIGAND FREE STATE
1232, d2z97A_, 0.7243, 3.65, 0.154, 405, 384, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 7- METHYL-7-DEPROPIONATED HEMIN
1233, d1j51C_, 0.7243, 3.65, 0.154, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1234, d4l4cA_, 0.7242, 3.65, 0.151, 405, 384, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1235, d4b7dB_, 0.7242, 3.64, 0.154, 405, 384, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1236, d3abbA1, 0.7242, 3.17, 0.189, 376, 371, CRYSTAL STRUCTURE OF CYP105D6
1237, d2y5nB1, 0.7242, 3.17, 0.189, 376, 371, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1238, d1cmnA_, 0.7242, 3.34, 0.122, 389, 377, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND THEIR SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1239, d2wi9B_, 0.7241, 3.34, 0.122, 389, 377, SELECTIVE OXIDATION OF CARBOLIDE C-H BONDS BY ENGINEERED MACROLIDE P450 MONOOXYGENASE
1240, d1cl6A_, 0.7241, 3.64, 0.151, 405, 384, CRYSTAL STRUCTURES OF FERRIC-NO COMPLEXES OF FUNGAL NITRIC OXIDE REDUCTASE AND ITS SER286 MUTANTS AT CRYOGENIC TEMPERATURE
1241, d2frzA_, 0.7240, 3.59, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1242, d1uyuA_, 0.7240, 3.65, 0.154, 405, 384, XENON COMPLEX OF WILDTYPE P450CAM FROM PSEUDOMONAS PUTIDA
1243, d1t87B_, 0.7240, 3.62, 0.151, 405, 384, CRYSTAL STRUCTURE OF THE FERROUS CO-BOUND CYTOCHROME P450CAM (C334A)
1244, d1gejA_, 0.7240, 3.65, 0.154, 405, 384, STRUCTURAL CHARACTERIZATION OF N-BUTYL-ISOCYANIDE COMPLEXES OF CYTOCHROMES P450NOR AND P450CAM
1245, d1dz6A_, 0.7240, 3.55, 0.179, 400, 380, FERROUS P450CAM FROM PSEUDOMONAS PUTIDA
1246, d4g3rA_, 0.7239, 3.55, 0.179, 400, 380, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1247, d4bf4L_, 0.7239, 3.61, 0.154, 407, 384, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1248, d2gr6A_, 0.7239, 3.62, 0.156, 403, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1249, d3fwgB_, 0.7238, 3.70, 0.167, 396, 384, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1250, d2vzmA_, 0.7238, 3.59, 0.149, 405, 383, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1251, d2qblA_, 0.7238, 3.67, 0.156, 406, 385, CRYSTAL STRUCTURE OF FERRIC G248T CYTOCHROME P450CAM
1252, d1gedA_, 0.7238, 3.64, 0.151, 405, 385, A POSITIVE CHARGE ROUTE FOR THE ACCESS OF NADH TO HEME FORMED IN THE DISTAL HEME POCKET OF CYTOCHROME P450NOR
1253, d5y5hA_, 0.7237, 3.31, 0.169, 384, 372, SF-ROX STRUCTURE OF CYTOCHROME P450NOR (NO-BOUND STATE) DETERMINED AT SACLA
1254, d5y5gA_, 0.7237, 3.62, 0.154, 405, 384, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
1255, d2qboA_, 0.7237, 3.60, 0.154, 405, 383, CRYSTAL STRUCTURE OF THE P450CAM G248V MUTANT IN THE CYANIDE BOUND STATE
1256, d2qbnA_, 0.7236, 3.62, 0.154, 405, 384, CRYSTAL STRUCTURE OF FERRIC G248V CYTOCHROME P450CAM
1257, d2h7rA_, 0.7236, 3.62, 0.165, 394, 382, L244A MUTANT OF CYTOCHROME P450CAM COMPLEXED WITH IMIDAZOLE
1258, d1c8jA_, 0.7236, 3.50, 0.164, 407, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1259, d5kyoB_, 0.7235, 3.63, 0.151, 405, 384, CRYSTAL STRUCTURE OF CYP101J2
1260, d4g47A_, 0.7235, 3.62, 0.154, 405, 384, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-(1H-124- TRIAZOL-1-YL)PHENOL
1261, d4g44A_, 0.7235, 3.59, 0.203, 395, 380, STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND MB286 3-((1H- 124-TRIAZOL-1-YL)METHYL)ANILINE
1262, d2a1mB_, 0.7235, 3.63, 0.154, 405, 384, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF WILD-TYPE CYTOCHROME P450CAM
1263, d1f26A_, 0.7235, 3.66, 0.153, 405, 385, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243VAL MUTANTS OF CYTOCHROME P450NOR
1264, d1f24A_, 0.7235, 3.63, 0.150, 399, 380, CRYSTAL STRUCTURE OF NO COMPLEX OF THR243ALA MUTANTS OF CYTOCHROME P450NOR
1265, p5op9A_, 0.7234, 3.63, 0.154, 405, 384, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7E
1266, d4yt3B_, 0.7233, 3.61, 0.156, 399, 379, CYP106A2
1267, d3wrmF_, 0.7233, 3.54, 0.151, 399, 378, CRYSTAL STRUCTURE OF P450CAM
1268, d3cxzA_, 0.7233, 3.59, 0.156, 399, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 R386L MUTANT FROM M. TUBERCULOSIS
1269, d2vzmB_, 0.7233, 3.54, 0.151, 399, 378, CRYSTAL STRUCTURE OF THE NARBOMYCIN-BOUND PIKC D50N MUTANT
1270, d5de9A1, 0.7232, 3.31, 0.150, 386, 374, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1271, d3g5fA_, 0.7232, 3.59, 0.154, 405, 383, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1272, d1ehgA_, 0.7232, 3.63, 0.154, 407, 384, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1273, d1eheA_, 0.7232, 3.60, 0.154, 404, 383, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1274, p5o4kA_, 0.7231, 3.54, 0.151, 399, 378, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6B.
1275, d5de9B1, 0.7231, 3.47, 0.156, 399, 377, THE ROLE OF ILE87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1276, d4ktjA_, 0.7231, 3.59, 0.154, 405, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-1H-PYRAZOL-4-YL)PHENOL
1277, d4g46A_, 0.7231, 3.60, 0.163, 393, 381, STRUCTURE OF CYTOCHROME P450 CYP121 IN COMPLEX WITH 4-OXO-4567- TETRAHYDROBENZOFURAN-3-CARBOXYLATE
1278, d5edtA_, 0.7230, 3.67, 0.153, 405, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH LIG9
1279, d4g1xA_, 0.7230, 3.63, 0.154, 405, 384, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(1H-124-TRIAZOL-1-YL)QUINOLIN-6-AMINE
1280, d3wrlE_, 0.7230, 3.63, 0.156, 405, 384, CRYSTAL STRUCTURE OF P450CAM
1281, d4ktlA_, 0.7229, 3.69, 0.180, 397, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-((4-HYDROXYPHENYL)AMINO)-1H-PYRAZOLE-45-DIYL)DIPHENOL
1282, d4ictA_, 0.7229, 3.60, 0.154, 404, 383, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1283, d4g48A_, 0.7229, 3.63, 0.161, 399, 379, STRUCTURE OF CYP121 IN COMPLEX WITH 4-(4-PHENOXY-1H-PYRAZOL-3-YL) BENZENE-13-DIOL
1284, d3wrhE_, 0.7229, 3.64, 0.154, 407, 384, CRYSTAL STRUCTURE OF P450CAM
1285, d2m56A_, 0.7229, 3.63, 0.156, 405, 384, THE STRUCTURE OF THE COMPLEX OF CYTOCHROME P450CAM AND ITS ELECTRON DONOR PUTIDAREDOXIN DETERMINED BY PARAMAGNETIC NMR SPECTROSCOPY
1286, p5mnvA_, 0.7228, 3.21, 0.167, 388, 371, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1287, d5ibeA_, 0.7228, 3.21, 0.167, 388, 371, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25A
1288, d4ktkA_, 0.7228, 3.49, 0.156, 399, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 4-(3-AMINO-4-(4-HYDROXYPHENYL)-1H-PYRAZOL-5-YL)BENZENE-13-DIOL
1289, d4g2gA_, 0.7228, 3.25, 0.189, 388, 370, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(1H-123-TRIAZOLE-15-DIYL)DIPHENOL
1290, d4bf4N_, 0.7228, 3.64, 0.154, 405, 384, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1291, d3cxvA_, 0.7228, 3.47, 0.193, 393, 379, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 A233G MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1292, d1ehfA_, 0.7228, 3.60, 0.154, 405, 383, CRYSTAL STRUCTURES OF CYTOCHROME P450NOR AND ITS MUTANTS (SER286 VAL THR) IN THE FERRIC RESTING STATE AT CRYOGENIC TEMPERATURE: A COMPARATIVE ANALYSIS WITH MONOOXYGENASE CYTOCHROME P450S
1293, d5kyoA_, 0.7227, 3.64, 0.154, 405, 384, CRYSTAL STRUCTURE OF CYP101J2
1294, d3cxxA_, 0.7227, 3.45, 0.160, 399, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 F338H FROM M. TUBERCULOSIS
1295, d2a1nB_, 0.7227, 3.28, 0.173, 384, 371, CRYSTAL STRUCTURE OF FERROUS DIOXYGEN COMPLEX OF D251N CYTOCHROME P450CAM
1296, d1dz4A_, 0.7227, 3.71, 0.182, 397, 384, FERRIC P450CAM FROM PSEUDOMONAS PUTIDA
1297, d5l91B1, 0.7226, 3.64, 0.154, 405, 384, THE 2.2 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM BOUND WITH FOUR CORTICOSTERONE MOLECULES
1298, d4iq7A_, 0.7226, 3.61, 0.151, 405, 383, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1299, d4g45A_, 0.7226, 3.45, 0.160, 399, 376, STRUCTURE OF CYTOCHROME CYP121 IN COMPLEX WITH 2-METHYLQUINOLIN-6- AMINE
1300, d3wrjE_, 0.7226, 3.45, 0.160, 399, 376, CRYSTAL STRUCTURE OF P450CAM
1301, d3cy0A_, 0.7226, 3.63, 0.185, 397, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 S237A MUTANT FROM MYCOBACTERIUM TUBERCULOSIS
1302, d2fe6A_, 0.7226, 3.61, 0.154, 405, 383, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1303, d4bf4J_, 0.7225, 3.50, 0.183, 391, 377, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1304, d3zk5B_, 0.7225, 3.50, 0.183, 391, 377, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1305, d2xbkA_, 0.7225, 3.64, 0.156, 405, 384, X-RAY STRUCTURE OF THE SUBSTRATE-BOUND CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1306, d1mpwB_, 0.7225, 3.62, 0.157, 404, 383, MOLECULAR RECOGNITION IN (+)-A-PINENE OXIDATION BY CYTOCHROME P450CAM
1307, d5ibiA_, 0.7224, 3.64, 0.154, 405, 384, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26A
1308, d4yt3A_, 0.7224, 3.50, 0.183, 391, 377, CYP106A2
1309, d4iq9A_, 0.7224, 3.66, 0.158, 405, 385, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1310, d1t88B_, 0.7224, 3.58, 0.154, 405, 383, CRYSTAL STRUCTURE OF THE FERROUS CYTOCHROME P450CAM (C334A)
1311, d1p2yA1, 0.7224, 3.63, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM IN COMPLEX WITH (S)- (-)-NICOTINE
1312, d1n40A_, 0.7224, 3.48, 0.188, 393, 378, ATOMIC STRUCTURE OF CYP121 A MYCOBACTERIAL P450
1313, d1j51D_, 0.7224, 3.13, 0.166, 379, 368, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1314, d3tzoB1, 0.7223, 3.56, 0.153, 397, 379, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1315, d3fwgA_, 0.7223, 3.56, 0.153, 397, 379, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM ARG365LEU GLU366GLN MONOCLINIC CRYSTAL FORM
1316, d5ibdA_, 0.7222, 3.61, 0.150, 399, 379, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 24A
1317, d3fwjA_, 0.7222, 3.56, 0.192, 394, 381, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND ORTHOROMBIC CRYSTAL FORM
1318, d3fwiA_, 0.7222, 3.59, 0.153, 399, 378, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND TETRAGONAL CRYSTAL FORM
1319, d3cy1A_, 0.7222, 3.68, 0.151, 405, 385, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 S279A MUTANT FROM M. TUBERCULOSIS
1320, d4ipsA_, 0.7221, 3.64, 0.151, 404, 384, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1321, d4bf4H_, 0.7221, 3.61, 0.154, 405, 383, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1322, d3wrkD1, 0.7221, 3.47, 0.160, 399, 376, CRYSTAL STRUCTURE OF P450CAM
1323, d2zwtA_, 0.7221, 3.63, 0.151, 404, 384, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1324, d1p7rA1, 0.7221, 3.65, 0.154, 407, 384, CRYSTAL STRUCTURE OF REDUCED CO-EXPOSED COMPLEX OF CYTOCHROME P450CAM WITH (S)-(-)-NICOTINE
1325, p5wp2A_, 0.7220, 3.68, 0.188, 397, 382, 1.44 ANGSTROM CRYSTAL STRUCTURE OF CYP121 FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH SUBSTRATE AND CN 
1326, d4ipwA_, 0.7220, 3.58, 0.157, 405, 383, SUBSTRATE AND REACTION SPECIFICITY OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP121
1327, d3g5hA_, 0.7220, 3.65, 0.159, 405, 384, CRYSTALLOGRAPHIC ANALYSIS OF CYTOCHROME P450 CYP121
1328, d2zuiA_, 0.7220, 3.67, 0.196, 395, 382, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297N)
1329, d2gqxB_, 0.7219, 3.60, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A) WITH PENTACHLOROBENZENE
1330, d5y5fA_, 0.7218, 3.56, 0.159, 399, 378, STRUCTURE OF CYTOCHROME P450NOR IN NO-BOUND STATE: DAMAGED BY LOW-DOSE (0.72 MGY) X-RAY
1331, d3zpiB_, 0.7218, 3.56, 0.159, 400, 378, PIKC D50N MUTANT IN P21 SPACE GROUP
1332, d3tzoA1, 0.7218, 3.59, 0.148, 400, 379, THE ROLE OF I87 OF CYP158A2 IN OXIDATIVE COUPLING REACTION
1333, d3cxyA_, 0.7218, 3.59, 0.148, 400, 379, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 CYP121 P346L MUTANT FROM M. TUBERCULOSIS
1334, d2gr6B_, 0.7218, 3.62, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/L244A/V247L/C334A)
1335, d3tywD1, 0.7217, 3.62, 0.154, 405, 383, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1336, d2zujA_, 0.7217, 3.67, 0.159, 405, 384, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT(D297L)
1337, d1yrdA_, 0.7217, 3.65, 0.154, 405, 384, X-RAY CRYSTAL STRUCTURE OF PERDEUTERATED CYTOCHROME P450CAM
1338, d1yrcA_, 0.7217, 3.38, 0.143, 393, 377, X-RAY CRYSTAL STRUCTURE OF HYDROGENATED CYTOCHROME P450CAM
1339, d4bf4P_, 0.7216, 3.51, 0.150, 394, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1340, d4bf4B_, 0.7216, 3.51, 0.150, 394, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1341, d3e5jA1, 0.7216, 3.64, 0.151, 405, 384, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE LIGAND-FREE FORM
1342, d2zwuA_, 0.7216, 3.47, 0.157, 399, 376, CRYSTAL STRUCTURE OF CAMPHOR SOAKED FERRIC CYTOCHROME P450CAM
1343, d2zuhA_, 0.7216, 3.47, 0.157, 399, 376, CRYSTAL STRUCTURE OF CAMPHOR-SOAKED FERRIC CYTOCHROME P450CAM MUTANT (D297A)
1344, p5o4lA_, 0.7215, 3.51, 0.150, 394, 380, CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH COMPOUND 6A.
1345, d5ibjA_, 0.7215, 3.59, 0.183, 388, 377, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 6
1346, d2zaxA_, 0.7215, 3.64, 0.151, 405, 384, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM
1347, d1j51B_, 0.7215, 3.51, 0.147, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A) WITH 135-TRICHLOROBENZENE
1348, d5ikiA_, 0.7214, 3.64, 0.187, 394, 380, CYP106A2 WITH SUBSTRATE ABIETIC ACID
1349, d2c6hA_, 0.7214, 3.55, 0.177, 400, 379, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1350, d1se6B1, 0.7214, 3.52, 0.145, 394, 380, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1351, d5ibhA_, 0.7213, 3.56, 0.151, 399, 378, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 26H
1352, d5ex6A_, 0.7213, 3.49, 0.160, 399, 376, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1353, d2zawA_, 0.7213, 3.51, 0.147, 394, 380, CRYSTAL STRUCTURE OF FERRIC CYTOCHROME P450CAM RECONSTITUTED WITH 6- METHYL-6-DEPROPIONATED HEMIN
1354, p5opaA_, 0.7212, 3.58, 0.177, 400, 379, THE CRYSTAL STRUCTURE OF P450 CYP121 IN COMPLEX WITH LEAD COMPOUND 7B
1355, d4l4cB_, 0.7212, 3.53, 0.145, 394, 380, STRUCTURE OF L358P/K178G MUTANT OF P450CAM BOUND TO CAMPHOR
1356, d3fwfB_, 0.7212, 3.52, 0.150, 394, 380, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1357, d1wiyB_, 0.7212, 3.53, 0.147, 394, 380, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1358, d3tywC1, 0.7210, 3.53, 0.145, 394, 380, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1359, d2c6hB_, 0.7210, 3.68, 0.151, 405, 385, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1360, d1c8jB_, 0.7210, 3.52, 0.147, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F)
1361, d3a51A_, 0.7208, 3.52, 0.150, 394, 380, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1362, d3a4zA_, 0.7208, 3.52, 0.150, 394, 380, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1363, d2xn8A_, 0.7208, 3.65, 0.156, 405, 384, X-RAY STRUCTURE OF THE SUBSTRATE-FREE MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125
1364, d2feuA_, 0.7208, 3.62, 0.154, 404, 383, P450CAM FROM PSEUDOMONAS PUTIDA RECONSTITUTED WITH MANGANIC PROTOPORPHYRIN IX
1365, d5y1iA_, 0.7207, 3.66, 0.174, 397, 380, THE CRYSTAL STRUCTURE OF GFSF
1366, d4g3rB_, 0.7207, 3.66, 0.174, 397, 380, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CAM
1367, d3a4hA_, 0.7207, 3.52, 0.147, 394, 380, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (ORTHORHOMBIC CRYSTAL FORM)
1368, d5ibfA_, 0.7206, 3.54, 0.145, 394, 380, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 19A
1369, d4b7sA_, 0.7206, 3.52, 0.150, 394, 380, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1370, d2frzB_, 0.7205, 3.67, 0.196, 397, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450CAM MUTANT (F87W/Y96F/V247L/C334A)
1371, d5kyoE_, 0.7204, 3.51, 0.145, 394, 380, CRYSTAL STRUCTURE OF CYP101J2
1372, d4b7sB_, 0.7204, 3.52, 0.156, 399, 377, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN- DIMETHYLAMINO)PROPANOATE ANCHORING GROUP
1373, d3a50A_, 0.7204, 3.35, 0.138, 394, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1374, d4bf4E_, 0.7203, 3.35, 0.138, 394, 376, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1375, d3zpiA_, 0.7203, 3.53, 0.142, 394, 380, PIKC D50N MUTANT IN P21 SPACE GROUP
1376, d3zk5A_, 0.7203, 3.66, 0.151, 405, 384, PIKC D50N MUTANT BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO)ETHANOATE ANCHORING GROUP
1377, d4bf4A_, 0.7202, 3.65, 0.151, 404, 384, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1378, d3wrkA1, 0.7201, 3.33, 0.169, 387, 372, CRYSTAL STRUCTURE OF P450CAM
1379, d4bf4I_, 0.7200, 3.53, 0.147, 394, 380, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1380, d3oftC_, 0.7200, 3.52, 0.147, 394, 380, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1381, d1lg9A_, 0.7199, 3.65, 0.154, 405, 384, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1382, d4ktfA_, 0.7198, 3.54, 0.145, 394, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH 44 -(3-AMINO-1H-PYRAZOLE-45-DIYL)DIPHENOL
1383, d3nc5A_, 0.7197, 3.66, 0.154, 405, 384, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1384, d3a4zB_, 0.7197, 3.71, 0.188, 397, 383, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1385, d1gjmA_, 0.7197, 3.55, 0.193, 394, 379, COVALENT ATTACHMENT OF AN ELECTROACTIVE SULPHYDRYL REAGENT IN THE ACTIVE SITE OF CYTOCHROME P450CAM
1386, d4bf4K_, 0.7196, 3.35, 0.149, 391, 370, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1387, d2wioA_, 0.7195, 3.35, 0.149, 391, 370, STRUCTURE OF THE  HISTIDINE TAGGED OPEN CYTOCHROME P450 ERYK FROM S. ERYTHRAEA
1388, d2vrvA_, 0.7195, 3.66, 0.151, 405, 384,  
1389, d3ofuE_, 0.7194, 3.49, 0.148, 393, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1390, d1lfkA_, 0.7194, 3.57, 0.186, 388, 376, CRYSTAL STRUCTURE OF OXYB A CYTOCHROME P450 IMPLICATED IN AN OXIDATIVE PHENOL COUPLING REACTION DURING VANCOMYCIN BIOSYNTHESIS
1391, d4aw3B_, 0.7193, 3.53, 0.147, 394, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1392, d3a51B_, 0.7193, 3.66, 0.151, 405, 384, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1393, d2xc3A_, 0.7193, 3.66, 0.154, 405, 384, X-RAY STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP125 BOUND TO THE REVERSE TYPE I INHIBITOR
1394, d3a51D_, 0.7192, 3.52, 0.147, 394, 380, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1395, d2y5zC_, 0.7192, 3.52, 0.147, 394, 380, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1396, d1odoA_, 0.7192, 3.66, 0.154, 405, 384, 1.85 A STRUCTURE OF CYP154A1 FROM STREPTOMYCES COELICOLOR A3(2)
1397, d4bf4G_, 0.7191, 3.57, 0.177, 400, 379, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1398, d4bf4C_, 0.7191, 3.65, 0.156, 404, 384, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1399, d1n4gA_, 0.7191, 3.53, 0.147, 394, 380, STRUCTURE OF CYP121 A MYCOBACTERIAL P450 IN COMPLEX WITH IODOPYRAZOLE
1400, d4bf4F_, 0.7190, 3.68, 0.161, 405, 384, PIKC D50N MUTANT IN COMPLEX WITH THE ENGINEERED CYCLOALKANE SUBSTRATE MIMIC BEARING A TERMIANL NN-DIMETHYLAMINO GROUP
1401, d3a50B_, 0.7190, 3.68, 0.161, 405, 384, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1402, d2ygxD_, 0.7190, 3.52, 0.147, 394, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1403, d4b7dA_, 0.7189, 3.53, 0.150, 394, 380, PIKC BOUND TO THE 10-DML ANALOG WITH THE 3-(NN-DIMETHYLAMINO) PROPANOATE ANCHORING GROUP
1404, d2y5zB_, 0.7189, 3.74, 0.180, 396, 383, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1405, d2ygxB_, 0.7188, 3.47, 0.165, 390, 375, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1406, d2ycaA_, 0.7188, 3.64, 0.157, 405, 383, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN P21212 SPACE GROUP
1407, d5gnmD_, 0.7185, 3.67, 0.154, 405, 384, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1408, d3e5kA1, 0.7185, 3.55, 0.147, 394, 380, CRYSTAL STRUCTURE OF CYP105P1 WILD-TYPE 4-PHENYLIMIDAZOLE COMPLEX
1409, d2y5nA_, 0.7183, 3.54, 0.147, 394, 380, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN V IN P21 SPACE GROUP
1410, d2ca0A_, 0.7183, 3.55, 0.145, 394, 380, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1411, d2l8mA_, 0.7181, 3.70, 0.156, 405, 385, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1412, d3ofuF_, 0.7180, 3.67, 0.154, 405, 384, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP101C1
1413, d3a51C_, 0.7177, 3.59, 0.148, 399, 378, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1414, d2ij5C_, 0.7177, 3.72, 0.188, 396, 382, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1415, d5kyoC_, 0.7176, 3.58, 0.177, 400, 379, CRYSTAL STRUCTURE OF CYP101J2
1416, d3tywB1, 0.7176, 3.49, 0.148, 393, 379, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1417, d3a4zC_, 0.7176, 3.61, 0.154, 405, 383, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1418, d2ygxA_, 0.7176, 3.50, 0.170, 395, 376, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1419, p5mnvH_, 0.7175, 3.68, 0.161, 405, 384, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1420, d3ivyA_, 0.7175, 3.64, 0.157, 405, 383, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 P212121 CRYSTAL FORM
1421, d2ygxC_, 0.7175, 3.64, 0.157, 405, 383, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN P21 SPACE GROUP
1422, d5l94A_, 0.7174, 3.60, 0.200, 396, 380, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1423, d4z5pA_, 0.7174, 3.68, 0.188, 397, 382, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1424, d3zsnC_, 0.7174, 3.55, 0.177, 389, 378, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1425, d3zsnA_, 0.7173, 3.67, 0.154, 405, 384, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1426, d3a4gA_, 0.7173, 3.67, 0.154, 405, 384, STRUCTURE OF CYTOCHROME P450 VDH FROM PSEUDONOCARDIA AUTOTROPHICA (TRIGONAL CRYSTAL FORM)
1427, d2c7xA_, 0.7173, 3.51, 0.148, 393, 379, CRYSTAL STRUCTURE OF NARBOMYCIN-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1428, d3zsnB_, 0.7172, 3.50, 0.148, 393, 379, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286A MUTANT IN COMPLEX WITH MYCINAMICIN IV
1429, d3fwfA_, 0.7172, 3.67, 0.154, 405, 384, FERRIC CAMPHOR BOUND CYTOCHROME P450CAM CONTAINING A SELENOCYSTEINE AS THE 5TH HEME LIGAND MONOCLINIC CRYSTAL FORM
1430, d4xe3A_, 0.7171, 3.61, 0.154, 405, 383, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1431, d3a51E_, 0.7171, 3.33, 0.183, 383, 371, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND 25-HYDROXYVITAMIN D3
1432, d5l92A_, 0.7170, 3.54, 0.193, 393, 378, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1433, d3a4zE_, 0.7170, 3.45, 0.170, 400, 376, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1434, d3a4zD_, 0.7170, 3.52, 0.148, 393, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION
1435, d2y46C_, 0.7170, 3.28, 0.190, 386, 369, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1436, d2y46B_, 0.7169, 3.70, 0.156, 405, 385, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1437, d3a50C_, 0.7168, 3.53, 0.145, 393, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1438, d3tywA1, 0.7167, 3.66, 0.157, 405, 383, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR A3(2)
1439, d3iw1A_, 0.7167, 3.74, 0.158, 405, 385, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ANDROSTENEDIONE
1440, d2y46A_, 0.7166, 2.81, 0.192, 362, 359, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN C 2 2 21 SPACE GROUP
1441, d4aw3A_, 0.7165, 3.55, 0.167, 395, 377, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG F286V MUTANT IN COMPLEX WITH MYCINAMICIN V IN P1 SPACE GROUP
1442, d5li8A_, 0.7164, 3.60, 0.195, 394, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH KETOCONAZOLE
1443, p5mnsA_, 0.7162, 3.69, 0.151, 405, 384, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1444, d3a50D_, 0.7162, 3.79, 0.176, 402, 381, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1445, d2ij5A_, 0.7162, 3.79, 0.176, 402, 381, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1446, d5gweB_, 0.7161, 3.79, 0.176, 402, 381, CYTOCHROME P450 CREJ
1447, d4z5pB_, 0.7161, 3.64, 0.153, 409, 380, CRYSTAL STRUCTURE OF THE LNMA CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.9 A RESOLUTION
1448, d4pwvA_, 0.7161, 3.69, 0.154, 404, 384, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS IN COMPLEX WITH A PEPTIDYL CARRIER PROTEIN DOMAIN
1449, d2y98A_, 0.7161, 3.52, 0.150, 388, 374, STRUCTURE OF THE MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN IV IN P21212 SPACE GROUP
1450, d2ij5B_, 0.7161, 3.66, 0.157, 405, 383, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1451, d2bvjA_, 0.7161, 3.55, 0.175, 400, 377, LIGAND-FREE STRUCTURE OF CYTOCHROME P450 PIKC (CYP107L1)
1452, d3a50E_, 0.7160, 3.54, 0.145, 393, 379, STRUCTURE OF CYTOCHROME P450 VDH MUTANT (VDH-K1) OBTAINED BY DIRECTED EVOLUTION WITH BOUND VITAMIN D3
1453, d5gnmC_, 0.7159, 3.71, 0.191, 397, 382, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1454, d2y5zA_, 0.7159, 3.69, 0.156, 405, 384, MIXED-FUNCTION P450 MYCG IN COMPLEX WITH MYCINAMICIN III IN C2221 SPACE GROUP
1455, d5ofqD_, 0.7158, 3.48, 0.138, 390, 378, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1456, p5mnsB_, 0.7158, 3.56, 0.190, 393, 378, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1457, p5d3uA_, 0.7158, 3.79, 0.176, 402, 381, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1458, d4xe3B_, 0.7158, 3.77, 0.188, 397, 383, OLEP THE CYTOCHROME P450 EPOXIDASE FROM STREPTOMYCES ANTIBIOTICUS INVOLVED IN OLEANDOMYCIN BIOSYNTHESIS: FUNCTIONAL ANALYSIS AND CRYSTALLOGRAPHIC STRUCTURE IN COMPLEX WITH CLOTRIMAZOLE.
1459, p5d40A_, 0.7157, 3.72, 0.189, 396, 381, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1460, d2z3tA_, 0.7157, 3.72, 0.185, 397, 383, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1461, d5gnlA_, 0.7156, 3.72, 0.185, 397, 383, CYTOCHROME P450 VDH (CYP107BR1) F106V MUTANT
1462, d2z3tC_, 0.7156, 3.68, 0.192, 396, 381, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1463, d3iw2A_, 0.7155, 3.47, 0.166, 389, 374, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450 CYP125 IN COMPLEX WITH ECONAZOLE
1464, p5mnvB_, 0.7153, 3.69, 0.192, 396, 381, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1465, d2ca0B_, 0.7149, 3.58, 0.169, 390, 378, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC ( CYP107L1)
1466, d2cd8B_, 0.7148, 3.11, 0.178, 377, 365, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1467, p4l36A_, 0.7147, 3.52, 0.143, 392, 378, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1468, d3vrmA_, 0.7147, 3.37, 0.173, 384, 370, STRUCTURE OF CYTOCHROME P450 VDH MUTANT T107A WITH BOUND VITAMIN D3
1469, d5l92B_, 0.7145, 3.70, 0.179, 402, 379, THE 2.1 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH CORTICOSTERONE
1470, p5d3uB_, 0.7143, 3.88, 0.153, 405, 386, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176F MUTANT OF CYTOCHROME TXTE
1471, d3wecA_, 0.7142, 3.76, 0.180, 397, 383, STRUCTURE OF P450 RAUA (CYP1050A1) COMPLEXED WITH A BIOSYNTHETIC INTERMEDIATE OF AURACHIN RE
1472, d5ibgA_, 0.7140, 3.73, 0.156, 393, 378, CRYSTAL STRUCTURE MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH INHIBITOR FRAGMENT 25B
1473, d5ofqC_, 0.7139, 3.74, 0.164, 391, 378, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1474, d5ofqA_, 0.7139, 3.58, 0.164, 390, 378, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1475, p5d40B_, 0.7137, 3.18, 0.166, 375, 367, CRYSTAL STRUCTURE OF THE 5-SELECTIVE H176Y MUTANT OF CYTOCHROME TXTE
1476, d5gnmB_, 0.7135, 3.48, 0.155, 393, 375, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1477, d4fxbA_, 0.7135, 3.70, 0.179, 402, 379, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1478, d5hdiA_, 0.7134, 3.56, 0.154, 409, 377, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1479, d4tx3A_, 0.7132, 3.77, 0.179, 402, 380, COMPLEX OF THE X-DOMAIN AND OXYB FROM TEICOPLANIN BIOSYNTHESIS
1480, d2ij7A_, 0.7132, 3.76, 0.152, 394, 381, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1481, d5ex6B_, 0.7131, 3.60, 0.148, 395, 379, STRUCTURE OF P450 STAH FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS
1482, d2nz5A1, 0.7131, 3.60, 0.148, 395, 379, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1483, d2ij7E_, 0.7130, 3.73, 0.197, 396, 381, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1484, d2dkkA1, 0.7130, 3.73, 0.197, 396, 381, STRUCTURE/FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1485, d2lqdA_, 0.7128, 3.53, 0.148, 392, 378, REDUCED AND CO-BOUND CYTOCHROME P450CAM (CYP101A1)
1486, d2ij7B_, 0.7127, 3.68, 0.200, 396, 380, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1487, d5gnmA_, 0.7126, 3.70, 0.179, 402, 379, CYTOCHROME P450 VDH (CYP107BR1) L348M MUTANT
1488, d2ij7F_, 0.7126, 3.65, 0.156, 393, 378, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1489, d2ij7C_, 0.7121, 3.57, 0.188, 393, 378, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1490, d2cd8A_, 0.7121, 3.77, 0.150, 394, 381, CRYSTAL STRUCTURE OF YC-17-BOUND CYTOCHROME P450 PIKC (CYP107L1)
1491, d2nzaB1, 0.7120, 3.65, 0.156, 393, 378, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1492, d2ij7D_, 0.7118, 3.73, 0.150, 393, 380, STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP121 IN COMPLEX WITH THE ANTIFUNGAL DRUG FLUCONAZOLE
1493, d2ij5D_, 0.7118, 3.73, 0.169, 401, 379, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1494, d2uuqA_, 0.7116, 3.28, 0.173, 380, 369, CRYSTAL STRUCTURE OF CYP130 FROM MYCOBACTERIUM TUBERCULOSIS IN THE LIGAND-FREE FORM
1495, d3nc3A_, 0.7115, 3.53, 0.152, 394, 376, CYP134A1 STRUCTURE WITH A CLOSED SUBSTRATE BINDING LOOP
1496, d2z3tD_, 0.7112, 3.60, 0.199, 393, 377, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1497, d2nzaA1, 0.7110, 3.78, 0.148, 405, 385, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1498, d2nz5B1, 0.7108, 3.63, 0.169, 390, 378, STRUCTURE AND FUNCTION STUDIES OF CYTOCHROME P450 158A1 FROM STREPTOMYCES COELICOLOR A3(2)
1499, d5lieB_, 0.7105, 3.80, 0.179, 401, 380, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1500, d5ofqB_, 0.7104, 3.64, 0.136, 394, 381, CRYSTAL STRUCTURE OF SUBSTRATE-FREE CYP109A2 FROM BACILLUS MEGATERIUM
1501, d5l94B_, 0.7103, 3.34, 0.139, 390, 373, THE 2.25 A CRYSTAL STRUCTURE OF CYP109E1 FROM BACILLUS MEGATERIUM IN COMPLEX WITH TESTOSTERONE
1502, d2x9pA_, 0.7103, 3.57, 0.165, 395, 375, X-RAY STRUCTURE OF THE SUBSTRATE-FREE CYTOCHROME P450 PIMD - A POLYENE MACROLIDE ANTIBIOTIC PIMARICIN EPOXIDASE
1503, p5mnsF_, 0.7102, 3.81, 0.176, 401, 380, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1504, d2whfA_, 0.7102, 3.67, 0.156, 393, 378, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1505, d5hh3C1, 0.7101, 3.68, 0.169, 395, 378, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1506, d3nc6A_, 0.7100, 3.56, 0.163, 399, 374, CYP134A1 1-PHENYLIMIDAZOLE BOUND STRUCTURE
1507, d3mgxB_, 0.7096, 3.68, 0.156, 393, 378, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1508, p4oqsA_, 0.7095, 3.52, 0.167, 385, 372, CRYSTAL STRUCTURE OF CYP105AS1
1509, d2wgyA_, 0.7089, 3.28, 0.159, 388, 370, CRYSTAL STRUCTURE OF THE G243A MUTANT OF CYP130 FROM M. TUBERCULOSIS
1510, d1wiyA_, 0.7083, 3.28, 0.159, 388, 370, CRYSTAL STRUCTURE ANALYSIS OF A 6-COORDINATED CYTOCHOROME P450 FROM THERMUS THERMOPHILUS HB8
1511, d3mgxA_, 0.7082, 3.77, 0.150, 393, 380, CRYSTAL STRUCTURE OF P450 OXYD THAT IS INVOLVED IN THE BIOSYNTHESIS OF VANCOMYCIN-TYPE ANTIBIOTICS
1512, d4rm4A_, 0.7080, 3.77, 0.150, 393, 380, THE CRYSTAL STRUCTURE OF THE VERSATILE CYTOCHROME P450 ENZYME CYP109B1 FROM BACILLUS SUBTILIS
1513, d4fxbB_, 0.7073, 3.58, 0.173, 395, 376, CRYSTAL STRUCTURE OF CYP105N1 FROM STREPTOMYCES COELICOLOR: A CYTOCHROME P450 OXIDASE IN THE COELIBACTIN SIDEROPHORE BIOSYNTHETIC PATHWAY
1514, d3o1aA_, 0.7064, 3.80, 0.188, 396, 382, STRUCTURE OF OXYE (CYP165D3) A CYTOCHROME P450 INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1515, d5kyoF_, 0.7063, 3.77, 0.150, 393, 380, CRYSTAL STRUCTURE OF CYP101J2
1516, d5hdiB_, 0.7059, 3.69, 0.157, 404, 383, STRUCTURAL CHARACTERIZATION OF CYP144A1 A MYCOBACTERIUM TUBERCULOSIS CYTOCHROME P450
1517, d5kyoD_, 0.7058, 3.71, 0.164, 394, 379, CRYSTAL STRUCTURE OF CYP101J2
1518, d3nc5B_, 0.7056, 3.70, 0.177, 401, 378, CYP134A1 STRUCTURE WITH AN OPEN SUBSTRATE BINDING LOOP
1519, d2ij5E_, 0.7056, 3.48, 0.167, 386, 371, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1520, d2z3tB_, 0.7053, 3.70, 0.180, 401, 378, CRYSTAL STRUCTURE OF SUBSTRATE FREE CYTOCHROME P450 STAP (CYP245A1)
1521, d2ij5F_, 0.7047, 3.72, 0.177, 401, 378, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP121 P212121 SPACE GROUP
1522, d2wh8A_, 0.7040, 3.78, 0.150, 393, 380, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1523, d3oo3A_, 0.7032, 3.78, 0.150, 393, 380, CRYSTAL STRUCTURE OF THE ORF6* (CYP165D3) MONOOXYGENASE INVOLVED IN TEICOPLANIN BIOSYNTHESIS
1524, d5hh3A_, 0.7031, 3.82, 0.179, 401, 380, OXYA FROM ACTINOPLANES TEICHOMYCETICUS
1525, d2wh8C_, 0.7029, 3.56, 0.168, 395, 376, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1526, d2wh8B_, 0.7024, 3.56, 0.168, 395, 376, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1527, d2wh8D_, 0.7022, 3.48, 0.164, 398, 372, INTERACTION OF MYCOBACTERIUM TUBERCULOSIS CYP130 WITH HETEROCYCLIC ARYLAMINES
1528, p5mnvG_, 0.7020, 3.78, 0.150, 393, 380, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1529, d5uhuA_, 0.7010, 3.54, 0.155, 393, 375, SOLUTION CONFORMATION OF CYTOCHROME P450 MYCG WITH MYCINAMICIN IV BOUND
1530, d1se6A1, 0.6983, 3.58, 0.130, 390, 376, CRYSTAL STRUCTURE OF STREPTOMYCES COELICOLOR A3(2) CYP158A2 FROM ANTIBIOTIC BIOSYNTHETIC PATHWAYS
1531, d5lieA_, 0.6970, 3.67, 0.158, 395, 379, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH IMIDAZOLE
1532, d5li6B_, 0.6952, 3.72, 0.177, 401, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1533, d3b4xA_, 0.6947, 3.60, 0.140, 392, 378, CRYSTAL STRUCTURE ANALYSIS OF SULFOLOBUS TOKODAII STRAIN7 CYTOCHROM P450
1534, d5li6A_, 0.6946, 3.55, 0.165, 396, 375, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH N-ISOPROPYL-N-((3-(4-METHOXYPHENYL)-124-OXADIAZOL-5-YL) METHYL)-2-(4-NITROPHENYL)ACETAMIDE
1535, d4e2pA_, 0.6904, 3.30, 0.159, 388, 370, CRYSTAL STRUCTURE OF A POST-TAILORING HYDROXYLASE (HMTN) INVOLVED IN THE HIMASTATIN BIOSYNTHESIS
1536, d1ue8A_, 0.6902, 3.63, 0.164, 404, 377, CRYSTAL STRUCTURE OF THERMOPHILIC CYTOCHROME P450 FROM SULFOLOBUS TOKODAII
1537, d2uvnA1, 0.6898, 3.80, 0.150, 393, 380, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1538, d1f4tB_, 0.6886, 3.50, 0.146, 390, 377, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1539, d5li7B_, 0.6864, 3.66, 0.199, 394, 377, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1540, d5li7A_, 0.6862, 3.71, 0.177, 401, 378, CRYSTAL STRUCTURE OF MYCOBACTERIUM TUBERCULOSIS CYP126A1 IN COMPLEX WITH 1-(3-(1H-IMIDAZOL-1-YL)PROPYL)-3-((3S5S7S)-ADAMANTAN-1-YL)UREA
1541, d4wpdB_, 0.6852, 3.69, 0.172, 401, 377, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1542, d1f4tA_, 0.6851, 3.69, 0.153, 393, 378, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS WITH 4- PHENYLIMIDAZOLE BOUND
1543, d4wpdA_, 0.6845, 3.37, 0.152, 387, 369, X-RAY CRYSTAL STRUCTURE OF CYP119 COMPLEXED WITH 4-(4-FLOUROPHENYL)- 1H-IMIDAZOLE
1544, d4wqjA_, 0.6844, 3.37, 0.152, 387, 369, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COLLECTED AT 298K AND COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1545, d1f4uB_, 0.6841, 3.64, 0.156, 395, 378, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1546, d1f4uA_, 0.6840, 3.89, 0.120, 403, 383, THERMOPHILIC P450: CYP119 FROM SULFOLOBUS SOLFACTARICUS
1547, d4tuvA_, 0.6839, 3.89, 0.120, 403, 383, X-RAY CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-CHLOROPHENYL)IMIDAZOLE
1548, d4tt5A_, 0.6835, 3.78, 0.158, 394, 380, CRYSTAL STRUCTURE OF CYP119 FROM SULFOLOBUS ACIDOCALDARIUS COMPLEXED WITH 4-(4-BROMOPHENYL)-1H IMIDAZOLE
1549, d4tvfA_, 0.6829, 3.89, 0.120, 403, 383, OXYB FROM ACTINOPLANES TEICHOMYCETICUS
1550, p3qi8A1, 0.6823, 3.46, 0.177, 385, 373, EVOLVED VARIANT OF CYTOCHROME P450 (BM3 CYP102A1)
1551, d2uvnB_, 0.6817, 3.73, 0.175, 395, 378, CRYSTAL STRUCTURE OF ECONAZOLE-BOUND CYP130 FROM MYCOBACTERIUM TUBERCULOSIS
1552, d1io9A_, 0.6817, 3.46, 0.177, 383, 373, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1553, d1io7A_, 0.6793, 3.42, 0.164, 398, 371, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1554, d1io8A_, 0.6774, 3.61, 0.159, 394, 377, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1555, d1io8B_, 0.6749, 3.68, 0.190, 393, 378, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1556, d1io7B_, 0.6748, 3.60, 0.193, 392, 378, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1557, d4z5qA_, 0.6734, 3.59, 0.122, 396, 377, CRYSTAL STRUCTURE OF THE LNMZ CYTOCHROME P450 HYDROXYLASE FROM THE LEINAMYCIN BIOSYNTHETIC PATHWAY OF STREPTOMYCES ATROOLIVACEUS S-140 AT 1.8 A RESOLUTION
1558, d1io9B_, 0.6696, 3.60, 0.181, 402, 375, THERMOPHILIC CYTOCHROME P450 (CYP119) FROM SULFOLOBUS SOLFATARICUS: HIGH RESOLUTION STRUCTURAL ORIGIN OF ITS THERMOSTABILITY AND FUNCTIONAL PROPERTIES
1559, d2rfcD_, 0.6661, 3.04, 0.180, 370, 361, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1560, d2rfbA_, 0.6601, 3.91, 0.123, 403, 383, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1561, d2rfcB_, 0.6576, 3.49, 0.147, 401, 375, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1562, d2rfcC_, 0.6570, 3.49, 0.147, 401, 375, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1563, p3g93A1, 0.6553, 3.56, 0.141, 390, 376, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1564, d2rfbB_, 0.6528, 3.50, 0.164, 386, 372, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1565, d2rfcA_, 0.6527, 3.34, 0.147, 386, 368, LIGAND BOUND (4-PHENYLIMIDAZOLE) CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1566, p6fshD1, 0.6524, 3.93, 0.125, 403, 384, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1567, p5tftB1, 0.6517, 3.68, 0.176, 399, 376, STRUCTURE OF CYTOCHROME P450 2D6 (CYP2D6) BACE1 INHIBITOR COMPLEX
1568, d2rfbC_, 0.6511, 3.64, 0.171, 390, 375, CRYSTAL STRUCTURE OF A CYTOCHROME P450 FROM THE THERMOACIDOPHILIC ARCHAEON PICROPHILUS TORRIDUS
1569, p6fshA1, 0.6502, 3.45, 0.137, 397, 371, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1570, p6fshB1, 0.6484, 3.45, 0.137, 397, 371, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1571, p6fshC1, 0.6478, 3.16, 0.185, 373, 363, CRYSTAL STRUCTURE OF HYBRID P450 OXYBTEI(BC/FGVAN) 
1572, p3g93C1, 0.6435, 3.61, 0.143, 391, 377, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1573, p3g93D1, 0.6407, 3.15, 0.184, 371, 364, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1574, p3r1bC1, 0.6369, 3.61, 0.144, 395, 374, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1575, p3r1bD1, 0.6232, 3.58, 0.141, 391, 376, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1576, p3r1bB1, 0.6212, 3.50, 0.140, 395, 372, OPEN CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 COVALENTLY BOUND TO THE MECHANISM-BASED INACTIVATOR TERT-BUTYLPHENYLACETYLENE
1577, p3g93B1, 0.6186, 3.91, 0.150, 405, 386, SINGLE LIGAND OCCUPANCY CRYSTAL STRUCTURE OF CYTOCHROME P450 2B4 IN COMPLEX WITH THE INHIBITOR 1-BIPHENYL-4-METHYL-1H-IMIDAZOLE
1578, d5bv5A_, 0.6160, 3.52, 0.144, 391, 375, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1579, d5bv5D_, 0.6053, 3.75, 0.176, 399, 376, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1580, d5bv5C_, 0.5899, 3.63, 0.141, 391, 377, STRUCTURE OF CYP119 WITH T213A AND C317H MUTATIONS
1581, p2vz7A1, 0.5789, 3.65, 0.138, 391, 378, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1582, p5u6tA1, 0.5764, 3.66, 0.188, 391, 377, THE CRYSTAL STRUCTURE OF 4-ETHOXYBENZOATE-BOUND CYP199A4 
1583, p5omuA1, 0.5758, 3.63, 0.152, 386, 374, CRYSTAL STRUCTURE OF AMYCOLATOPSIS CYTOCHROME P450 GCOA IN COMPLEX WITH SYRINGOL 
1584, p4l0eA2, 0.5757, 3.63, 0.141, 391, 377, STRUCTURE OF P450SKY (CYP163B3) A CYTOCHROME P450 FROM SKYLLAMYCIN BIOSYNTHESIS (HEME-COORDINATED EXPRESSION TAG)
1585, p2vz7B1, 0.5743, 3.62, 0.141, 391, 377, CRYSTAL STRUCTURE OF THE YC-17-BOUND PIKC D50N MUTANT
1586, p3be0A1, 0.5729, 3.71, 0.132, 394, 378, THE ROLE OF ASN 242 IN P450CIN
1587, p6bldA1, 0.5717, 3.37, 0.172, 380, 366, MYCOBACTERIUM MARINUM CYTOCHROME P450 CYP268A2 IN COMPLEX WITH PSEUDOIONONE
1588, p5livB1, 0.5667, 3.44, 0.176, 379, 370, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1589, p5mnvD1, 0.5641, 3.68, 0.160, 395, 375, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1590, p5yswA1, 0.5627, 3.72, 0.147, 395, 375, CRYSTAL STRUCTURE ANALYSIS OF RIF16 IN COMPLEX WITH R-L 
1591, p5livC1, 0.5617, 3.74, 0.133, 397, 376, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1592, p6f8cA1, 0.5591, 3.74, 0.133, 397, 376, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1593, p6f8aB1, 0.5585, 3.41, 0.149, 386, 368, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1594, p6f88A1, 0.5578, 2.97, 0.182, 360, 358, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH PROGESTERONE
1595, p4tpoA1, 0.5570, 3.40, 0.145, 385, 365, HIGH-RESOLUTION STRUCTURE OF TXTE WITH BOUND TRYPTOPHAN SUBSTRATE
1596, p5mnvF1, 0.5560, 3.67, 0.162, 393, 376, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1597, p4oqrA1, 0.5555, 3.77, 0.135, 394, 379, STRUCTURE OF A CYP105AS1 MUTANT IN COMPLEX WITH COMPACTIN
1598, p5livA1, 0.5554, 3.49, 0.144, 387, 369, CRYSTAL STRUCTURE OF MYXOBACTERIAL CYP260A1
1599, p2yjnB_, 0.5552, 3.49, 0.144, 387, 369, STRUCTURE OF THE GLYCOSYLTRANSFERASE ERYCIII FROM THE ERYTHROMYCIN BIOSYNTHETIC PATHWAY IN COMPLEX WITH ITS ACTIVATING PARTNER ERYCII
1600, p3be0B1, 0.5543, 3.18, 0.168, 374, 363, THE ROLE OF ASN 242 IN P450CIN
1601, p6f85B1, 0.5540, 3.65, 0.150, 391, 374, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276N) BOUND WITH HISTIDINE
1602, p5ysmA1, 0.5538, 3.65, 0.150, 391, 374, CRYSTAL STRUCTURE ANALYSIS OF RIF16 
1603, p4tpnA1, 0.5538, 3.26, 0.152, 384, 361, HIGH-RESOLUTION STRUCTURE OF TXTE IN THE ABSENCE OF SUBSTRATE
1604, p6f8cB1, 0.5536, 3.26, 0.152, 384, 361, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH PROGESTERONE
1605, p3bdzB1, 0.5530, 3.76, 0.135, 394, 378, THE ROLE OF ASN 242 IN P450CIN
1606, p3nc7B1, 0.5529, 2.75, 0.194, 358, 351, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1607, p6f8aA1, 0.5527, 3.62, 0.147, 387, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450 CYP260A1 (S276I) BOUND WITH HISTIDINE
1608, p4lhtA1, 0.5513, 3.20, 0.166, 364, 361, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1609, p3bdzA1, 0.5513, 3.20, 0.166, 364, 361, THE ROLE OF ASN 242 IN P450CIN
1610, p4fyzA1, 0.5510, 3.45, 0.178, 370, 366, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1611, p5ex9A2, 0.5509, 3.40, 0.143, 383, 363, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; GLYCEROL CRYO
1612, p4l77B1, 0.5509, 3.40, 0.143, 383, 363, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1613, p4l77A1, 0.5509, 3.60, 0.151, 383, 370, P450CIN ACTIVE SITE WATER: IMPLICATIONS FOR SUBSTRATE BINDING AND SOLVENT ACCESSIBILITY
1614, p5mnsE1, 0.5508, 3.55, 0.135, 393, 370, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1615, p3wvsA1, 0.5508, 3.44, 0.144, 384, 369, CRYSTAL STRUCTURE OF CYTOCHROME P450REVI
1616, p4l6gA1, 0.5507, 3.27, 0.171, 373, 362, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1617, p5mnvC1, 0.5506, 3.59, 0.142, 387, 372, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1618, p4lhtB1, 0.5503, 3.45, 0.174, 376, 367, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 3 MM 18- CINEOLE
1619, p4fyzB1, 0.5498, 3.53, 0.143, 384, 371, CRYSTAL STRUCTURE OF NITROSYL CYTOCHROME P450CIN
1620, p4l6gB1, 0.5497, 3.69, 0.134, 392, 374, CRYSTAL STRUCTURE OF P450CIN Y81F MUTANT CRYSTALLIZED IN 7 MM 18- CINEOLE
1621, p4fmxA1, 0.5497, 3.37, 0.147, 371, 361, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1622, p4l36B1, 0.5496, 3.79, 0.144, 381, 369, CRYSTAL STRUCTURE OF THE CYTOCHROME P450 ENZYME TXTE
1623, p4fmxB1, 0.5489, 3.61, 0.140, 388, 372, CRYSTAL STRUCTURE OF SUBSTRATE-BOUND P450CIN
1624, p1t2bB1, 0.5487, 3.82, 0.136, 392, 375, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1625, p1t2bA1, 0.5485, 3.66, 0.137, 389, 373, CRYSTAL STRUCTURE OF CYTOCHROME P450CIN COMPLEXED WITH ITS SUBSTRATE 18-CINEOLE
1626, p5mnsC1, 0.5484, 3.42, 0.176, 380, 364, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1627, p5ex8A2, 0.5481, 3.64, 0.162, 393, 371, STRUCTURE OF P450 STAF FROM GLYCOPEPTIDE ANTIBIOTIC A47934 BIOSYNTHESIS; ETHYLENE GLYCOL CRYO
1628, p5xntA1, 0.5476, 3.34, 0.183, 382, 361, STRUCTURE OF CYP106A2 FROM BACILLUS SP. PAMC 23377
1629, p5mnvE1, 0.5467, 3.36, 0.138, 379, 362, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN PEG
1630, p5mnsD1, 0.5452, 3.27, 0.139, 376, 359, STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF OLEP IN COMPLEX WITH 6DEB IN SODIUM FORMATE
1631, p4fb2A1, 0.5436, 3.10, 0.167, 367, 353, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1632, p4fb2D1, 0.5431, 3.34, 0.139, 377, 360, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1633, p4fb2B1, 0.5427, 3.55, 0.150, 370, 360, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1634, p3nc7A1, 0.5422, 3.55, 0.150, 370, 360, CYP134A1 2-PHENYLIMIDAZOLE BOUND STRUCTURE
1635, p4fb2C1, 0.5409, 3.21, 0.161, 367, 354, CRYSTAL STRUCTURE OF SUBSTRATE-FREE P450CIN
1636, p5xw2A1, 0.5391, 4.09, 0.136, 397, 375, CRYSTAL STRUCTURE OF THE HYDROXYLASE HMTN IN C 1 2 1 CRYSTAL FORM 
1637, p4zgxG4, 0.5088, 4.09, 0.136, 397, 375, STRUCTURE OF ALDOSTERONE SYNTHASE (CYP11B2) IN COMPLEX WITH (+)-(R)-N- (4-(4-CHLORO-3-FLUOROPHENYL)-5678-TETRAHYDROISOQUINOLIN-8-YL) PROPIONAMIDE
